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SUMMARY 
 
The mature central nervous system (CNS) is unable to repair following traumatic brain 
injury (TBI). Intervention is difficult as the pathobiology of the brain following injury is 
a complex sequence of events that needs to be fully elucidated.  Understanding the 
endogenous mechanisms evoked by the damaged brain when attempting repair from 
injury is vital for devising effective therapies to treat brain injury.  The current thesis is 
based upon the hypotheses that ultimately, recovery following trauma will require the 
induction of neurogenesis and either appropriate regeneration or compensatory 
plasticity of pre-existing neural pathways and that the mechanisms underlying 
regeneration of mature axons is fundamentally different to developmental growth.  
 
This thesis investigated the reactive and regenerative alterations associated with the 
neural response to physical injury in the adult mammalian brain.  This thesis studies are 
focused upon the potential for regeneration following injury and how comparable 
regenerating neurons characteristics are to their developmental counterparts. It 
investigated the alterations within the damaged neurons and the surrounding brain area 
which may be indicative of an intrinsic capacity for regeneration including frank 
neuronal replacement following injury, and the role of the neuronal cytoskeleton in 
neuronal regenerative events, as the mechanisms underlying these processes are 
currently poorly understood. 
 
This thesis demonstrated that heterogenous populations of cultured cortical neurons are 
able to survive and regenerate following severe structural injury, suggesting that 
neurons have an intrinsic capacity for regeneration, regardless of the mode of injury. 
Additionally, alteration of the intrinsic cytoskeletal environment, through the knockout 
of the neurofilament light chain protein, decreased the regenerative ability of mature 
neurons, providing further evidence for the intrinsic regulation of regeneration. Results 
from this thesis indicate that the growth cones of regenerative sprouts differ from their 
developmental counterparts in their predominant morphology, their dynamic behaviour 
and their ability to respond to critical growth factors. These differences between the 
regenerating and developing growth cones may account for the inability of regenerative 
  vii 
sprouting axons to make accurate pathway decisions and successfully respond to 
trauma.   
 
The presence of neurogenesis was investigated following structural injury in vitro, 
which indicated no evidence of neurogenesis following injury.  While focal brain injury 
in vivo induced proliferation of neural progenitors, immunohistochemistry confirmed 
that astrocytic but not neuronal, cell proliferation was evoked by focal injury, consistent 
with the in vitro data. However focal injury induced an axonal regenerative response 
into the injury site, which was neuronal cell type specific, and significant remodelling in 
a subpopulation of interneurons away from the injury, demonstrating that the adult 
cortex is capable of significant remodelling following brain injury.   
 
These studies address the central issues examining the potential for neuronal repair and 
appropriate regeneration with an emphasis on developmental versus regenerative 
growth. This thesis provides significant insight into why regenerative attempts are 
limited or aberrant and how responses exhibited by cortical neurons are specific to 
subpopulations. This knowledge will provide the evidence base for new therapeutic 
strategies to improve clinical outcomes for sufferers of TBI. 
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1 INTRODUCTION 
 
Traumatic brain injury (TBI) is a leading cause of death and disability in persons under 
the age of 45 years, in developed nations. (Adams, 1995; Egeler-Peerdeman, 1993; 
Povlishock, 2005; Maas et al., 2008). TBI can affect individuals at any age, and 
encompasses any form of acquired injury to the head that causes central nervous system 
(CNS) damage.  Currently in Australia the most common causes of TBI include 
transport accidents, falls, collisions with objects and water related injuries (The 
Victorian Neurotrauma Initiative, 2009). The incidence of TBI is rising rapidly on a 
global scale, for two main reasons (Maas et al., 2008).  Firstly there is an increasing use 
of motor vehicles in low to middle income countries.  Secondly, for persons over the 
age of 65 accidental falls represent the most common form of injury and 
epidemiological evidence indicates that as the population ages an increase in the 
number of head injuries from falls is also occurring.  TBI equates to a major health and 
socio-economic burden, as head injury often affects individuals in the most productive 
years of their lives (Duff, 2001; Finnie and Blumbergs, 2002).   The current cost burden 
of TBI in Australia alone is estimated to be 8.6 billion dollars (The Victorian 
Neurotrauma Initiative, 2009).  
 
While TBI incidence is rising rapidly on a global scale, there still remains no effective 
treatment. The inability to recover following TBI can be accounted for by the relatively 
limited capacity of the mature CNS to repair and regenerate.  This is in distinct contrast 
to both the peripheral nervous system (PNS) and the developing CNS, which both 
demonstrate remarkable regenerative capacities. Hence the basis for the inability of the 
mature CNS to recapitulate these systems remains a pertinent research question at the 
forefront of neuroscience research.   
 
Moderate to severe head injury often causes overt brain damage resulting in widespread 
neuronal dysfunction. However, even mild brain trauma can elicit a cascade of cellular 
changes that culminates in neuropathology. Additionally, head injury has been 
implicated in the development of neurodegenerative diseases, such as Alzheimer's 
disease, later in life (Smith et al., 1999; Graham et al., 2000; King et al., 2000a; Vickers 
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et al., 2000; Jellinger et al., 2001).  However, there are varying degrees of focal and 
diffuse injury that can occur in TBI, affecting various regions of the brain (reviewed in 
Farkas and Povlishock, 2007), making the pathobiology complex and intervention 
difficult. Due to the array of mechanisms evoked by TBI and individual patient 
differences, the response of the adult brain remains to be fully elucidated.  The sequence 
of events following injury must be fully comprehended before successful therapeutic 
intervention can occur.   Understanding the structural and functional architecture of the 
mammalian brain is key in endeavouring to comprehend the pathobiology of TBI. 
 
1.1 THE MAMMALIAN BRAIN  
 
The mammalian nervous system is a network of nerve cells and fibres that infiltrates 
virtually all areas of the body.   The nervous system is broadly divided into the CNS and 
PNS.  The brain, together with the spinal cord makes up the CNS and can be is divided 
into grey and white matter. Grey matter consists predominantly of neuronal cell bodies 
and dendrites and is highly vascularised, whereas white matter is composed primarily of 
axons, the majority of which are ensheathed by specialised myelinating glial cells.  The 
brain can further be subdivided into the cerebrum, cerebellum and brainstem.  The 
cerebrum is comprised of a pair of cerebral hemispheres, their surface thinly coated by 
the cerebral neocortex.  The cerebral neocortex, which is between just two and four 
millimetres thick, is made up of an estimated 25 billion neurons, and is responsible for 
up to 80% of the function of the human brain (Markram et al., 2004; Nolte, 2009).   
1.1.1 Neurons of the neocortex 
During evolution, higher vertebrates developed a large cerebral cortex, with the most 
recent development being the outer neocortex (meaning new cortex) (Medina and 
Abellan, 2009; Rakic, 2009). The neurons within the neocortex can be generally 
categorised into two groups, pyramidal cells and cortical interneurons, or non-pyramidal 
cells, based primarily on morphology (Hendry, 1989; Molnar et al., 2006). Interactions 
between cortical pyramidal cells and interneurons facilitate highly integrated cortical 
processing.  A notable feature of the neocortex is the sorting of neurons in the outer 
region into six horizontal layers, denoted layer I through VI, from the most superficial 
to deep layer (Silberberg et al., 2005; Nolte, 2009) (Figure 1.1).  Laminae are 
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determined by variations in cell body size and density throughout the cortical depth 
(Parnavelas, 2000) (Figure 1.1). Each layer can be distinguished based on the 
predominant neuronal cell population. Layer I, the molecular layer, is relatively cell 
free.  Layers II and IV, the external and internal granular layers are comprised of 
relatively small locally projecting interneurons, whereas layers III and V contain 
characteristic large cortical pyramidal cells and are thus designated the external and 
internal pyramidal layers, respectively. In addition to the laminar organisation, the 
neocortex also has a distinct columnar organisation with several structures, including 
the apical dendrites of pyramidal cells, cortical afferents, axons of some intra-cortical 
cells and the cell bodies of cortical neurons, arranged horizontally and perpendicular to 
the cortical surface.  
 
Synaptic transmission within the neocortex follows a distinct and highly complex 
pattern, with integration both within and between the cortical laminae (reviewed by 
Silberberg et al., 2005).  Briefly, thalamic input primarily enters layer IV and is passed 
onto layer III pyramidal cells that, in turn, project to layer II.   Layers II and III also 
receive input from association brain regions and provide descending input to layer V 
pyramidal cells.  Depending on their type, layer V pyramidal neurons either project to 
subcortical regions, comprising the major source of neocortical output, or to the 
contralateral hemisphere.  Layer V pyramidal cells also project to layer VI, forming 
both cortico-cortical interconnections and corticothalamic feedback circuits.  The 
majority of neocortical pyramidal cells also project their dendrites into layer I, forming 
an additional level of cortical processing and integration.  
 
1.1.1.1 Pyramidal neurons 
Pyramidal neurons are the primary glutamatergic excitatory cells of the neocortex 
(Elston et al., 2001).  Pyramidal neurons have large cell bodies ranging from 10-50 
micron in diameter (Lynch, 2006), extensive dendritic arborisations that have 
specialised synaptic protrusions termed dendritic spines and one long projecting axon. 
The pyramidal-shaped soma elaborates a prominent apical dendrite that extends up 
towards the pial surface.  Basal dendrites extend horizontally from the base of the soma.  
The axon of pyramidal cells, which is usually myelinated, generally extends from the 
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base of the soma, opposite to the apical dendrite, but may instead arise from a basal 
dendrite (Feldman, 1984). Pyramidal neurons are primarily contained within layers II to 
VI and comprise approximately 70-80% of all neocortical neurons (Peters and Jones, 
1984; Markram et al., 2004; Voelker et al., 2004; Silberberg et al., 2005).  The 
pyramidal cell layers contain predominantly neurons that project long axons to other 
regions of the CNS.  
 
1.1.1.2 Interneurons 
Interneurons incorporate a sub-population of cortical neurons with a vast array of 
morphological features and molecular identities (Parnavelas, 2000). Knowledge on the 
various subtypes of gamma -aminobutyric acid-ergic (GABAergic) interneurons have 
been predominately derived from immunohistochemical studies looking at the 
localisation of the three calcium binding proteins (Xu et al., 2010); calbindin (Hof and 
Morrison, 1991; Seress et al., 1993; Leuba et al., 1998), calretinin (Hof et al., 1993; 
Fonseca and Soriano, 1995; del Rio and DeFelipe, 1997) and parvalbumin (Aria et al., 
1987; Hof et al., 1991; Hof and Nimchinsky, 1992; Hof et al., 1999).  The three types of 
calcium binding proteins are found within mutually exclusive populations of 
interneurons.  Calbindin positive proteins are found mainly in granule cells of the 
dentate gyrus (Seress et al., 1993), interneurons in cortical layers II/III, and to a lesser 
extent in layers V/VI (Leuba et al., 1998).  The interneuron population positive for 
parvalbumin is found in cortical layers II and III and the molecular layer of the dentate 
gyrus and throughout the subiculum (Seress et al., 1993; Leuba et al., 1998).  Calretinin 
positive interneurons reside predominately in the superficial portions of cortical layers 
II and IV (Leuba, 1998).  Other subpopulations of neurons immunopositive for calcium 
binding proteins occur in subcortical regions as well as the cingulate cortex and 
amygdala (Hof and Nimchinsky, 1992; Hof et al., 1999).  Interneurons are 
predominantly inhibitory (mostly GABA inhibitory) in function and play a vital role in 
modulating cortical output (Segal and Barker, 1984; Markram et al., 2004; Otsuka and 
Kawaguchi, 2009; Xu and Callaway, 2009).   Interneurons’ axons essentially do not 
leave the immediate vicinity of the soma, and therefore modulate the intrinsic activity of 
the directly surrounding pyramidal cells (Kawaguchi and Kubota, 1997; Otsuka and 
Kawaguchi, 2009; Xu and Callaway, 2009).  These neurons are morphologically 
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identified by the absence of a prominent apical dendrite and the presence of few, if any, 
dendritic spines; although specific sub-types of interneurons may have dendritic spines 
equivalent to pyramidal neurons (Fairen et al., 1984; Markram et al., 2004).  Thus, 
interneurons have less extensive dendritic arborisations, a short, locally projecting axon 
and a small cell body (Hof et al., 1999; Markram et al., 2004; Nolte, 2009).  
 
1.2 DEVELOPMENT OF THE MAMMALIAN BRAIN 
 
The complexity and relative large size of the human brain elicits the mental capabilities 
that distinguish humans from all other species. During development a relatively simple 
neural tube is transformed into this intrinsically complex organ through a stringently 
controlled pattern of neuronal proliferation, migration and maturation (Noctor et al., 
2004; Corbin et al., 2008).  The process of development of the cortex, corticogenesis, 
has been widely described (see reviews by Frisén et al., 1998; Parnavelas, 2000; 
Nadarajah and Parnavelas, 2002; Honda et al., 2003; Kubo and Nakajima, 2003; 
Marshall et al., 2003).  Neurons destined to form the neocortex are generated at the 
ventricular lining and periventricular zones.  More specifically, cortical pyramidal 
neurons are generated in the germinal ventricular zones of the dorsal telencephalon, 
whereas sources of cortical interneurons include the lateral ganglionic eminence and 
medial ganglionic eminence of the ventral telencephalon (Parnevelas, 2000; Kreigstein 
and Noctor, 2004; Wonder and Anderson, 2006). The neocortex develops in two 
distinct stages (Figure 1.2).  Firstly post-mitotic neurons migrate toward the margin of 
the cerebral wall to form the primordial plexiform layer, or preplate.  New born neurons 
migrate into the preplate and as they accumulate, form a new series of layers called the 
cortical plate, which thereby splits the preplate into the superficial marginal zone (layer 
I) and a deeper layer, the subplate (layers II-VI); the second stage of development.  The 
later born post-mitotic neurons that form layers II-VI of the cortical plate are arranged 
in an ‘inside-out’ sequence, where new cells migrate through the existing cells before 
stopping at the top of the plate (reviewed by Parnevalas, 2000; Kreigstein and Noctor, 
2004).  The subplate and ventricular zone are separated by the intermediate zone, which 
will eventually contain the axons of the cortex (Bielas and Gleeson, 2003).   
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There are two main modes by which new neurons migrate, known as radial and 
tangential migration (Naradajah et al., 2001).  Neurons of the cerebral cortex, 
specifically those destined to become pyramidal neurons, take on a mode of radial 
migration, moving in a direction perpendicular the pial surface, guided by radial glia 
(Huang, 2009).  Interneuronal precursors of the cerebral cortex, on the other hand, 
undergo tangential migration, moving from the ganglionic eminence in a direction 
parallel to the pial surface (Huang, 2009).  However not all precursor neurons are able 
to reach their appropriate destination by radial migration and tangential migration alone. 
A third mode of migration, termed ‘multipolar migration’ also exists (Tabata and 
Nakajima, 2003) characterised by net radial migration, interspersed with episodes of 
tangential migration. After completing migration a neuron enters a phase of growth, the 
first stage of which involves developing multiple neurites (Dotti et al., 1988; Deitch and 
Banker, 1993).  Following initiation, one neurite will polarise and grow more rapidly 
than the other neurites to form the axon (Dottie et al., 1988) while the other shorter, 
highly branched processes become dendrites.  Axons then extend through a carefully 
selected pathway to find their final, specific target where they form synapses.  The 
highly precise neuronal network of the brain is established through temporal and spatial 
regulation of guidance molecules that direct growth of the axons along specific 
pathways (Dickson et al., 2002; Osterfield et al., 2003). 
 
1.2.1 Neuron outgrowth and the cytoskeleton 
The extensive neuronal network of the brain is developed by the highly accurate 
pathway selection of axons. Growth cones are transient structure present on the tips of 
elongating axons that enable this stringent pathway selection (Figure 1.3).  The growth 
cone is present for a finite time during development, between the commencement of 
neuronal differentiation and the phase of synaptogenesis. Fundamentally, growth cones 
translate extracellular guidance cues into a mode of either extension or retraction, 
depending on whether the cue is attractive or repulsive.  Upon reaching the desired 
target the growth cone immobilises, remodels and forms a synapse. 
 
Growth cones have both sensory and motor capabilities, which enables the integration 
of environmental cues to be translated into path finding behaviour, such as outgrowth, 
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retraction, stalling, turning and fasciculation (for review see Tessier-Lavigne and 
Goodman, 1996; McFarlane, 2000; Suter and Forscher, 2000; Gordon-Weeks, 2004) 
(Figure 1.3). Growth cones undergo dramatic shape changes ranging from large fan like 
shapes to a more stream like structure (Kalil, 1996).  Morphological analysis of growth 
cones in different regions of developing central and peripheral pathways in a variety of 
species has demonstrated that the change in morphology is related to the environmental 
cues (Halloran and Kalil, 1994; Kalil, 1996; Skaliora et al., 2000).  When growth cones 
track along straight trajectories, such as the internal capsule, they exhibit simple 
streamline forms (Skaliora et al., 2000).  The internal capsule represents a compact 
curved sheath of cortical projection axons and as such the axons grow fast in direct 
trajectories with minimal pausing and exploring of their surrounding.  When 
encountering a decision region, such as the ventral intermediate zone for the cortical 
projection axons, growth cones undergo dynamic alterations in morphology becoming 
large and considerably more complex in shape.  When reaching a decision region such 
as the ventral intermediate zone, growth cone motility slows down with extensive 
exploration of the environment and pausing, which can last up to several hours 
(Skaliora et al., 2000).   
  
Environmental guidance cues are either attractive cues that the growth cone will turn 
toward, or repulsive guidance cues that cause a collapse in the growth cone.  It is 
important to note however, that growth cone turning, and advances, are actually 
regulated independently, except when the guidance cue is particularly strong (Sanford et 
al., 2008). Guidance cues in the growth cone environment can be either anchored in the 
extracellular matrix, on a cell membrane or presented as a concentration gradient that 
diffuses from an intermediate or final target source (Chilton, 2006). Growth cones are 
responsible for translating extracellular guidance cues, which dictate trajectory into 
cytoskeletal rearrangements, which establishes axonal morphology and route taken 
(Tanaka and Sabry, 1995; Nakamura et al., 2000; Pak et al., 2008; Hung et al., 2010). 
Guidance molecules such as neurotrophins, semaphorins, ephrins, netrins and slits are in 
abundance within the developing brain (Dickson, 2002; Sanchez-Camacho and 
Bovolenta, 2009; Hung et al., 2010; Yukawa et al., 2010).  Neurotrophins act as 
attractants and the semaphorins, ephrins and slits act predominately as a repellent, 
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however they can also be attractive in some contexts.  Netrins can act as either an 
attractant or repellent, depending on the context (Dickson, 2002).  Binding to and 
activation of receptors for these guidance molecules in the growth cone cytoplasm 
triggers intracellular signalling pathways directed predominately at the growth cone 
cytoskeleton (Gallo and Letourneau, 2004; Kalil and Dent, 2005; Zhou and Schnider, 
2006).  However, it is important to note that the intracellular environment of the growth 
cone also plays a role in the response to guidance molecules.  Specifically cyclic 
nucleotide levels, the intracellular calcium concentration and membrane potential all 
moderate the response of the growth cone to a certain guidance cue (Mcfarlane, 2000; 
Wen et al., 2004).  
 
Growth cones are highly structured due to the diversity and organisation of their 
cytoskeletal components.  Within the axon and the growth cone, the cytoskeleton is 
classified into three components, the microtubules, microfilaments and neurofilaments 
(Figure 1.4).  The central zone of the growth cone, including the termination of the 
neurite shaft, consists predominantly of bundles of microtubules (reviewed in 
Gungabissoon and Bamburg, 2003; Gordon-Weeks, 2004).  The central zone is also rich 
in membranous organelles required for membrane elaboration (Figure 1.3).  The 
peripheral area, specifically the lamellipodia and filopodia, are dominated by 
microfilaments, in the form of filamentous actin (F-actin) (Figure 1.3). While 
microtubules reside predominately in the central zone and F-actin in the peripheral 
zone, there is extensive overlap of these cytoskeletal components between the two 
regions, within the transitional zone.  Within growth cones, microtubules and actin are 
the cytoskeletal components responsible for movement and are the ultimate targets of 
directional signalling. 
 
1.2.1.1 Microtubules within the developing axon and growth cone. 
 Microtubules are long hollow structures comprised of protofilament aggregates of 
tubulin.  Two subunits of tubulin, α and β tubulin, polymerise to form these 
protofilaments.  Thirteen protofilaments then aggregate together to form the 
microfilament. Within the axon, microtubules participate in the active process of axonal 
transport. This allows fast transport of macromolecules and organelles to the distal area 
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of axons and to the growth cone.  The role of microtubules in axon transport has been 
compared to a railroad track, on which two microtubule associated ATPases serve as 
“motors” (Waterman-Storer, 1997; Pfister, 2000; Hollenbeck and Saxton, 2005). Within 
the axonal shaft, microtubules form a dense parallel array that upon entering the growth 
cone splays apart. Studies over the past decade convincingly indicate that dynamic 
microtubules within the growth cone play a crucial role in growth cone steering (Buck 
and Zheng, 2002). 
 
Within the growth cone microtubules reside principally in the central domain of the 
growth cones, however are present at times in both the transitional and peripheral zone.  
Microtubules within the central domain are frequently in a fan like splayed out 
orientation, however in slow growing growth cones and growth cones that are pausing, 
they become bundled and form loops (Sabry et al., 1991; Tanaka and Kirschner, 1991; 
Dent and Kalil, 2001).  The majority of microtubules enter the central domain of the 
growth cone through the terminal end of the neurite shaft.  The microtubules contained 
within the central zone are in a state of dynamic instability, which means they are 
constantly undergoing rapid periods of growth and shrinkage (Buck and Zheng, 2002, 
Gordon-Weeks, 2004; Chilton, 2006; Lee and Suter, 2008; Lowery and Vactor, 2009).  
The dynamic growth of microtubules that results from this dynamic instability allows 
the microtubules to respond to the growth cones’ intracellular environment, namely F-
actin.  The dynamic growth is a result of the process of end polymerisation of 
heterodimer subunits of tubulin.  Tubulin heterodimers are intrinsically polar polymers 
that associate in a head to tail formation within each protofilament (Gordon-Weeks, 
2004).  The positively charged (plus) end of the microtubules is orientated to the distal 
area of the growth cone and the negatively charged (minus) ends are orientated 
proximally toward the axon shaft.  Both the plus and minus end have potential for 
growth, however the plus ends have a far greater capacity and growth occurs at a more 
rapid rate than the minus ends.  Orientation of the fast growing plus ends of the 
microtubules toward the distal part of the growth cone allows for the extension of the 
growth cone along a trajectory. Microtubules are in a constant state of dynamic 
instability, alternating between slow growth at the minus end and rapid growth at the 
plus end.  The transition from slow growth at the proximally orientated minus end to 
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rapid growth at the distally orientated plus can result in complete depolymerisation 
(termed a catastrophe) and retraction of the microtubule, unless rescued to another 
transition of slow growth.  This dynamic instability is likely to be structurally due to a 
loss of a structural cap (GDP β-tubulin) at the end of the microtubule (Gordon-Weeks, 
2004). Microtubules dynamics is regulated by two families of proteins, microtubule 
associated proteins (MAPs) and plus end tracking proteins (TIPs).  MAPS regulate 
dynamic instability by increasing the rate of rescue and decreasing the rate of 
catastrophes (Pryer et al., 1992).  TIPs are located on the plus end of growing 
microtubules and are involved in facilitating the microtubule and F-actin interaction 
(Geraldo et al., 2008). Tyrosination of microtubules is also required for successful 
microtubule and F-actin interactions, and the knock out of ligases responsible for 
tyrosination leads to a decrease in ability to path find (Marcos et al., 2009). 
 
The formation of microtubules and promotion of the bundle formation (stabilisation) 
and conversely the dissolution of the bundles and aggregate formation (destabilisation) 
of microtubules has also been shown to be important in the turning of growth cones.  
Local stabilisation and destabilisation of microtubules via the drugs taxol and nocodazol 
respectively has been shown to alter growth in vitro (Buck and Zheng, 2002; 
Chuckowree and Vickers, 2003).  When microtubules are locally stabilised the growth 
cone turns toward the site of stabilisation and reciprocally local destabilisation results in 
the turning away from the site of destabilisation.  The actin cytoskeleton actively 
participates in microtubule initiated growth cone turning (Buck and Zheng, 2002) with 
local microtubule stabilisation and growth within the growth cone being dependent 
upon the F-actin interaction. Microtubules growing toward the front of the growth cone 
transverse the transitional zone and get into the peripheral domain.  This allows 
interaction between the microtubules and F-actin within the peripheral zone, 
microtubules preferentially interacting with the filopodial F-actin bundles (Lee and 
Suter, 2008; Geraldo et al., 2008; Geraldo and Gordon-Weeks, 2009; Lowery and 
Vactor, 2009).  
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1.2.1.2 Microfilaments within the developing axon and growth cone 
The second principal cytoskeletal component within developing axons and growth 
cones is the microfilaments, specifically F-actin.  Monomeric globular, G-actin subunits 
polymerise to form filamentous, F-actin.  Morphology of the peripheral domain is 
largely determined by the F-actin and its organisation into filopodia and lamellipodia. 
Filopodia are narrow, cylindrical and highly motile extensions of the growth cone.  
They interact with the environment, having the capacity to extend tens of microns from 
the growth cone.  F-actin forms rod-like parallel bundles within the filopodium.  
Lamellipodia, the veil like membranous extensions situated between the filopodia, 
contain a meshwork of connected and branched F-actin. The predominance of 
lamellipodia or filopodia correlates with the translocation rate of the growth cone 
(Argiro et al., 1984; reviewed in Pak et al., 2008).  These dynamic structures are 
constantly extending and retracting, enabling the growth cone to explore the 
extracellular environment for potential guidance cues.  
 
The guidance and growth of growth cones is determined by the interactions of filopodia 
and the F-actin, through transmembrane receptors, with the extrinsic environment.  The 
F-actin present within in the filopodia also undergoes dynamic assembly, which is the 
precursor for membrane protrusion and extension (Forscher and Smith, 1988).  
Polymerised F-actin within the peripheral domain is under constant retrograde transport, 
powered by myosin motors, towards the central domain of the growth cone (for reviews 
see Suter and Forscher, 2000; Gallo and Letourneau, 2004).  During this retrograde 
transport, F-actin is dynamic, undergoing filamentous turnover; near approach of the 
central domain, filaments undergo depolymerisation and actin subunits are recycled for 
future polymerisation to F-actin.   The surface of the filopodium is rich in 
transmembrane proteins which act as receptors for cell adhesion molecules.  The 
adhesion of the filopodia to a suitable substrate activates transmembrane signalling 
causing F-actin polymerisation, and results in elongation of the filopodium. Outward 
movement of an axon is inversely proportional to retrograde F-actin flow (Hely and 
Willshaw, 1998).  The slower the retrograde flow of F-actin toward the central zone of 
the growth cone, the faster the microtubule invasion into the target area. 
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Axonal outgrowth is achieved by an interaction between the actin and microtubules 
cytoskeleton, which creates stretch of the axon (Lamoureux et al., 2010).  A growth 
cone in a straight trajectory contains actin bundles uniformly distributed throughout the 
lamellipodia, however a concentration of the actin meshwork occurs at the leading edge.  
Assembly of F-actin occurs at this leading edge and at the tips of the filopodium.  The 
retrograde F-actin flow from this area is at a diminished rate compared to the 
polymerisation rate of the microtubules within the central domain.  This allows the 
growing microtubules to extend into the peripheral domain where there is decreased 
retrograde F-actin flow (Buck and Zheng, 2002).  Contact with an actin bundle within 
the peripheral domain induces the microtubule to advance in a linear path along the 
bundles toward the leading edge; microtubules that do not come in contact with actin 
are swept back toward the central domain (for review see Zhou and Cohan, 2004).  The 
microtubule and F-actin interaction results in outgrowth of the growth cone in the 
direction of the leading edge.  The majority of known guidance molecules affect 
direction of growth through the rapid reorganisation of the actin/microtubule 
cytoskeleton in the peripheral zone (Cohen-Corey and Fraser, 1995; Gallo and 
Letourneau; 2003; Hou et al., 2008; Geraldo and Gordon-Weeks, 2009; Hall and Lalli, 
2010), further highlighting the importance of the actin/microtubules reorganisations. 
 
1.2.1.3 Intermediate filaments within the developing axon and growth cone 
The intermediate filaments are integral to the structural morphology of the neuron and 
axon.  Neurofilaments provide tensile strength as well as stabilising neuronal structure 
(Hamberger et al., 2003). They are involved in controlling axonal calibre, an important 
factor in the speed of conductance down the axon. The neuronal intermediate filament 
protein family is made up of neurofilament light chain (NF-L), middle chain (NF-M) 
and heavy chain (NF-H), α-internexin and peripherin (Lee et al., 1993; Lee and 
Cleveland, 1996). Neurofilament triplet proteins, with α-internexin comprise the 
neuronal intermediate filament family of type IV intermediate filament proteins 
(Lariviere and Julien, 2004) (Figure 1.5A).  During development, two more 
intermediate filaments vimentin and nestin are also present within CNS neurons (Gates 
et al., 1995; Arnold and Trojanowski, 1996).  These proteins share a common structural 
organisation comprising a central α helical rod domain flanked by amino terminal head 
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and carboxy-terminal tail domains (Figure 1.5A). Together NF-L, NF-M and NF-H 
copolymerise to form neurofilaments.  The expression of intermediate filaments varies 
throughout development and facilitates the transition of a developing neuron, from a 
highly plastic mitotic cell, to a post-mitotic highly polarised structure with distinct 
morphological features (Nixon and Sihag, 1991; Nixon and Shea, 1992). Specifically, 
the first intermediate protein to be expressed is vimentin, in undifferentiated cells 
(Bignami et al., 1982; Cochard and Pauin, 1984). Later in development as the 
undifferentiated cells form neuroblasts the expression of nestin, α-internexin and 
peripherin is initiated (Porttier et al., 1983; Parysek and Goldman, 1987; Kaplan et al., 
1990; Lendahl et al., 1990).  This expression persists until neuron differentiation, which 
triggers the expression of the neurofilament proteins (Shaw and Weber, 1982; Carden et 
al., 1987; Nixon and Shea, 1992); the presence of neurofilaments are indicators 
associated with mature neurons and thus increased expression of these proteins is 
concomitant with a decrease in the other development-associated intermediate filaments 
(Lariviere and Julien, 2004).  NF-L expression is detected initially, at the beginning of 
neural differentiation and can regularly overlap with α-internexin and peripherin 
expression (Willard and Simon, 1983; Carden et al., 1897).  Subsequently NF-M 
expression is correlated with neurite formation and NF-H expression occurs later in 
neuronal differentiation, during the postnatal period (reviewed in Larivere and Julien, 
2004).  The expression of intermediate filaments is not conserved in neurons and 
subpopulations of pyramidal neurons have been shown to express different intermediate 
filaments (Masliah et al., 1993; Dickson et al., 2000; 2005). Neurofilament expression 
is dramatically elevated after synapse formation, axonal diameter expansion and 
myelination (Nixon and Shea, 1992; Lee and Cleveland, 1996).  The distribution of 
neurofilaments in mature neurons is not uniform; neurofilaments are generally more 
abundant in axons than dendrites and are more heavily phosphorylated in the axonal 
than somato-dendritic cellular compartment (Shaw and Weber, 1991).  
 
The phosphorylation state of neurofilaments, and their interaction with the MAPs, 
governs the state of axonal integrity. The highly phosphorylated neurofilament present 
in axons allows the formation of side arms (reviewed in Lariviere and Julien, 2004) 
(Figure 1.5B).  Side arms form a cross bridge with microtubules, other neurofilaments 
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and cortical F-actin, contributing to the structural characteristics of the axonal 
cytoskeleton.  Not surprisingly, neurofilaments are particularly abundant in neurons 
with large diameter axons such as those of motor neurons where fast impulse 
conduction velocities are crucial for appropriate functioning.  Additionally they are also 
involved in the regulation of axonal transport and the anchoring of cellular constituents 
(for review see Lariviere and Julien, 2004). However neurofilaments rarely enter the 
developmental growth cone, being contained to the axon and the axonal shaft.  
Furthermore, the presence of neurofilaments within the growth cone may be indicative 
of inappropriate growth cone function (King et al., 2001; Zhang et al., 2005). 
 
Within the mature brain neurofilaments provide the structural framework required by 
neurons to maintain their polarised morphology.  This axonal and dendritic polarisation 
is vital in creating the intricate network of fibres within the brain that transfers 
information in the form of electrical signals.  The electrical connections of the brain is 
not maintained by the internal scaffolding alone, the surrounding glial cells within the 
brain play a vital role in the support and maintenance of neuronal function. 
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1.3 GLIAL CELLS OF THE MAMMALIAN BRAIN 
 
Glial cells are the non-neuronal cells of the nervous systems and within the CNS 
include astrocytes, microglia, oligodendrocytes and ependymal cells (Figure 1.6).  Glial 
cells are closely associated with neurons within the CNS (Figure 1.6) and have 
historically been understated in their roles within the brain.  It was originally believed 
that glial cells played only a role in providing the scaffolding for neurons.  However, 
many studies over the past decades have highlighted that glial cells are involved in a 
wide variety of functions within the brain and play many vital roles (Araque and 
Navarrete, 2010). Specifically, under normal conditions glial cells perform a variety of 
structural, nutritive and physiological functions including structurally supporting 
neurons, suppling vital nutrients and gases, insulating axons and facilitating action 
potentials, and destroying pathogens and the removal of debris (reviewed in Todd et al., 
2006; Amor et al., 2010; Araque and Navarrete, 2010; Perea and Araque, 2010).  
Additionally during development, glial cells provided scaffold and guidance support to 
developing neurons.  
 
1.3.1 Astrocytes 
Astrocytes are the most common cell type in the CNS and there are approximately 10 
times more astrocytes than neurons in the human brain (Bignami, 1982).  Astrocytes are 
stellate-shaped cells with a highly ramified cytoskeleton and small cell body (three-five 
microns). There are two major populations of astrocytes; the protoplasmic astrocytes 
reside in the grey matter and the fibrous astrocytes reside in the white matter (Nolte, 
2009).  However, both types have essentially the same features, and both can be 
histologically identified by the expression of the astrocyte specific marker, glial 
fibrillary acidic protein (GFAP). Unlike neurons that interconnect through synapses, 
astrocytes are interconnected and communicate through gap junctions between cells. 
Astrocytes play a crucial role in structurally supporting neurons and the formation of 
the blood brain barrier.  Astrocytes also play crucial roles in maintaining local ion 
concentrations and pH homeostasis in the extracellular space, assist neurons in the 
turnover of nutrients and metabolic by-products and neurotransmitters (glutamate), 
regulate synapse development and modulate synaptic strength (for reviews see 
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Nedergaard et al 2003; Haydon, 2001 and Seth and Koul, 2008).  One such example of 
their other functions is glycogen metabolism.  Astrocytes are the main source of 
glycogen in the CNS, which serves as an endogenous source of energy to both 
astrocytes themselves and the surrounding neurons (reviewed in Benarroch, 2010).  
Hence astrocytes are constantly interacting with neurons and contact is highly dynamic 
(Hirrlinger et al., 2004; Haber et al., 2006) and activity dependent (Genoud et al., 2006).  
One single astrocyte domain has the potential to contact hundreds of dendrites and up to 
10000 synapses (Halassa et al., 2007; reviewed in Fellin, 2009). 
 
1.3.2 Oligodendrocytes 
Oligodendrocytes, another predominant type of glia in the CNS, have small cell bodies 
(one-three microns) and an elaborate array of branched projections (Nolte, 2009).  
Oligodendrocytes reside predominately in the white matter, which is rich in axons.   The 
primary function of oligodendrocytes is to insulate axons, control axonal diameter and 
facilitate saltatory conduction with a specialised membrane sheath called myelin. 
Myelin wraps around axons, mainly large calibre pyramidal axons (Bradl and 
Lassmann, 2010); in fact they specifically select axons with a diameter of above 0.2 
microns (Simons and Trajkovic, 2006).  Myelin acts as an insulator to electrical signals 
travelling down the axon, thus increasing the speed of conductance. An individual 
oligodendrocyte can myelinate numerous axons, however each axon is myelinated by a 
single oligodendrocyte.  The myelin sheath is not continuous down a single axon; 
between the myelin sheaths are gaps where the axon is exposed and action potential is 
regenerated in a saltatory manner, with these gaps termed nodes of Ranvier (Thaxton 
and Baht, 2010). These regions are dense in sodium voltage-gated ion channels 
(Waxman and Ritchie, 1993) and have an accumulation of axonal organelles (reviewed 
in Edgar and Nave, 2009).  While their main purpose is myelination of axons, 
oligodendrocytes also play another supportive role for CNS neurons that involves the 
production of growth factors and guidance cues.  Specifically they provide trophic 
support of the soma through the secretion of neurotrophins (reviewed in Tigue and 
Tripathi, 2008; Bradl and Lassmann, 2010).   Furthermore, during development 
oligodendrocytes secrete inhibitory extracellular guidance cues that act to confine 
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developing neurites to correct trajectories (Nagashima et al., 1999; Goldberg and 
Barres, 2000), aiding in path finding. 
 
1.3.3 Microglia 
Resident microglia, which are the CNS-resident macrophages, when resting are smaller 
than astrocytes and oligodendrocytes and constitute approximately 5-12 percent of the 
total glial population (Nolte, 2009). Microglial cells are the primary immune cell type 
of the otherwise immune privileged CNS and are present throughout the CNS, however, 
generally the grey matter contains more microglia than the white matter (Rivest, 2009). 
Following entry into the CNS during embryonic, fetal and postnatal stages, microglial 
precursors undergo a defined sequence of developmental events involving dispersion 
and differentiation to generate a brain-resident population of macrophages (Cuadros and 
Navascués, 1998; Navascués et al., 2000).  Once residing within the CNS, microglia 
develop a ramified morphology with active processes (Barron, 1995; Navascués et al., 
2000). During brain development, microglia function as phagocytic cells that remodel 
the developing tissue (Barron, 1995). In the adult brain they participate in dynamic 
immune-surveillance functions (Nimmerjahn et al., 2005) activating in response to 
infectious organisms, brain injury and chronic disease (for a recent review see Rivest 
2009). 
 
Microglia, in conjunction with astrocytes and oligodendrocytes work closely together 
with neurons to achieve the highly integrated processing that occurs in the CNS.  The 
complex interactions between all cell types allows fast and efficient transfer of electrical 
signals around the brain and to and from the brain stem and spinal cord.  The 
complexity and specificity of connections renders the cells of the brain vulnerable to 
insults such as TBI. 
 
 
1.4 THE RESPONSE OF THE MAMMALIAN BRAIN TO TBI 
 
TBI causes trauma to a range of cells in and around the injury area.  Accumulating 
evidence now indicates that rather than respond passively to brain injury, the brain 
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evokes an adaptive sequence of alterations directed at healing and remodelling 
(Maxwell et al., 1990; King et al., 2001; Oehmichen, 2004). Astrocytes, 
microglia/macrophages, oligodendrocytes, neurons, neural progenitor cells and brain 
vasculature all undergo adaptive alterations in response to a traumatic insult (Maxwell 
et al., 1990; Christman et al., 1997; Deller and Frotscher, 1997; Vickers et al., 2000; 
King et al., 2001; Finnie and Blumbergs, 2002; Tonchev et al., 2003; Lee et al., 2003; 
Lie et al., 2004; Emsley et al., 2005).  Furthermore, inflammation is a common 
pathological consequence following injury, which disrupts the blood brain barrier 
(Lossinsky et al., 2004; Habgood et al., 2007) allowing cells from the blood stream to 
come in contact with the injury site. This post-traumatic inflammatory response can be 
characterised by glial activation, leukocyte recruitment, and upregulation and secretion 
of mediators such as cytokines and chemokines (reviewed in Ziebell et al., 2010). 
Understanding the coordinated response of the different cells types to injury is 
imperative in fully comprehending the brain’s response to TBI.  
 
The principal mechanisms causing brain injury can be divided into two broad 
categories: contact and non-contact injury (Finnie and Blumbergs, 2000).  Contact 
injuries results from direct impact and may be penetrative, such as a gunshot wound, or 
non-penetrative, such as a direct strike to the head.  Contact injuries additionally often 
generate local effects such as scalp laceration, skull fracture and extradural haematoma.  
Non-contact injuries are non-penetrative and result from dynamic inertial forces that 
rapidly rotate the brain within the skull, such as a rapid de-acceleration in a car accident.  
Both contact and non-contact injuries are capable of generating focal, multifocal and 
diffuse lesions (Povlishock and Katz, 2005).  Focal lesions incorporate focal cortical 
contusion as well as both deep and extracerebral haemorrhage.  In addition, shock 
waves generated at the site of impact may travel through the skull and brain, possibly 
causing contusions and intracerebral haemorrhage remote from the site of impact.  
Differential movement between the brain and the cranium may also generate diffuse 
injuries in which pressure gradients within the brain tissue create shear, tensile and 
compressive forces (Adams, 1995; Steward et al, 1999).  Due to the combined 
influences of injury type and severity, and factors intrinsic to the patient, brain injury 
initiates an array of pathophysiological mechanisms.  
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The principal mechanisms evoked by TBI are classified as either primary or secondary 
damage. Primary damage following brain injury involves any neural disruption that is a 
direct result of the injury, occurring at the time of injury (Maxwell et al., 1997; Graham 
et al., 2000; Finnie and Blumbergs, 2002).  Such damage may involve neuronal and 
glial cell populations as well as brain vasculature, inflammatory, neurochemical and 
metabolic alterations (Finnie and Blumbergs, 2002; Werner and Engelhard, 2007).  In 
this regard, cells and blood vessels may be sheared, torn or stretched at the time of 
injury casing haemorrhage, axonal damage and immediate cell death (Finnie and 
Blumbergs, 2002). Primary injury initiates a progressive wave of secondary injury, 
exacerbating the original injury.  
 
Secondary injury develops latently and can occur over a period of hours, days and 
weeks following the primary injury evoked by the initial trauma (Graham et al., 2000).  
Secondary perturbations include ischemia, excitotoxicity, spreading neurotoxicity due 
to disruption of ionic homeostasis and tissue destruction, energy failure, cerebral 
swelling, initiation of necrotic and apoptotic neuronal death cascades, neuronal 
degeneration due to downstream deafferentation/denervation and inflammation, which 
may in turn compound other responses and add to the spread of neurotoxic effects 
(Maxwell et al., 1997; Finnie and Blumbergs, 2002; Bayir et al., 2003; Chen et al., 
2003a; Liou et al., 2003; Povlishock and Katz, 2005).  Thus the delayed alterations 
following injury compounds the original effect of the primary injury resulting in further 
anatomical and functional deficits.  For injury resulting from the direct insult there is 
limited scope for therapeutic intervention following injury. However the delayed 
clinical manifestations of secondary injury such as ischemia and hypertension are more 
malleable to therapeutic interventions. 
 
1.4.1 The neuronal response to TBI 
Studies from both experimental models of neuronal injury and cases of human TBI 
indicate that neurons undergo a stereotypical sequence of reactive and potentially 
regenerative alterations following injury (Maxwell et al., 1997).  Neuronal alterations 
following injury are either a rapid result of primary injuries or a downstream effect of 
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secondary injury, with the time course ranging from hours to weeks. Changes in the 
soma may culminate in cell atrophy, death or survival (Kelly, 1981; Tuszynski and 
Gage, 1995; Martin, 2001; Singleton et al., 2002; Selzer, 2003). Due to their relatively 
long-distance projection and fragility, axons are particularly vulnerable to TBI, with 
axonal injury a common occurrence, even in seemingly mild cases of injury (Gennarelli, 
1996; Maxwell et al., 1997; Smith et al, 2000).  
 
1.4.1.1 Axonal injury 
Axonal injury, either as a result of primary injury or a secondary effect, results in the 
formation of two axonal segments.  Primary injury involves the direct physical 
disconnection of the axon into two separate segments. Disconnection of the axon as a 
result of secondary injury can be described as a nine-step process (Maxwell et al., 
1997).  Firstly perturbation of the axolemma occurs; secondly axon mitochondria swell; 
third involves the development of nodal blebs and decreased internode diameter; fourth 
is the loss of microtubules and changes in neurofilaments; fifth is an involution of the 
axolemma from the myelin sheath; causing, sixth, the formation of periaxonal spaces; 
seventh axon swelling occurs; eighth is the development of “myelin intrusions” and 
lastly the disconnection of the axon and the formation of axon bulbs, or “retraction 
balls”.  This process occurs at varying rates and may take several days to reach 
axotomy.  Regardless of the mode of injury, following disconnection, the axonal ends 
almost immediately seal over and the proximal and distal sections begin to retract away 
from each other and enlarge.  This is due to the blocked anterograde and retrograde 
transport of organelles and other material, including mitochondria, vesicles, 
multivesicular bodies and neurofilaments (Kelly, 1981; Di Giovanni, 2009).  The distal 
segment becomes completely separated from the cell body of origin and ultimately 
degenerates by a mechanism that is known as Wallerian degeneration (Figure 1.7).  The 
degeneration of the distal segment also results in a loss of synaptic input to the target 
cells.  This leads to an alteration in synaptic activity in the post-synaptic cells, which 
can ultimately lead to dysfunction of that cell (Martin, 2001).  Hence, a lesion at one 
site in the CNS can cause widespread disruption involving distant cells, according to the 
connections interrupted by the lesion. The persisting proximal segment of an axon has 
the ability to attempt to regenerate, or sprout (Figure 1.7). 
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1.4.1.2 Alterations in the cytoskeleton following injury 
The neuronal cytoskeleton plays an important role in the neural response to both 
primary and secondary injury.  Primary injury, in which axolemmal permeability is 
compromised, typically results in loss, accumulation or compaction of certain 
cytoskeletal components. However, as previously described, trauma without the 
disruption of axolemmal permeability can also cause cytoskeletal abnormalities (Pettus 
et al., 1994; Pettus and Povilshock, 1996; Maxwell et al., 1997 Graham et al., 2000).  
 
While axons can recover from seemingly mild forms of compression, severe levels of 
compression can irreversibly block fast axonal transport due to mechanical breakage of 
the axoplasm (Gallant, 1992).  Local reduction in the number of microtubules is a 
common consequence of axonal disruption (Hoffman et al., 1984; 1985; Jafari et al., 
1997; 1998; Maxwell and Graham, 1997; Adlard et al., 2000), notably at the nodes of 
Ranvier (Maxwell and Graham, 1997), and may be accompanied by a loss MAPs such 
as tau and dendritic MAP-2 in the damaged neurons (Saatman et al., 1998; Zhang et al., 
2000).  Conversely the proximal stumps of severed axons have also been demonstrated 
to have an accumulation of tau (Smith et al., 1999). This loss of microtubules may be a 
result of a post-traumatic calcium influx, which favours microtubule dissolution 
(Graham et al., 2000).  Disruption of microtubules and their associated motor proteins 
can disrupt the process of fast axonal transport, resulting in a failure of membrane-
bound vesicles and cytoskeletal elements to be conveyed to distal axonal regions. 
However, this disruption may be only local, with fast transport continuing normally in 
regions where microtubules are intact, resulting in accumulations of cytoskeletal and 
other organelles at different sites along the damaged axon, contributing to multi-focal 
axonal swelling (Maxwell et al., 1997). 
 
Neurofilament disruption following injury (Yaghmai and Povlishcok, 1992) can 
additionally have severe effects on neuronal structure and function (Posmantur et al., 
2000), as neurofilaments provide mechanical strength to axons by counteracting 
compressive forces of the local environment (Hoffman et al, 1984; Cleveland et al., 
1991). Neurofilament density is relatively constant over a wide range of axonal calibres 
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(Julien and Grosveld, 1991). Therefore larger axons will tend to contain a greater 
number of neurofilaments than smaller axons and respond in different ways when 
damaged, particularly when inflicted with tensile strain (Maxwell et al., 1997; Reeves et 
al., 2005).   
 
Neurofilament compaction is a common consequence of injury (Okonkwo et al., 1998).  
Neurofilaments can persist in both proximal and distal axonal stumps for long periods, 
potentially due to the steric protection given by the remaining filamentous structure 
(Hall and Lee, 1995). This compaction can occur in both mild and severe forms of 
injury, and is dependent upon disruption of axolemma permeability (Jafari et al., 1997; 
1998; Polvishock et al., 1997; Chung et al., 2005; DiLeonardi et al., 2010).  Compaction 
can occur within minutes of injury and can persist for hours following the insult and is 
thought to be the result of loss and/or collapse of neurofilament side arms, with 
concomitant preservation of filamentous structure (reviewed by Maxwell et al., 1997).  
Neurofilament side-arm collapse following axonal injury may be the result of altered 
interaction between protein kinases and phosphatases.  Alternatively, post-traumatic 
disruption of calcium homeostasis may abnormally activate proteolytic calpains, which 
cleave the neurofilament side arms from the core filamentous structure.  Both processes 
could theoretically lead to a reduction in intra-filament spacing and therefore 
neurofilament compaction.  It should be noted however, that even in the absence of 
disrupted axolemmal permeability and consequent neurofilament compaction, 
neurofilament disarray and misalignment could still occur (Maxwell, 1997). 
 
Aberrant phosphorylation of neurofilaments is a hallmark of neurodegenerative diseases 
and injury (Petzold, 2005; Anderson et al., 2008; Staal et al., 2009; Shea et al., 2009). In 
the cell body and dendrites, serine/threonine phosphatases may maintain neurofilaments 
in a predominantly dephosphorylated form; while in the axon the phosphorylated 
neurofilament side-chains are maintained by protein kinases (Maxwell et al., 1997). 
After injury abnormally phosphorylated neurofilaments tend to accumulate in the cell 
body, while neurofilaments within the axons may become dephosphorylated.  
Neurofilament phosphorylation in the cell body impedes neurofilament transport into 
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the axon, subsequently contributing to decreased axon calibre following axonal damage 
(Schlaepfer, 1987).  
 
Neurofilaments are present throughout the neurons except for the axon terminals.  
Calpains present in axon terminals are responsible for the breakdown of neurofilaments 
in this region; this degradation providing normal synaptic signalling feedback to the cell 
body (Schlaepfer 1987; King et al., 2000a).  In the post-traumatic period, 
neurofilaments can be observed in distended axonal regions as well as infiltrating axon 
terminals, possibly indicating a disruption in calpain mediated neurofilament 
breakdown (King et al., 2000a).  Support for this comes from in vitro (Dickson et al, 
2000) and in vivo (King et al., 2000b; 2001) studies which have demonstrated extensive 
accumulations of neurofilaments into ring- and bulb-like structures in severed axonal 
stumps. Both structures lacked microtubules and appeared to contain a dense core of 
organelles (including mitochondria), surrounded by either a whorl (in ring-like 
structures) or dense ball (in bulb-like structures) of bundled neurofilaments. 
Interestingly, these damaged axons exhibit similar morphological changes to a subtype 
of dystrophic neurites characteristically observed in Alzheimer's disease (King et al., 
2000b; Dickson et al., 2005). 
 
The highly polarised nature of neurons renders them particularly vulnerable to TBI and 
axonal injury regularly occurs as a result of the insult.  However it is not neurons alone 
that are affected during an injury.  The surrounding glial cells are also susceptible to 
injury and they too are involved in the stereotypic response of the brain, undergoing an 
array of injury-induced alterations. 
 
1.4.2 Response of glial cells to TBI 
Glial cells undergo a variety of alterations following injury that can have both desirable 
and undesirable effects.  Classically, reactive glial cells have been identified as the main 
inhibitor to regeneration following TBI. Indeed, the incapacity for axonal regeneration 
in the adult CNS can be attributed, at least in part to the limited ability of neurons to 
extend new processes in a non-permissive environment (Compston, 1995).  Following 
injury, astrocytes, oligodendrocytes and microglia undertake active responses directed 
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at isolating and clearing the injured area.  Specifically, astrocytes actively respond to 
injury, culminating in the formation of a glial scar, which acts to seal the injury site to 
prevent cytotoxic spread at the same time inhibiting neuronal regeneration (for a recent 
review see Sofroniew and Vinters 2010). Brain-resident microglia are also activated to 
transform into phagocytosing macrophages and along with macrophages derived from 
the circulatory system act to clear cell debris from the lesion site (Amor et al., 2010). 
  
While astrocytes facilitate brain function in an uninjured brain, whether astrocytes play 
an overall beneficial or adverse function after brain injury remains unclear.  Astrocytes 
undergo a stereotypical sequence of reactive alterations following TBI referred to as 
reactive gliosis.  This process is characterised by cellular hypertrophy and hyperplasia, 
cytoplasmic enlargement, elongated cytoplasmic processes and an upregulation in the 
expression of GFAP (Maxwell et al., 1990; Ridet et al., 1997; Raivich et al., 1999; 
Kernie et al., 2001; McGraw et al., 2001; Chirumamilla et al., 2002; Chen et al., 2003a, 
b; Laird et al., 2008). Activated and enlarged astrocytes migrate to the lesion border and 
actively form the glial scar (Raivich et al., 1999; Kernie et al., 2001; Chen et al., 2003a, 
b; Laird et al., 2008).  The glial scar is a dense structure comprised of these activated 
astrocytes and extracellular matrix proteins.  It forms a physical barrier which acts to 
segregate the damaged from non-damaged tissue and may facilitate the isolation of the 
damaged area and removal of debris from the surrounding healthy tissue (Laird et al., 
2008).  Studies in transgenic mice in which reactive astrocytes were conditionally 
knocked out following experimentally induced injury demonstrated that the loss of 
reactive astrocytes results in a reduction in glial scar, which exacerbated the magnitude 
and duration of inflammatory activation with prolonged leukocyte infiltration, in 
comparison to non transgenic controls (Bush et al., 1999; Faulkner et al., 2004; Myer et 
al., 2006).  Reactive astrocytes have also been implicated in other repair processes 
following injury including the facilitation of both blood brain barrier restoration and 
synaptogenesis (reviewed in Laird et al., 2008) 
  
However, numerous studies have demonstrated that reactive astrocytes play inhibitory 
roles following injury as well (Fawcett and Asher, 1999). Classically, astrogliosis has 
been considered one of the fundamental extrinsic limitations to regeneration (Fawcett, 
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2006; Fitch and Silver 2008). Primarily the glial scar is impenetrable to regenerating 
neurites, making reconnection of the injured tissue impossible (Rieer and Houle, 1988; 
Silver and Miller, 2004).  The reactive astrocytes within the scar release a range of 
extracellular matrix proteins that are inhibitory to axon growth, including the chondrotin 
sulphate proteoglycans, aggregan and versicam and neural-glial antigen-2 (Fawcett, 
1992, 1997; Caroni, 1998; Fawcett and Asher, 1999; Mathews et al., 2002; Rhodes and 
Fawcett, 2004).   Additionally, astrocytes play a crucial role in taking up extracellular 
glutamate in the uninjured brain.  Following injury, astrocytes down regulate expression 
of glutamate transporters (Rao et al., 1998; Beschorner et al., 2007) leading to an 
increase in extracellular glutamate, which has excitotoxic effects in the injured brain 
(reviewed in Floyed and Lyeth, 2007).  Reactive astrocytes are also implicated in the 
formation of brain edema following injury (Kimelberg, 1992) and the inflammatory 
response of the brain to injury, releasing a range of pro-inflammatory cytokines 
(reviewed in McGraw et al., 2001; Morganti-Kossmann et al., 2002; Laird et al., 2008). 
 
Extended loss of oligodendrocytes can be a prominent feature of CNS injury (Emery et 
al., 1998; McTigue et al., 2001).  Demyelination of axons, as a result of the 
oligodendrocyte loss, leads to dysfunction of axon potential conduction in the affected 
segments.  As previously mentioned, oligodendrocytes may aid in path finding, 
confining developing neurites to correct trajectories (Nagashima et al., 1999; Goldberg 
and Barres, 2000).  The oligodendrocyte guidance molecules that are present during 
development are inhibitory to axonal growth in the adult brain, which may be a factor in 
the inhibition of axonal regeneration following injury (Fawcett and Asher, 1999; 
Bandtlow and Schwab, 2000; Watkins and Barres, 2002; Grados-Munro and Fournier, 
2003). Myelin plays a key role in the extrinsic inhibition to regeneration.  CNS 
myelination is associated with cessation of axon growth (Nagashima et al., 1999) and 
loss of neuronal plasticity (Goldberg and Barres, 2000).  Myelination may therefore 
provide growth inhibitory signals as the nervous system nears maturity.  Furthermore, 
contact of regenerating neurites with either myelin or oligodendrocytes causes long 
lasting growth cone collapse, through intracellular signalling mechanisms (reviewed in 
Schwab et al., 1993; Filbin, 2003).  Preventing oligodendrocyte development and the 
formation of myelin in vivo through local and repetitive X-irradiation induces enhanced 
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sprouting around the lesion site, in conjunction with persistent increased levels of the 
growth associated protein, GAP-43 (Kapfhammer and Schwabb 1994; Schwegler et al., 
1995; Vanek et al., 1998).  Oligodendrocytes have been linked to growth inhibition 
following injury due to the release of growth inhibitory factors, such as NogoA, myelin 
associate glycoprotein and oligodendrocyte myelin glycoprotein.  Studies have 
demonstrated that these three proteins inhibit axon growth both in vivo and in vitro.  
Interestingly, all three proteins mediate their inhibitory activity through primarily the 
same receptor, Nogo-66.  However, the myelination state alone does not appear 
sufficient in explaining the limited regenerative attempts. Studies have demonstrated 
that although central white matter substantially inhibits neuronal regeneration, 
regeneration is also inhibited by the relatively myelin-free CNS grey matter (Nagashima 
et al., 1999).  Furthermore when the inhibitory myelin environment is removed 
completely while there is an increase in axonal outgrowth this rarely exceeds a few 
millimetres (Fawcett, 2006). Additionally, Davies et al. (1997) found that regenerating 
mature axons were able to extend for considerable distances in un-injured CNS white 
matter tracts. The PNS is capable of regeneration over relatively long distances, and 
differences between oligodendrocytes and Schwann cells, the myelinating cells of the 
PNS, may be attenuating the CNS regenerative capability (Watkins and Barres, 2002).  
Myelin within the PNS is rapidly removed following axonal injury.  In contrast, this 
process takes considerably longer in the CNS, indicating that certain components of 
CNS myelin are likely to inhibit regeneration (Watkins and Barres, 2002).  
Additionally, in the PNS, myelin sheaths may not be disrupted, or myelinating cells 
may form new myelin conduits to guide and nurture regenerating axons (Kelly, 1981).  
This difference between myelinating cells ability to facilitate regeneration in the PNS in 
comparison to the CNS is due to intrinsic differences between PNS and CNS neurons 
and additionally differences in the myelinating cells themselves.   However, while the 
myelin debris and myelin growth factors are inhibitory to growth in the injured brain, 
replacement of lost oligodendrocytes and remyelination following injury is required for 
proper neuronal functioning to be reinstated. 
 
Microglia are activated in a range of neurodegenerative disease processes and also in 
response to brain injury (Ling et al., 2001; Kelley et al., 2007). Microglia are the main 
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cell type involved in the inflammatory response of the brain.  In response to injury 
microglia migrate to sites of injury, multiply and develop into brain macrophages 
responsible for clearing neuronal debris and destroying pathogens (Thomas, 1992; 
Lotan and Schwartz, 1994; Aihara et al., 1995; Barron, 1995; Ravivich et al., 1999).  
 
Classifying the response of glial cells to injury as either a desirable or adverse response 
remains under dispute.  Indeed it is clear that a reactive response from the one cell type 
can evoke an array of effects.  Specifically reactive astrocytes play a vital role in 
isolating and preventing the spread of neurotoxic damage following injury.  Why this 
same structure prevents axonal regeneration remains to be determined. Similarly, 
guidance molecules secreted by oligodendrocytes inhibit axonal outgrowth.  However, 
in a contrasting effect, remyelination following injury will be vital for proper axonal 
function.  This intrinsic response of non-neuronal cells to prevent neuronal regeneration 
is curious as it indicates that induction of axonal growth following injury may not be 
functionally appropriate in the mature brain. 
 
1.5 THE REGENERATIVE CAPACITY OF THE MATURE MAMMALIAN 
BRAIN 
 
Full recovery following TBI will require the replacement of the dead and dying cells 
lost as a result of the injury, and either the appropriate extension of new axons to trace a 
path to their original target, mimicking the path finding abilities demonstrated by axons 
during development, or the compensatory remodelling of surrounding intact pathways 
to overcome the synaptic loss that occurred due to the injury.   TBI does evoke an array 
of mechanisms within the injured neurons that are indicative of an attempt to regenerate 
and repair.  Neurons respond to injury with a complex sequence of morphological, 
biochemical and gene expression alterations, some of which are directed towards the 
production of new neurons as well as sprouting, regeneration and synaptogenesis in 
resident injured neurons (Deller and Frotscher, 1997; Christman et al., 1997; King et al., 
2000a; Magavi et al., 2000; Pastor et al., 2000; Kernie et al., 2001; Rice et al., 2003; 
Kerschensteiner et al., 2005).  Injury can trigger the activation of precursor cell 
populations that in conjunction with resident cell proliferation have remarkable 
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potential to produce new neurons and glia in and around the injury site.  Axons in the 
CNS often respond actively, rather than passively, to injury and undergo a distinctive 
sprouting response or regenerative attempt.  The ultimate goal in this field of research is 
to facilitate full functionally recovery following TBI, which currently, cannot occur.  
 
1.5.1 Neurogenesis and gliogenesis following injury 
The notion that the mature brain is comprised only of post-mitotic, terminally 
differentiated cells and held in a rather static state, lacking the capacity to re-enter the 
cell cycle or regenerate following injury is no longer entirely valid. There is now 
convincing evidence that germinal regions within the CNS remain present in the adult 
brain, primarily the subventricular zone (SVZ) of the anterior lateral ventricles and the 
dentate gyrus of the hippocampus (Doetsch and Hen, 2005).  The SVZ, in particular, is 
viewed as the principle germinal region of the adult brain and is comprised of neural 
progenitor cells capable of differentiating into neurons, astrocytes and oligodendrocytes 
(Reynolds and Weiss, 1992; Richards et al., 1992; Doetsch et al., 1997, 1999; Conover 
and Allen, 2002; Doetsch, 2003; Marshall et al., 2003; Mignone et al., 2004; Abrous et 
al., 2005; Doetsch and Hen, 2005).  
 
Interestingly, it has now been demonstrated that trauma can alter the rate of cell 
proliferation in the mature brain.  Alterations in progenitor populations and cell 
proliferation have been demonstrated in diverse models of experimental brain lesion 
and stroke conditions and are proposed to contribute to post-lesion brain recovery 
(Clarke et al., 1994; Duggul et al., 1997; Holmin et al., 1997; Kernie et al., 2001; 
Arvidsson et al., 2002; Chen et al., 2003a; Douen et al., 2004; Salman et al., 2004). 
Ultimately, injury-induced proliferation and progenitor cells may result in the 
generation of new neurons and/or glia (Gu et al., 2000; Magavi et al., 2000; Jin et al., 
2001; Chen et al., 2003a, b; Douen et al., 2004; Salman et al., 2004). For example, 
experimentally induced ischemia can lead to the generation of new neurons in the 
injured neocortex (Gu et al., 2000). Furthermore, neural progenitor cells capable of 
extensive migration and integration have been demonstrated in several other brain 
regions (reviewed by Emsley et al., 2005).   Studies have indicated that migrating 
neuroblasts, produced throughout life and largely destined for the olfactory bulb, may 
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be recruited to sites of brain injury (Ramaswamy et al., 2005). The extent of 
neurogenesis in the mature brain following injury remains to be fully determined.  
 
Cellular proliferation following injury is not exclusive to neuronal progenitor 
populations, as gliogenesis has also been shown to increase following injury. For 
example resident microglia strongly increase their proliferation rate in response to 
injury (reviewed Rezaie and Male, 2002).  Importantly astrogliogenesis has been shown 
to play a significant role in the formation of the glial scar (Tan et al., 2005; reviewed in 
White and Jakeman, 2008). While the presence of newly born astrocytes is correlated 
with traumatic insults to the brain, the origin of this astrogliogenesis remains under 
question.   Thymidine analogue fate mapping experiments, in conjunction with 
retroviral and transgenic models to map cell fate, have demonstrated that the most likely 
origin of astrogliogenesis is NG2+ expressing glial precursor cells (Alonso, 2005; Burns 
et al., 2009).  The role of NG2+ cells within the mature CNS is largely unknown; 
however it is clear that they greatly increase in number following traumatic insults 
(Dawson et al., 2000; Levine et al., 2001).  NG2+ cells have the potential to generate a 
wide variety of cell types including astrocytes, but also oligodendrocytes and neurons, 
both in vitro and in vivo (Alonso, 2005; Belachew et al., 2003; Baracskay et al., 2007).  
Resident GFAP expressing astrocytes may also undergo proliferation in response to 
injury, these new astrocytes contributing to the glial scar (Buffo et al., 2008).  It is 
important to note that the field of reactive astrocytes and the origin of gliogenesis 
following injury remain contentious.  It is hard to determine whether an activated 
astrocyte within the injury site expressing precursor cell proteins is in fact a newly born 
astrocyte or a resident astrocyte reversing its differentiation state.  This is due to the fact 
that studies have demonstrated that reactive astrocytes significantly alter the expression 
of a range of proteins, including the intermediate filament nestin, a filamentous protein 
classically associated with progenitor cells (Lin et al., 1995; Krum and Rosenstein, 
1999; Douen et al., 2004). Thus is it hard to conclusively determine the origin of an 
activate astrocyte expressing the precursor protein nestin. 
 
When damage results in extensive cell death the presence of newly born neurons may 
play a vital role in recovery of the brain following injury.  Full functional recovery will 
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require the replacement of the dead and dying cells that were a consequence of a 
traumatic insult. Harnessing this intrinsic response of the resident progenitor cell 
population may provide a powerful tool to replace the neuronal loss that occurs in TBI. 
 
1.5.2 Axonal sprouting following injury 
Santiago Ramón Y Cajal first described the potential for neurons to respond to injury in 
the early 1900s, sketching reactive bulbs of injured neurite using light microscopy and 
silver staining techniques (DeFelipe and Jones, 1991).  Numerous studies have now 
demonstrated an active response by damaged mature central CNS neurons, culminating 
in an attempt to regenerate (Salin et al., 1995; McKinney et al., 1997; Dickson et al., 
2000; King et al., 2001; Bareyre et al., 2004; reviewed in Chuckowree et al., 2004).   
Frequently when the damaged mature neuron survives an insult the cell body and 
remaining portion of the injured axon undergo reactive changes involving the specific 
regulation of proteins, particularly cytoskeletal components, in preparation for an 
attempt at sprouting or regeneration (King et al., 2000a). Importantly, axonal 
regeneration and axonal sprouting are two distinct responses to axotomy, which may 
occur at the proximal stump of surviving injured axons.  Regeneration implies 
successful restoration of the specific contacts between an axotomised neuron and its 
target, whereas sprouting describes the abortive response of the proximal stump to 
regenerate, leading to multiple local axonal collaterals without the restoration of normal 
connectivity (Berry et al., 1994; Deller and Frotscher, 1997).  Many studies have now 
convincingly demonstrated that following injury surviving neurites have the ability to 
sprout axons into the local injury site (King et al., 2001; Chuckowree and Vickers, 
2003; Haas, 2004).  
 
Damaged axons in most regions of the mature CNS do not spontaneously regenerate 
and instead tend to undergo an abortive regenerative response restricted to the local 
neuropil (Cotman et al., 1994; Kapfhammer, 1997; Rhodes and Fawcett, 2004).   The 
lack of full functional recovery is often attributed to the essentially inhibitory local 
environment of the mature brain (reviewed in Yiu and He, 2006) including the presence 
of myelin-associated inhibitors and the formation of the glial scar.  However, as 
demonstrated in spinal cord injury, removal of the inhibitory CNS environment alone is 
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not sufficient in evoking full functional recovery (reviewed in Fawcett, 2006). Recent 
research indicates that there is an intrinsic loss of robust axonal extension. Whether the 
inability of the mature CNS to regenerate is due to the local non growth permissive 
environment, or to an inability to extend long axons which may be lost in a 
developmental switch (Li et al., 1995; Blackmore and Letourneau, 2006), or due to a 
switch from axonal to dendritic growth (Goldberg et al., 2002) or even a combination of 
all these factors, remains a priority research topic in the field of neuroscience. It is 
important to note however that the sprouting response into an injury site is not limited 
to directly injured neurons. 
 
The restricted regenerative capacity of the mature CNS is seemingly not present in early 
development, being an acquired limitation.  Long distance axon regeneration and full 
functional recovery following CNS injury has been displayed in embryonic models 
across species (Shimizu et al., 1990; Treherne et al., 1992; Hasan et al., 1993; Saunders 
et al., 1998).  Both in vivo and in vitro models of perinatal healing and plasticity are 
indicative of mammalian cerebral cortical structures being capable of undergoing 
dramatic healing interactions and rapid new circuit reorganisation during the perinatal 
period.  Comparison between regeneration in mature animals and younger animals 
highlights that growth occurring from regeneration in the mature CNS is shorter and 
less abundant (Varga et al., 1995).  This capacity for greater regeneration is believed to 
be lost during a discrete developmental transition.  The reduction of regenerative 
capacity occurs a few weeks postnatally in rodents and a few months in humans (Chen 
et al., 2002). 
 
A key event in axonal survival and the potential for regeneration is a substantial 
reorganisation of the cytoskeleton (Christman et al., 1997) and the formation of an 
axonal growth cone (Spira et al., 2003; Erez et al., 2008).  While the cellular 
mechanisms that govern the transformation of a severed axon into a growth cone have 
been extensively investigated (Ashery et al., 1996; Spira et al., 2003; Sahly et al., 2003; 
Erez and Spira, 2008) the precise mechanisms underlying this transformation remains 
unclear.  What is clear however, in Aplysia neurons, is the formation of regenerative 
growth cones is governed by the level of intracellular calcium (Kamber et al., 2009). If 
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the calcium level is too low the injured neurite forms an end bulb whereas when 
calcium reaches adequate levels, the stump forms a growth cone (Kamber et al., 2009).   
Local protein synthesis at the distal portion of the proximal axon enables these intrinsic 
triggers to form a regenerative cone (Twiss and Minnen, 2006).  Neurofilaments may 
also play a crucial role in determining whether and how central neurons regenerate 
following axon transection (Hall and Yao, 2000) as indicated by the disrupted 
regeneration exhibited by neurofilament-deficient mice (Zhu et al., 1997) and quail 
(Jiang et al., 1996) following peripheral nerve injury.  However, sprouting axons around 
the injury site rarely result in a true regenerative attempt and the formation of correct 
synapses (Neumann and Wolf, 1999; Neumann et al., 2002; Hammarlund et al., 2009). 
Enhancing the regenerative response is a key goal in many studies, however, any 
modification that results in an extensive and functionally appropriate sprouting response 
still remains to be elucidated.  
 
A prominent theme in current research in neuroscience is based upon facilitating and 
promoting axonal regeneration following brain injury.  However, still little is known 
about the accuracy of these regenerating sprouts.   Sprouting around the injury site may 
not always be beneficial or desirable.  Both in vitro (McKinney et al., 1997) and in vivo 
(Salin et al., 1995) experimental models indicate that post-injury sprouting may not 
always be functionally appropriate, with potential aberrant axonal connectivity possibly 
contributing to the development of epilepsy following brain traumas such as stroke 
(Carmichael, 2003).   Indeed many of the new connections that form when damaged 
axons sprout and re-synapse with targets are hyperexcitable (McKinney et al., 1997) 
and traumatic epilepsy is a common consequence of traumatic head injury (Willmore, 
1995; Jacobs et al., 2000; Santhakumar et al., 2001).  The onset of epileptic seizures 
typically occurs one to three years after head injury and the likelihood of seizure 
evolution is correlated with the severity of the initial injury (Willmore, 1995).  
Additionally, post-lesion sprouting has also been implicated in the generation of 
abnormal circuitry in other brain lesion paradigms (Jacobs et al., 2000; Parent, 2002; 
Parent and Lowenstein, 2002).  Thus the induction of growth, after injury, may be 
inappropriate, potentially exacerbating a clinically poor outcome. There is a current 
interest in rehabilitation in conjunction with induction of axonal growth following 
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injury as a TBI intervention.  Interestingly, rehabilitation has the potential to reinforce 
appropriate synapses and induce the dieback of inappropriate connections (reviewed in 
Fawcett, 2009).  This therapeutic intervention may provide a non-invasive mechanism 
to eliminate aberrant sprouting.  Induction of appropriate axonal sprouting of injured 
and collateral axons, synaptogenesis and a generalised plasticity will be of vital 
importance in promoting functional recovery from injury to the CNS. Clearly any 
intervention that prevents post-traumatic neurodegeneration, or inappropriate axonal 
sprouting and enhances adaptive neural responses has the potential to substantially 
improve the prognosis of TBI.  A great deal of emphasis is therefore being placed upon 
developing strategies to promote neural repair following injury.  However, many of the 
basic mechanisms underlying endogenous repair mechanism are not fully understood 
and need to be discovered to prevent adverse outcomes. 
 
1.5.3 Potential for structural plasticity in mature mammalian brain following 
injury 
The current body of research emerging indicates a remarkable plasticity retained within 
the brain which, until recently was thought not to exist. The cental dogma that the 
mature brain is a fixed, undynamic structure is no longer valid.  The advancement of 
multi-photon microscopy techniques in the past decade (Denk et al., 1990) has 
convincingly demonstrated that the mature brain does retain a capacity for remodelling 
and plasticity. Collateral sprouting from uninjured axons also play a large role 
following axonal injury (Salin et al., 1995; Deller and Frotscher, 1997; Jin et al., 2006), 
possibly due to availability of vacant synaptic territory within the injury site (McKinney 
et al., 1997).  However if the injury has resulted in significant cell death, collateral 
sprouting cannot account for the lost synaptic connections alone, replacement of the lost 
cells must first occur. 
 
Under normal physiological conditions the mature brain is a dynamic network of 
connections that are constantly remodelling and responding to experience-dependent 
learning.  This day to day plasticity is predominantly in dendritic spines which undergo 
rapid turnover through extension and retraction and alterations in their shapes and sizes  
(for a selection of recent papers see Grutzendler et al., 2002; Knott et al., 2002; 
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Trachtenberg et al., 2002; Majewska and Sur, 2003; Portera-Cailliau et al., 2003; 
Holtmaat et al., 2005; Majewska et al., 2006; Brown et al., 2007; Brown et al., 2008; 
Lee et al., 2008; Brown et al., 2010); which has been associated with synapse formation 
and elimination (Trachtenberg et al., 2002; Holtmat et al., 2008).  Additionally, studies 
have shown a remarkable extension and retraction of dendrite tips within 
subpopulations of neurons in the naïve brain (Lee et al., 2006; 2008). 
 
Alterations in synaptic strength and wiring, remodelling of axonal and dendritic arbors 
and changes in dendritic spine and axonal bouton turnover, have been observed not only 
in the naïve brain but also in response to injury. Cortical neurons demonstrate axonal 
and synaptic remodelling in response to various models of injury (for examples see 
King et al., 2001; Knott et al., 2002; Trachtenberg et al., 2002; Majewska et al., 2006). 
Reorganisation such as this may correlate with functional recovery not only in stroke 
(Carmichael, 2003; Carmichael, 2006; Brown, 2008; De Filippo et al., 2008), but 
comparable plasticity may also account for the recovery observed after forms of spinal 
cord injury (reviewed in Edgerton, 2004; Dunlop, 2008). Experimentally induced 
complete infarction of the somatosensory cortex induced a new pattern of electrical 
circuit activity in the intact ipsilateral hemisphere (Takatsuru et al., 2009).  
Compensatory plasticity can involve axonal sprouting of intact neurites and synapse 
alterations or the growth of new horizontal connections.  However another early plastic 
mechanism evoked by injury is the unmasking of silent pathways in the affected 
network and can occur within hours of a nerve lesion (Merzenich et al., 1983; 
Donoghue et al., 1990). Spontaneous reorganisation in small cortical lesions results in 
adjacent cortical areas taking over the function of the damaged areas (Nudo, 1999; 
Kolb, 2003).  This activation of functionally inactive connection occurs through an 
increase in excitatory transmitter release, an increase in density of postsynaptic 
receptors and changes in membrane conductance in conjunction with a decrease in 
inhibitory input or removal of inhibition from excitatory input.  Plasticity can also occur 
over a longer time period, evoked through different mechanisms.  Long-term changes 
occur through long-term potentiation and depression, and, evidenced in the motor 
cortex, involve synaptic alterations in N-methyl-D-aspartic acid receptor activation and 
an increase in intracellular calcium concentration (Hess and Donoghue, 1994; 1996). 
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When damage to a circuit is relatively small, it is feasible that reorganisation of the 
surrounding networks can recover the functional loss, however complete destruction 
within an injury site will require the replacement of lost and dying cells and frank 
extension of lost axons.  The specificity and degree of remodelling that can occur in 
response to injury has not been fully elucidated.  To understand how to manipulate both 
the uninjured and injured brain’s potential for plasticity to facility a functionally 
desirable outcome following injury, the full potential and plastic response of neurons to 
injury must first be fully understood. 
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1.6 THESIS AIMS 
 
Despite an accumulating body of literature regarding the capacity for neural 
remodelling and regeneration following structural brain injury many aspects of this 
response remain to be fully elucidated.  This thesis investigated the reactive and 
regenerative alterations associated with the neural response to physical injury in the 
adult mammalian brain.  The studies to be included utilised a range of in vitro and in 
vivo models of primary injury.  To investigate the regeneration potential of the mature 
mammalian brain a variety of procedures were utilised, including 
immunohistochemical, molecular and imaging techniques, to examine the 
morphological, cellular and molecular events that characterise the neural response to 
injury.  This thesis studies are focused upon the potential for regeneration following 
injury. Specifically, how comparable regenerating neurons are to their developmental 
counterparts, characterising alterations within the damaged neurons and the surrounding 
brain following injury, and the role of the neuronal cytoskeleton in neuronal 
regenerative events, as the mechanisms underlying these processes are currently poorly 
understood. 
 
Aim 1: To determine the motile characteristics which govern axotomised CNS 
neurons during regeneration and how these changes compare to initial neurite 
development. Axonal outgrowth and pathway selection plays a crucial role in 
development of the mammalian brain and will thus be important in axonal sprouting 
and/or regeneration.  The first aim addressed by this thesis endeavoured to characterise 
the motile capabilities of regenerating axons in comparison to development in vitro.  It 
utilised an established model of axonal transection of rat cortical neurons, grown to 
relative maturity.  The response of developing and regenerating axons was analysed 
using multi-labelling immunocytochemistry and live cell imaging.   
 
Aim 2:  To characterise the response and regenerative attempt of injured neurons 
to a novel model in injury in vitro and determine what degree the injury response 
is dependent upon mode of injury.  Due to the wide varieties in injury that can occur 
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as a result of a TBI, full comprehension of the response of the brain to various modes of 
injuries and mechanisms underlying these responses will be vital in devising successful 
treatment.  Thus the current aim endeavoured to develop an in vitro model of axonal 
injury that involved a total shearing of axonal process from the neuronal cell body, to 
determine how much the neuronal regenerative response relied upon mode and degree 
of injury.  The ability of relatively mature neurons to survive and attempt a regenerative 
response after this novel model of axonal shearing was investigated. The response of the 
neurons to this mode of axonal injury, and in comparison to the transection model of 
injury utilised in Aim 1 was examined using a combination of live imaging and 
immunocytochemical analysis. 
Aim 3. To investigate the reactive and regenerative changes that characterise the 
neural populations response to injury in vivo, exploring the co-ordinated 
alterations, in both neuronal and glial cell populations, which occur following 
injury.  The extent to which the adult brain undergoes recovery following injury 
remains controversial. A rodent model of structural injury specific to the neocortical 
grey matter of the somatosensory cortex was utilised. These studies aimed to determine 
the ultimate fate of injury-induced proliferating and progenitor cells and the potential 
for these cells to contribute towards neuronal replacement in the injured adult 
neocortex.  Furthermore the response of various populations of neural cells, including 
neurons, astrocytes, microglia and macrophages as well as alterations in brain 
vasculature, was analysed with immunohistochemical techniques, focussing specifically 
upon the neuronal cell type specific response to injury in vivo. 
Aim 4. To characterise the phenotype of neurons derived from a transgenic mouse 
lacking the neurofilament light chain protein and determine the regenerative 
abilities of the neurofilament light chain null neurons.  The axonal cytoskeleton, 
including the neurofilaments, plays a crucial role in both initial neurite outgrowth and 
elongation and regeneration.   This aim examines the cytoskeletal alterations, 
specifically the reactive and regenerative changes that characterise the axonal response 
to physical injury in neurons lacking the neurofilament triplet protein NF-L.  To meet 
this aim, a novel in vitro model of axonal injury derived from transgenic mice with a 
NF-L deletion was utilised, in conjunction with the focal acute neocortical injury 
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utilised in Aim 3. The neuronal characteristics and response of regenerating axons was 
analysed using multi-labelling immunohistochemistry, immunocytochemistry and 
molecular techniques. 
 
This thesis endeavoured to characterise the reactive and regenerative response of mature 
CNS neurons to injury.  These studies included provide insight in to some of the aspects 
of the post-injury neuronal response and further explain why the mature CNS is 
incapable of repair.  Results from theses studies enhance current knowledge regarding 
the basic mechanisms underlying neuronal and axonal regeneration and highlight 
certain neuronal responses to injury in which therapeutic intervention may be possible. 
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2 MATERIALS AND METHODS 
 
2.1 CORTICAL NEURON CULTURE 
2.1.1 Preparation of coverslips and cell culture trays 
Glass coverslips were nitric acid etched through submersion in nitric acid overnight, 
followed by 5 milli Q® washes. Coverslips were then oven dried at 80°C and 
autoclaved. Coverslips were singularly placed into either 12-well or 24-well microplates 
(Iwaki, Japan) within a laminar flow hood and further sterilised through ultraviolet 
radiation for 30 mins.  1mg/mL poly L-lysine (Sigma, USA) in borate buffer, pH 7.4 
was filter sterilised onto the coverslips using Acrodisc® 25 mm syringe filters and left 
for 24 hrs.  After this time the poly-L-lysine was removed from the coverslips and 1mL 
of NeurobasalTM media supplemented with 2% B27, 10% foetal calf serum, (all from 
Invitrogen, USA) 0.5mM L-glutamine, 25µm glutamate and penicillin/streptomycin 
antibiotics (all from Gibco BRL, Life Technologies, USA) at 37°C was added.  The 
coverslips were then incubated at 37°C in 5% CO2, until plating of culture. 
 
2.1.2  Dissection and dissociation of cortical tissue 
The Animal Experimentation Ethics Committee of the University of Tasmania approved 
all procedures involving animals. 
 
Primary dissociated cortical neuron cultures were prepared from embryonic day 18 
(E18) Hooded-Wistar rats under sterile conditions as previously described (Banker and 
Goslin, 1988). Rats were euthanased through CO2 asphyxiation at 7 L/min for 6 mins.  
Each rat is checked for reflexes and the site of incision alcohol sterilised.  An incision 
was made along the midline of the stomach and the embryos removed and placed on 
ice.  Within the laminar flow hood, the embryos were removed from the amniotic sac 
and decapitated.  The outer layers of the skull and meninges were dissected and the 
superficial layers of the frontal cortex of both hemispheres removed and placed in 5mL 
of 10mM HEPES at 37°C. 
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Following the complete dissection of all embryos, 0.25mL of 0.025% trypsin (Sigma, 
USA) was added to the 10mM HEPES and cortical tissue and incubated in a water bath 
at 37°C for 10 mins.  Following this, all solution was carefully removed, and 5mL of 
fresh 10mM HEPES added. The tissue was then incubated in the water bath at 37°C for 
five mins, this washing procedure repeated twice.  After the final wash 5mL of fresh 
10mM HEPES was added and cell dissociation was completed through gentle trituration 
using a 1mL pipette.  Cell viability was assessed using trypan blue vital dye exclusion 
(Sigma, USA). Cells were plated onto the prepared coverslips, to a density of 5.0x105 
for the 24-well plates and a density of 1.0x106 for the 12-well plates. The plates were 
then returned to the incubator. 
 
2.1.3 Maintenance 
Two days after plating, the NeurobasalTM media containing 10% foetal calf serum was 
removed and replaced with 2ml of subsequent NeurobasalTM media supplemented with 
2% B27, 0.5mM L-glutamine and penicillin/streptomycin antibiotics to selectively 
promote the growth of neurites (Brewer et al., 1993, Brewer 1995; 1997).  Every three 
to four days half of the media was removed and replaced with fresh media.  Cells were 
maintained in the 37°C humidified atmosphere of CO2 for up to 24 days in vitro (DIV). 
 
2.2 IN VITRO AXONAL INJURY 
 
Axonal injury was carried out as previously described in Dickson et al., (2000) and 
Chuckowree and Vickers, (2003) on mature cortical culture.  Cell culture maturity is 
reached at 21 DIV, when a lack of expression of developmental proteins (Chuckowree 
and Vickers, 2003; Haas et al., 2004) coincides with the expression of proteins 
correlating to maturity of the neuron and its processes (Chuckowree and Vickers, 2003; 
King et al., 2006).  At 20 DIV, coverslips were transferred to individual 35 mm sterile 
plastic petri dishes (Iwaki, Japan) within the laminar flow hood and allowed to re-
acclimatise to the incubator conditions for 24 hrs.  At 21 DIV, individual axonal 
bundles interconnecting discrete neuronal aggregates adherent to underlying substrate 
were selected for transection.  Transection was performed under microscope guidance 
using a 12cm Barkan goniotomy curved-blade diamond knife (Kaisers, Germany).  A 
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transection was made with the knife blade on appropriate axonal bundles to completely 
transect axons and leave a cell free lesion.  Several injuries (2-5) were made per 
coverslip. 
 
2.3 IN VIVO FOCAL NEORCORTICAL INJURY 
 
Acute focal neocortical injuries were performed as previously described (King et al. 
1997, 2001; Dickson et al. 2005).  Briefly, following intraperitoneal administration of 
anaesthetic (pentobarbitone sodium, 72mg/kg, Abbot Laboratories, Australia) and 
analgesic (Carprogen, 4mg/kg, Pfizer, Australia), animals were immobilised in a 
Stoelting stereotaxic frame.  A burr hole was drilled into the skull, (5mm anterior and 
4.5mm lateral to lambda for rat, 2.5mm anterior and 2mm lateral to lambda for mice) 
and a focal injury was made in the somatosensory cortex (Par1 region) by lowering a 
25-gauge Hamilton needle (Reno, USA) to a depth of 1.5mm into the grey matter for 
rats and a 29-gauge needle to a depth of 1mm into the grey matter for mice.  The needle 
was left in place for ten minutes prior to removal and suturing of the wound. 
 
2.4 IMMUNOCYTOCHEMISTRY AND IMMUNOHISTOCHEMISTRY 
 
Fixed cultures and brain sections were incubated in combinations of mouse and rabbit 
primary antibodies in diluent (0.3% Triton X-100 in 0.01 M phosphate buffered saline 
(PBS)) for two-hours at room temperature on a shaker followed by incubation at 4°C 
overnight (16-20 hr).  Primary antibodies were then removed through three ten-minute 
washes in 0.01 M PBS.  Secondary antibodies goat anti-mouse Alexa Fluor® 594 and 
goat anti-rabbit Alexa Fluor® 488 (dilution 1:1000; Molecular probes, USA) were 
diluted in 0.01 M PBS and incubated on coverslips for 90 mins on a shaker in the dark. 
Nuclear yellow (Molecular Probes, USA, 0.01%) was added for the final 5 min of the 
secondary antibody incubation, prior to washing and mounting.  Coverslips and sections 
were then washed three times in 0.01 M PBS and mounted on to glass slides using 
Permaflour aqueous mounting medium (Immunotech, France).  Immunoreactivity 
visualised using a Leica (Germany) DM BL2 upright fluorescent microscope. 
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Table 2.1 Primary antibodies used for immunohistochemistry 
Antibody name Species Immunoreactivity Dilution Supplier 
α-internexin R Class IV intermediate filament 
subunit 
1:2000 Novus  
Biologicals 
β-III-tubulin M Neuron specific β-tubulin subunit 1:10000 Promega 
BrdU M Bromodeoxyuridine, thymidine 
analogue 
1:1000 Sigma 
Calretinin R Interneuron calcium binding 
protein 
1:2000 Chemicon 
ERM M IgM Actin/membrane binding exrin-
radixin-moesin protein 
1:500 Gift from F. 
Solomon 
Ferritin R Microglial iron binding protein 1:2000 Dako 
GFAP R Glial fibrillary acidic protein 1:2000 Dako 
Ferritin R Proliferating cell nuclear antigen 1:500 Zymed 
Ndel1 R Mammalian NudE protein 1:100 Gift from D. 
Smith 
Nestin M Intermediate filament protein 
marker of neural progenitor 
1:1000 BD 
Biosciences 
NF-L R 68kD neurofilament triplet light 
molecular weight subunit 
1:1000 Millipore 
NF-M R 150kD neurofilament triplet 
medium molecular weight subunit 
1:2000 Serotec 
Parvalbumin MC Interneuron calcium binding 
protein 
1:2000 Swant 
PCNA R Proliferating cell nuclear antigen 1:500 Zymed 
SMI312 MC Pan-axonal neurofilament marker 1:2000 Swant 
Tau R Microtubule associated protein 1:15000 DAKO 
 
Trk B R Tyrosine kinase receptor B 1:500 Santa Cruz 
R = Rabbit polyclonal antibody, M = Mouse monoclonal antibody, MC = Mouse 
monoclonal cocktail.  Antibodies are IgG unless otherwise specified. 
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2.5 LIVE CELL IMAGING 
 
Time lapse imaging was carried out using differential interference contrast (Normarski) 
microscopy on a Leica (Germany) DM IRB inverted microscope.  Selected coverslips 
were transferred to a mounted 0.17mm Delta T dish (Bioptechs, USA) containing 
imaging buffer (in mM: 124 NaCl, 5 KCl, 0.2 CaCl2, 1 MgCl2, 30 dextrose and 24 
HEPES, pH 7.3) (Zhang and Benson, 2001, Chuckowree and Vickers, 2003) at 36°C, 
CO2 enriched. Temperature inside the dish was maintained through a Delta T4 culture 
dish controller (Bioptechs, USA).  Imaging buffer underwent constant replenishment 
from a stock of imaging buffer, maintained at 37°C with carbogen (5% CO2 in oxygen; 
BOC gases, Australia) being pumped through at 3 L/min.  Imaging buffer was replaced 
and removed from the Delta T dish at a constant rate. Preliminary trials determined the 
optimal rate of imaging buffer replenishment and carbogen enrichment. Appropriate 
cells clusters were randomly selected which were free from contact with surrounding 
neuronal cells clusters and glial populations.  A standard minimum distance of 50µm 
from the selected axon and surrounding cells was set. 
  
Live cell images were captured every minute over a two-hour period with a Hamamatsu 
Orca ER (Hamamatsu Photonics, Japan) digital camera attached to a G4 Macintosh 
computer (Apple Computers, USA) using the Open Lab 4.0.2 program. To ensure that 
the intrinsic motility of axons was the variable investigated, all external variables of 
growth cone and axonal motility were controlled.  The imaging environment 
constructed was completely devoid of external stimuli except for a constant light 
source.  All cells included in the data were imaged once; stimulus history of growth 
cone in vitro can alter behavioural response (Diefenbach et al., 2000).  The strict 
regulation of content of imaging buffer and replenishment rate ensured calcium levels 
(0.02mM CaCl2) were kept at a controlled physiological level. 
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3 CELLULAR DYNAMICS UNDERLYING REGENERATION OF 
DAMAGED AXONS DIFFERS FROM INITIAL AXON DEVELOPMENT 
 
3.1 INTRODUCTION 
 
While the mature brain, unlike the immature CNS and mature PNS, cannot completely 
repair following injury, it is now clear that the mature brain evokes an active response 
to injury and that this response culminates in an attempt to regenerate (Salin et al., 
1995; McKinney et al., 1997; Dickson et al., 2000; King et al., 2001; Bareyre et al., 
2004; reviewed in Chuckowree et al., 2004). The lack of full functional recovery is 
often attributed to the essentially inhibitory local environment of the mature brain 
(reviewed in Yiu and He, 2006) including the presence of myelin-associated inhibitors 
and the formation of the glial scar.  However, experimental evidence has convincingly 
demonstrated that removal of the inhibitory environment alone is not sufficient in 
evoking full functional recovery (reviewed in Fawcett, 2006), thus indicating that there 
must also be an intrinsic limitation to full functional recovery. Understanding the 
intrinsic limitation to mature CNS regeneration will be vital in devising effective 
strategies to treat TBI. 
 
Recent studies have indicated that the lack of robust axonal extension following injury 
may be an intrinsic limitation. It has been postulated that this ability to extend long 
axons may be lost in a developmental switch (Li et al., 1995; Blackmore and 
Letourneau, 2006). Following TBI, to re-establish the lost connections, thus reinstating 
the neuronal network, an injured axon must robustly extend into the injured 
environment and navigate its way to the correct, original target. During development, 
neurons become polarised and their axons extend relatively long distances correctly 
tracing a path to their ultimate target.  Critical to this precise and accurate axonal 
outgrowth that occurs during brain development is the growth cone. These transient 
structures, present on the tips of elongating axons, have both sensory and motor 
capabilities, which enable the integration of environmental cues, such as growth factors, 
resulting in precise path finding, ultimately culminating in the establishment of 
connectivity in extensive neuronal networks (for review see Tessier-Lavigne and 
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Goodman, 1996; Suter and Forscher, 2000; Gordon-Weeks, 2004). During development 
growth cone form is behaviour specific (Mason and Wang, 1997; Szebenyi et al., 1998), 
with these structures exhibiting striking changes in their morphology in different 
cellular contexts.  
 
Aspects of the neuronal regenerative response recapitulate the sequence of dynamic 
cellular and morphological features displayed by developing neurites (reviewed in Harel 
and Strittmatter, 2006).   Numerous studies (eg Hoffman et al., 1987, 1993; Goldstein et 
al., 1988; Hoffman and Cleveland, 1988; Muma et al, 1990; Nixon and Shea, 1992) 
have shown that following axonal injury and during regenerative attempts, 
neurofilament expression is down-regulated, whereas expression of other cytoskeletal 
elements is elevated, suggesting that the sequence of cytoskeletal gene expression 
occurring in development is recapitulated during attempted regeneration (Hoffman and 
Cleveland, 1988; Lee and Cleveland, 1996). It has be demonstrated, both in vitro 
(Dickson et al., 2000) and in vivo (Christman et al., 1997; King et al., 2001), that the 
regenerative attempt mounted by axons is associated with cytoskeletal reorganisation 
and accompanied by an up-regulation of GAP-43.  GAP-43, a neuron specific growth 
and membrane-associated phosphoprotein, is one of the most abundant proteins in 
neuronal growth cones, where it is implicated in filopodial motility, axon guidance, 
synaptogenesis and synaptic plasticity (Brandt, 1998).  It is, therefore, not surprising 
that the expression of GAP-43 is down-regulated in the mature CNS, but elevated 
during both neuronal development and regeneration (Goslin et al., 1988; Cantallops and 
Routtenberg, 1999).  
 
However, observations from fixed preparations of focally damaged neocortex, suggest 
that regenerating axons also have a number of features that differ from developing 
neurites, such as a high intra-axonal density of neurofilaments and club-like endings on 
distal regenerating tips (King et al., 2001). Similarly, live imaging of acute slices 
revealed that although regenerative sprouts are highly motile, they differ substantially in 
morphology to classical developmental axonal growth cones, being relatively simple 
finger-like structures (Dickson et al., 2007). Similarly,  post-injury regenerating axons 
described in the adult lamprey CNS, are neurofilament-rich, relatively simple in 
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structure and lacking filamentous actin at the sprouting tip (Zhang et al., 2005). The 
similarities and differences between regenerating and developing axons are still under 
investigation. While the cytoskeletal composition, form and behaviour of growth cones 
during development has been intensively investigated (Kalil et al., 2000; Dent and 
Gertler, 2003; Zhou and Cohan, 2004), comparatively, little is known about the 
morphology, pathway selection and biochemistry of the tips of regenerating axons. 
 
This Chapter investigated the cytoskeletal and dynamic characteristics of mature 
regenerating axons compared to developing axons in vitro, endevouring to classify the 
similarities or differences that may be present between regenerating and developing 
axons.  It involved the direct comparison of axons and growth cones in vitro during 
development and after injury, the latter ultilising an in vitro neuronal transection injury 
model (Dickson et al., 2000; Chuckowree and Vickers, 2003; Chung et al., 2003).  
Neurite transection was performed at 21 DIV, when neurons are relatively mature.  
These neurons are considered relatively mature due to the absence of developmental 
markers such as GAP-43 (Dickson et al., 2000) and the Ezrin-Radixin-Moesin family of 
membrane-cytoskeletal linker proteins (Haas et al., 2004), and the presence of markers 
indicative of neuronal maturity such as punctate synaptic proteins (mature N-methyl D-
aspartate receptors and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
receptors localized to dendritic spines) microtubule associated protein 2 (MAP-2) and 
the neurofilament triplet proteins (for example, Chuckowree and Vickers, 2003; King et 
al; 2006).  Immunolabelling for cytoskeletal markers were used to compare growth 
cones on regenerating axons to growth cones at comparable time-points during 
development in vitro.  The behaviour of growth cones during regeneration and 
development was also investigated utilising live imaging time-lapse microscopy. 
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3.2 MATERIALS AND METHODS 
 
3.2.1 Neuronal culture and in vitro model of axonal transection 
Primary dissociated cortical cultures were prepared as previously described (Chapter 
2.1)  
Axonal transection was carried out as described in Chapter 2.2 on developmental 
cultures at 5 DIV and on relatively mature cultures (21 DIV). The sprouting response 
observed in cortical culture in vitro has been shown to commence between 4 to 6 hours 
(hrs) post-injury (PI) (Chuckowree and Vickers, 2003). Therefore the imaging time-
point, 6hrs PI, represents the initial sprouting response of the transected axons, whereas 
analysis at 24hrs PI allows the examination of the sustained sprouting response. 
 
3.2.2 Growth factor application 
Two growth factors were selected on the basis of their well-established ability to 
enhance neurite outgrowth during development (Tucker et al., 2001, Airaksinen and 
Saarma, 2002, Goldberg et al., 2002) and affect terminal axonal sprouting in response to 
injury (Zhou and Shine, 2003; Hafidi et al., 2004) in other neuronal populations. Human 
recombinant Brain Derived Neurotrophic Factor (BDNF) (20ng/mL, reconstituted in 
milli Q®) (Chemicon, Temecula, CA) or Glia Derived Neurotrophic Factor (GDNF) 
(20ng/mL, reconstituted in milli Q®) (Chemicon, Temecula, CA) and vehicle controls 
(milli Q®) were bath applied to cultures at 3, 5 and 7 DIV and immediately following 
transection at 21 DIV for 16 hrs. Concentrations were based on preliminary 
investigations determining maximal effect on outgrowth, with application of an 
increased concentration (50ng/mL) not associated with enhanced neurite growth (data 
not shown). 
 
3.2.3 Immunocytochemistry 
Cultures (3, 5 and 7 DIV and 6 and 24 hrs post-injury in 21 DIV cultures) were fixed in 
4% paraformaldehyde (PFA)/0.01M PBS for 30 mins at room temperature on an orbital 
shaker. Coverslips were then processed for immunocytochemistry as described in 
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Chapter 2.4 (for antibody details see Table 2.1). To label for filamentous actin (F-actin), 
cultures were incubated with AlexaFluor 594 phalloidin (dilution 1:200; Molecular 
Probes), for 30 min after immunocytochemistry.  
 
3.2.4 Live Cell Imaging and Analysis 
Live cell imaging was carried out as described in Chapter 2.4. For the post-injury 
investigations, images immediately prior to injury were captured and referred to at the 
later time-points to ensure the axons under investigation were severed.  Axonal 
extension and growth cone motility over the 2 hr imaging time period was quantitated 
using the individual time-lapse images. Twenty-five 2 hr time-lapse images were 
included in the analysis, 5 images for each time-point from separate cultures. To 
analyse the dynamic movement of the individual axons the centre of the growth cone of 
the axon under investigation was assigned an X, Y co-ordinate every 2 mins (n=25). 
The original position of the growth cone, at the time-point 0, was assigned the X, Y co-
ordinate 0,0. The original X, Y position was then subtracted from subsequent X, Y co-
ordinates. Mean axonal extension was calculated by determining axonal length over the 
two-hours, measured at 10 min intervals. Growth cone behaviour was analysed every 
minute (n=25) and classified as extending, pausing or retracting, calculated as a 
percentage of the total time imaged. For growth factor application experiments, neurite 
length was measured using OpenLab software. t tests or ANOVA were performed on 
quantitative data, with post hoc comparisons (Bonferroni test) as appropriate using 
Prism v4.0 software (Graphpad, USA).
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3.3 RESULTS 
3.3.1 Regenerating cortical neurons have a similar cytoskeletal profile to 
developing neurons in vitro 
Immunocytochemistry was performed at 5 DIV and following transection at 6 hrs post-
injury (Figure 3.1). Immunolabelling with antibodies to both tau (an axonal marker) and 
MAP-2 (a somato-dendritic marker) was used to confirm the axonal identity of the 
neurites under investigation (Figure 3.1A,B,E and F). Tau and MAP-2 were co-localised 
within the cell bodies of developing neurons, with MAP-2 immunolabelling confined to 
the cell bodies, dendrites and proximal axonal extensions by 5 DIV (Figure 3.1). At 6hrs 
PI, tau labelled neurites traversed the injury site. These sprouts, were not immunopositive 
for MAP-2, suggesting that they were predominately of axonal origin. High power 
magnification of growth cones labelled with antibodies to both tau and MAP-2 
additionally confirmed that the growth cones under investigation were of axonal origin, ie 
tau immunopositive only (Figure 3.1E and F). Furthermore, the regenerative sprouts were 
immunopositive for βIII-tubulin, but showed little immunolabelling for the medium 
molecular weight neurofilament triplet protein (NF-M) (phosphorylation independent 
epitope). Similarly, labelled developing cultures revealed an abundance of βIII-tubulin 
throughout the neurites and extending into the growth cone with NF-M confined to the 
centre of the axon shaft (Figure 3.1C and D).  
 
Comparison of growth cones on developing axons and on the tips of regenerative sprouts 
demonstrated distinct differences between the two structures. F-actin staining (Figure 
3.2C and D), labelling with antibodies to the actin/membrane binding ERM proteins 
(Figure 3.2A and B) and DIC images (Figure 3.4) indicated that regenerating growth 
cones were notably smaller than their developmental counterparts, with shorter filopodial 
extensions. Immunolabelling with antibodies to βIII-tubulin, ERM proteins, tau and F-
actin staining with phalloidin, demonstrated similar labelling patterns within the 
developing and regenerating growth cones. βIII-tubulin was confined to the central 
domain while ERM proteins were localised to the peripheral domain and the distal tips of 
filopodia (Figure 3.2A and B). Furthermore, there was colocalisation of F-actin and tau 
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throughout both developmental and regenerative growth cones (Figure 3.2C and D), with 
tau localised not only within the central domain, but additionally it crossed the 
transitional domain into the periphery of the growth cone. 
 
3.3.2 There was a significant difference in axonal outgrowth between developing 
and regenerating cortical neurons in vitro  
Analysis of growth cone position over a 2 hr period demonstrated that developing axons 
exhibit a wide range of movement involving rapid phases of extension and retraction 
with many changes in direction (Figure 3.3).  This exploratory motility, was observed at 
3, 5 and 7 DIV, however, the mean axonal outgrowth was shown to decrease with age 
of culture. Neurons at 3 DIV exhibited the greatest mean axonal extension over the 
imaging period (14.39 +/- 4.01µm n=5).  At 5 DIV, the mean axonal extension was less 
(12.98 +/- 2,32µm n=5), but not significantly (p>0.05), with significantly (p<0.05) less 
axonal extension occurring at 7 DIV (6.19 +/- 0.98µm n=5). The post-injury sprouting 
axons also exhibited the exploratory motility observed in developing axons, however, 
their mean axonal extension was significantly (p<0.05) less at 6 hrs (4.03 +/- 0.89µm 
n=5) and 24 hrs post-injury (5.12 +/- 1.2µm n=5), in comparison to that observed in the 
developing axons at 3 and 5 DIV. There was no significant difference between the two 
PI time-points. 
 
3.3.3 Growth cone morphology and behaviour in response to injury was 
significantly different in comparison to development 
Time-lapse analysis of developing axons revealed a range of growth cone 
morphological forms. Furthermore, as previously reported, the morphology of the 
growth cone was related to the growth cones’ behaviour (Skaliora et al., 2000). 
‘Extending’ and ‘retracting’ growth cones exhibited simple streamline forms (Figure 
3.4A). However, when a growth cone was ‘pausing’, with no net growth, the 
morphology dramatically changed to become large and considerably more complex in 
shape (Halloran and Kalil, 1994; Kalil, 1996; Skaliora et al., 2000). The same range of 
dynamic morphological alterations was not observed in the regenerating sprouts (Figure 
3.4B). Instead growth cones of regenerating axons exhibited a constant morphology, 
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with less elaborate protrusions over the two-hour imaging sequence independent of 
behaviour.  Dynamics after axonal injury was also investigated in 5 DIV developing 
neurons at 6 hrs PI, however, consistent with previous studies in our laboratory, no net 
growth or growth cone elaboration occurred (Figure 3.4C) (Dickson et al., 2000). 
 
Growth cones of developing and regenerative axons underwent distinct and quantifiable 
phases of extension, retraction and pausing (Figure 3.5A). At 3 DIV, growth cones 
spent 46.39 +/-2.06% extending, 28.82 +/-1.30% retracting and 24.79 +/-1.31% 
pausing. At 5 DIV growth cones spent 40.09 +/-2.94% extending, 30.80 +/-1.67% 
retracting and 29.10 +/-3.20% pausing. At 7 DIV growth cones spent 38.55 +/-2.87 % 
extending, 26.67 +/-1.15% retracting and 35.19 +/-3.2% pausing. At 3 DIV, 
significantly (p<0.05) more extension and less pausing than 7 DIV was observed 
(p<0.05). The tips of post-injury regenerative sprouts behaved quite differently. At both 
6 (57.75 +/-2.48% extending, 34.36 +/-2.56% retracting and 8.03 +/- 0.65 % pausing) 
and 24 hrs post-injury (55.56 +/-4.49% extending, 34.68 +/-2.04% retracting and 9.77 
+/-1.53% pausing), the growth cones on the end of regenerative neurites spent a 
significantly (p<0.05) greater percentage of time extending and less time pausing.  
There was a 36% increase in extension behaviour and a striking 70% reduction in 
pausing behaviour in the growth cones of regenerative neurites compared to 
developmental growth cones. 
 
3.3.4 Post-injury regenerative sprouts were unresponsive to growth factors 
At 3 DIV application of both BDNF and GDNF significantly (p<0.05) increased the 
mean neurite length of neurons in vitro (Figure 3.5B). At 3 DIV the mean neurite length 
of the control treatment was 41.22 +/- 2.18µm (n=380). The mean neurite length with 
BDNF treatment was 54.86 +/-4.92µm (n=404); the mean neurite length with GDNF 
treatment was 53.97 +/- 3.36µm (n=445). Similarly at 5 DIV, both BDNF and GDNF 
treatment resulted in  significant (p<0.05) increase in the mean neurite length. At 5 
DIV, the mean neurite length of the control treatment was 64.56 +/-8.11µm (n=344), 
with BDNF treatment was 75.53 +/-9.15µm (n=329) and the mean neurite length with 
GDNF treatment was 79.71 +/-9.93µm (n=334). At both 3 and 5 DIV there was no 
significant (p>0.05) difference between the effects of the two growth factors, relative to 
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controls. BDNF and GDNF had little effect on neurite length at 7 DIV, the mean neurite 
length of the control treatment was 90.33 +/-7.23µm (n=349), with BDNF treatment 
was 93.34 +/-8.46µm (n=343) and the mean neurite length with GDNF treatment was 
96.98 +/-9.22µm (n=313). Incubation of relatively mature cell cultures with BDNF, 
GDNF or a vehicle control following axonal bundle transection had no significant 
(p>0.05) effect on neurite outgrowth in the 16hrs following transection (Figure 3.5B). 
The mean neurite length of the control treatment was 59.03 +/-6.44µm (n=96). The 
mean neurite outgrowth with 20ng/mL BDNF treatment was 59.87 +/-5.27µm (n=112); 
the mean neurite outgrowth with 20ng/mL GDNF treatment was 57.22 +/-6.19µm 
(n=98).  The punctate pattern of localisation of the BDNF receptor, Trk B, throughout 
the cell clusters and processes in development and relative maturity (Barnabé-Heider 
and Miller, 2003; Swanwick et al., 2004; Gomes et al., 2006) demonstrated widespread 
receptor expression by multiple cortical neuronal phenotypes, as shown by co-
immunolabelling for βIII-tubulin (Figure 3.6). 
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3.4 DISCUSSION 
 
Immunocytochemistry, with antibodies to both the axon and dendrite specific 
microtubule associated proteins, tau and MAP-2 respectively, enabled the visualisation 
of stages of neuronal morphogenesis - the rapid elongation of multiple dendrites and a 
single axon. Furthermore, the sprouting response of the mature injured axons in vitro 
(Dickson et al., 2000; Chuckowree and Vickers, 2003) was also demonstrated with 
axon-specific markers. Developmental axon extension requires the assembly and 
reorganisation of the cytoskeleton (Dent and Gertler, 2003), with the role of 
microtubules, neurofilaments and F-actin in this process well characterised (reviewed in 
Brandt, 1998). Recent data suggests that assumptions that the same dynamic processes 
are required for regenerative sprout elaboration may not be valid. Studies on 
regenerating lamprey reticulospinal axons indicate that regenerating axons appear to 
extend without growth cones or F-actin accumulation at their tips (Lurie et al., 1994; 
Zhang et al., 2005). It has been postulated that regenerative axonal outgrowth may be a 
direct result of protrusive forces created by tubulin and neurofilaments (Jones et al., 
2006).  
 
In the current study, DIC/live images, with F-actin staining and labelling for the ERM 
family of actin/membrane binding proteins demonstrated that the growth cones present 
on the tips of regenerative sprouts were smaller, with some lacking the complex 
morphology of developmental growth cones (Chuckowree and Vickers, 2003; Haas et 
al., 2004). Despite these differences, the regenerating and developing axons exhibited 
the same labelling profile for a range of cytoskeletal proteins.  Both the developmental 
growth cones and the tips of the regenerating axons contained isoforms of microtubules, 
as indicated by tau and ßIII-tubulin labelling. Likewise, there was comparable 
localisation of F-actin and associated binding proteins, indicated by phalloidin staining 
and ERM labelling.  However, immunoreactivity for the medium molecular weight 
neurofilament triplet protein, NF-M, consistent with previous investigations (King et al., 
1997; Dickson et al., 2000; 2005), was confined to the neurite shafts proximal to the 
lesion, and was completely absent from regenerative and developmental growth cones.  
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This pattern of labelling has been reported for other intermediate filament proteins at 
these ages including α-internexin (Dickson et al., 2005) and the high molecular weight 
subunit of the neurofilament triplet proteins, NF-H (Dickson et al., 2000). The 
comparable expression and localisation of tau and ßIII-tubulin, NF-M and F-actin in 
post-injury and developing axons and growth cones suggests that regenerating axons 
possess the cytoskeletal capacity for motility and extension (Chuckowree and Vickers, 
2003; Haas et al., 2004). 
 
In agreement with in vivo studies, developing axons, in vitro, exhibited characteristic 
movement, such as outgrowth, retraction, stalling and turning and a mean decrease in 
outgrowth with age (Suter and Forscher, 2000; Gordon-Weeks, 2004). This decline in 
outgrowth, demonstrated in vivo (Li et al., 1995; Blackmore and Letourneau, 2006) may 
be representative of the decreased requirement for outgrowth as development 
progresses, and the axon reaches its correct target and synaptogenesis occurs. A 
significantly decreased rate of axonal outgrowth also occurred after injury, again 
indicating that maturing neurons undergo a decline in the expression of genes associated 
with developmental axonal growth (Cia et al., 1999), resulting in less regenerative 
capacity.  
 
In vivo and in vitro analysis has shown that growth cone morphology correlates with 
characteristic movement (Halloran and Kalil, 1994; Kalil, 1996; Skaliora et al., 2000). 
In the current study, developmental growth cones spent a proportional percentage of 
time extending, pausing and retracting, which was highly comparable to characteristic 
behaviour analysis in vivo by neurons, at decision points in the developing brain 
(Skaliora et al., 2000). Regenerative growth cone behaviour was in striking contrast to 
that observed during development. The regenerating growth cones exhibited a greater 
tendency to extend and spent little time pausing. Growth cone pausing is implicitly 
linked to pathway selection (reviewed in Dent et al., 2003). Additionally, pausing of the 
primary growth cone of developing neurons has been highly correlated with interstitial 
axonal branching (Szebenvi et al., 1998; Kalil et al., 2000). The regenerating axons lack 
of pausing may result in impeded pathfinding and/or an inability to appropriately 
branch, both of which would contribute to a poor outcome post-injury. Furthermore, 
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aberrant sprouting has been documented in both in vitro (McKinney et al., 1997) and in 
vivo (Salin et al., 1995; Kerschenstiner et al., 2005) studies of CNS trauma. This 
sprouting may be attributable to an intrinsic lack of the regenerative growth cones 
ability to ‘path-find’ appropriately.   
 
The inability of mature axons to regenerate may also be due in part to the absence of 
growth permissive signals or the presence of growth inhibitory cues at the site of injury. 
The current chapter investigated the application of two known growth cues, in an 
environment absent of inhibitory cues. Previous studies by Goldberg and colleagues 
demonstrated BDNF, GDNF and ciliary neurotrophic factor, to be the most potent axon 
growth factors on retinal ganglion cells (Goldberg et al., 2002).  Interestingly, both 
BDNF and GDNF act on the same family of receptors and potentially affect the same 
downstream signalling pathway for neurite outgrowth.  Acting on tyrosine kinases 
receptors (BDNF acting on the Trk B receptor and GDNF eliciting its effect on neurons 
through a multicomponent receptor complex involving GFRα-1 and Ret) both BDNF 
and GDNF have been implicated in survival, differentiation and neurite outgrowth 
(reviewed in Korsching, 1993).  In this chapter’s experiments, both growth factors 
caused an increase in neurite extension during development (Tucker et al., 2001; 
Airaksinen and Saarma, 2002; Goldberg et al., 2002), with the effect decreasing with 
age (Niwa et al., 2002). The increase in neurite length was irrespective of the growth 
factor applied, indicating the degree of functional redundancy in the signalling 
pathways. In contrast, neither growth factors affected post-injury axonal outgrowth, 
suggesting that growth promoting signals alone is not sufficient to overcome the 
intrinsic inhibition of mature axons to regenerate.  Growth factors have been shown to 
promote terminal axonal sprouting in the mature nervous system in other neuronal 
phenotypes including cortical neurons (Zhou and Shine, 2003; Hafidi et al., 2004). 
Differential expression of BDNF and GDNF receptor components has been 
demonstrated in neurons of the cortex in the immediate post-injury period (Bakshi et al., 
2006), however, the present experiments demonstrated robust and consistent Trk B 
localisation in the cortical cultures at both 5 and 21DIV across multiple neuronal 
phenotypes, therefore making it unlikely that lack of responsiveness was due to simply 
to lack of receptor expression. This data further supports recent reports indicating the 
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presence of Trk B receptors in cultured cortical neurons, both excitatory and inhibitory, 
from 1 to 16DIV (Gomes et al., 2006) and in cultured hippocampal neurons from 1 to 
21DIV (Swanwick et al., 2004). 
 
Classically, the local sprouting of axons at the site of injury has been taken to indicate 
that CNS neurons successfully initiate axon regeneration that is then impeded by the 
non-permissive environment. Whereas recent advances have lead to attempts at 
identifying and overcoming the extrinsic inhibitory factors that exist in the CNS 
environment the mechanisms underpinning the intrinsic incapacity of mature CNS 
neurons to recover from trauma remain to be fully elucidated. The current Chapter 
provides significant insight into why regenerative attempts are limited or aberrant, with 
increased understanding of this phenomena essential to the development of post-trauma 
interventions. Our results indicating a preserved cytoskeletal capacity to respond to 
trauma suggest that the differences responsible for the variation may lie at the level of 
the growth cone, specifically with regards to expression of growth and guidance factor 
receptors. 
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4 AXONAL SHEARING IN MATURE CORTICAL NEURONS INDUCES 
ATTEMPTED REGENERATION AND THE REESTABLISHMENT OF 
NEURITE POLARITY 
 
4.1  INTRODUCTION 
 
There are varying degrees and regions of focal and diffuse injury that can occur in TBI 
(reviewed in Farkas and Povlishock, 2007), which plays a role in making the 
pathobiology complex and intervention difficult.  A full understanding of the response 
of the brain to various modes of injuries and mechanisms underlying these responses is 
a fundamental priority in neuroscience research.  Thus, a range of animal models both 
in vitro and in vivo has been developed in an endeavour to elucidate the response of the 
brain to TBI.  In vitro animal models, while largely two dimensional, can be 
advantageous in unravelling specific pathology and mechanisms as they allow for the 
precise control of the extracellular environment, are repeatable, have relatively low 
economic costs (Morrison et al., 1998) and have been shown to produce results 
consistent with those obtained from comparable in vivo models (Dotti et al., 1988; 
Banker and Goslin, 1988; King et al., 2001; Dickson et al., 2005; Chuckowree and 
Vickers, 2003). 
 
As previously discussed, successful regeneration will require the survival and 
appropriate polarisation of injured neurons with the formation, robust extension and 
pathfinding of the axonal growth cone.  Furthermore, the neuronal response to injury is 
heavily influenced by the action of surrounding non-neuronal cells such as the 
oligodendrocytes, astrocytes and microglia (Aldskogius and Kozlova 1998; Tao and 
Aldskogius 1999; Cullheim and Thams, 2007; Carlson et al 2009).  Astrocytes undergo 
adaptive reactive alterations in response to injury involving proliferation, hypertrophy 
and the secretion of various factors that culminate in the formation of the glial scar 
(Maxwell et al., 1990; Raivich et al., 1999; Chen et al., 2003 a,b and Galtry et al., 
2007). Thus, the response of mature neurons to injury is dependent upon the neuronal 
injury and the surrounding cells.  Firstly, the intrinsic response of axons to injury 
remains to be fully elucidated.  Secondly, how the inhibitory environment affects the 
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response of injured axons still needs to be clarified.  For example while astrocytes 
facilitate brain function in an uninjured brain, whether astrocytes play an overall 
beneficial or adverse function after brain injury remains unclear.  
 
While axons are particularly vulnerable in TBI (Maxwell et al., 1997), focal injury of a 
specific single axon rarely occurs (Farkas and Povlishock, 2007). Rather, most axonal 
injury occurs in a diffuse manner affecting multiple neuronal and non-neuronal cells 
(Stone et al., 2004; Singleton and Povlishock, 2004; Gallyas et al., 2006).  Thus the 
current chapter endeavoured to develop an in vitro model of axonal injury that involved 
a total shearing of many axonal process from the neuronal cell body.  The ability of 
relatively mature neurons to survive and attempt a regenerative response after this novel 
model of axonal shearing was under investigation.  The axonal shearing injury was 
performed through enzymatic dissociation and mechanical axonal stripping which 
resulted in a complete stripping of axons from the cell body clusters.  The response of 
the neurons to this mode of axonal injury, and in comparison to the transection model of 
injury previously described in Chapter 1, was investigated using a combination of live 
imaging and immunocytochemical analysis. Furthermore, the effects an activated 
astrocyte monolayer had on the response of the regenerating axons was also determined. 
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4.2 MATERIALS AND METHODS 
 
4.2.1 In vitro model of structural injury 
Primary neuronal culture was prepared as described in Chapter 2.1.  Structural injury, 
using a combined chemical and mechanical approach, was performed on cortical 
neurons in long-term culture (21 DIV). Specifically, cultures were treated with 200µL 
of 0.05mg/mL trypsin/EDTA (Sigma, USA) for 5mins at 37°C, at which time neuronal 
cells clusters were beginning to loosen and lift from the underlying substrate.  Neuron 
clusters were then mechanically dislodged from the coverslip using a cell scraper 
(Iwaki, Japan). 200µL of initial NeurobasalTM media was added to each well to inhibit 
trypsin activity prior to centrifugation (200g, 5 mins). The cell pellet was resuspended 
in initial NeurobasalTM media and gently triturated through a 1mL pipette. This did not 
result in the formation of a single cell suspension, but instead maintained the structural 
integrity of the original cell clusters, and the processes within it, whilst completely 
removing the interconnecting axonal bundles.  Suspended cell clusters were re-plated on 
poly-L-lysine coated coverslips in 1mL of NeurobasalTM initial plating media (see 
above). At 24 hrs post-injury, media was removed and replaced with 2ml of 
NeurobasalTM supplemented with 2% B27, 0.5mM L-glutamine and 
penicillin/streptomycin antibiotics.  To investigate the interaction between injured 
neurons with astrocytes, structurally injured neurons were also re-plated onto a 
confluent astrocyte monolayer. As a control for astrocyte reactivity, supernatant from 
the injured neurons was also plated onto an astrocyte monolayer. For cell proliferation 
studies 5-bromo-2’-deoxyuridine (BrdU, Sigma, USA, 5mM) was applied to cultures at 
4 hrs post-injury and the cells fixed at 24 hrs post-injury. 
 
4.2.2 Immunocytochemistry 
Cultures were fixed in 4% PFA/0.01M PBS for 30mins at room temperature on an 
orbital shaker at either 3 or 21 DIV and 6 or 24 hrs post-injury and double-
immunolabelled with a range of primary antibodies (as detailed in Table 2.1), as 
previously described (Chapter 2.4). To label for filamentous actin (F-actin), cultures 
were incubated with AlexaFluor® 594 phalloidin (dilution 1:200; Invitrogen, USA), for 
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30mins after immunocytochemistry. Immunolabelling was visualised using microscopes 
and cameras detailed in Chapter 2.4.  
 
4.2.3 Live Imaging 
Time-lapse imaging was conducted as previously described (Chapter 2.4; Chapter 
3.2.4).  
4.2.4 Statistical analysis 
For quantitative analysis of mean fluorescence intensity, images were captured at the 
same exposure, time and magnification (400x). Regenerative sprout lengths and 
percentages with growth cones (n= 473) and growth cone area (n=400 for each 
condition) were quantitated with ImageJ software. ANOVA, with post hoc comparisons 
(Bonferroni test), and Students’ t-test was performed on quantitative data as appropriate 
using Prism v4.0 software (Graphpad, USA). 
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4.3 RESULTS 
 
4.3.1 Cortical neurons survive injury and exhibit a post-injury regenerative 
response  
Dissociated cortical neurons adhered, formed cell clusters and elaborated neurites 
within the first week in vitro. By 21 DIV neuronal clusters, interconnected by large 
networks of axonal bundles, were extensive across the coverslip surface (Dickson et al., 
2000; Chuckowree et al., 2003; Haas et al., 2004) (Figure 4.1A,B).  
 
Neuronal clusters were completely stripped of extending axonal processes through a 
chemical - trypsin mediated, dissociation from the substrate combined with mechanical 
removal of the clusters using a cell scraper, and the remaining axonal connections 
through trituration. By 6hrs post-injury, neurons that had been replated onto a new 
substrate of poly-L-lysine, remained clustered, however, no neurites extending from the 
clusters were present (Figure 4.1C). By 24hrs post-injury the injured neurons had 
elaborated new processes, extending out on the substrate, mean length 67.31 +/-
15.01µm (Figure 4.1D). Unlike the tightly associated axon bundles present prior to 
injury, the newly sprouting neurites were present as single processes (Figure 4.1E) that 
by 7 DIV were able to connect with other surrounding cell clusters (Figure 4.1F).  
 
Previous investigations indicate that cultured neurons derived from the cortex represent 
a heterogeneous population of cells (Dickson et al., 2000; Chuckowree et al., 2003; 
Haas et al., 2004). To determine if the post-injury sprouting response was restricted to 
particular subsets of this population, injured neurons were fixed at 24 hrs post-injury 
and immunolabelled for cell-type specific proteins. A population of the surviving 
injured neurons that elaborated sprouts post-injury were positive for calretinin (Figure 
4.2), a calcium binding protein localised to a subset of GABAergic interneurons 
(Pappas and Parnavelas, 1998).  However these sprouts remained locally within the 
neuronal cell cluster and did not extend out onto the poly-L-lysine substrate, beyond 
0.00µm from the cell cluster border. Other sprouts emanating from injured neurons 
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were immunopositive for SMI312, an antibody that labels phosphorylated 
neurofilament triplet proteins (Figure 4.2).  SMI312 sprouts were emanating out from 
the cluster into the lysine substrate.  No colocalisation between labelling for calretinin 
and SMI312 was evident.  
 
4.3.2 Neurite lesion does not stimulate neurogenesis 
BrdU incorporation with double labelling immunofluorescence studies were performed 
to determine whether neurogenesis had occurred in our in vitro neurite lesion model.  
The injured neurons that had adhered to the fresh substrate did not incorporate BrdU 
(Figure 4.3A-C). Double labelling with nestin an intermediate filament protein 
expressed by neural precursors (Figure 4.3D) (for a review see Michalczyk and Ziman, 
2005) and the neuronal marker tau (Figure 4.3E), indicated that there were nestin 
positive cells within the cell cluster, however these cells did not co-localise with tau 
(Figure 4.3F).  Nestin positive cells (Figure 4.3G) were also immunopositive for the 
antibody directed towards the astrocyte marker protein glial fibrillary acidic protein, 
GFAP (Figure 4.3H,I). 
 
4.3.3 Relatively mature neurons demonstrate neurite polarisation following 
injury 
Chapter 3 demonstrated that at 21 DIV, prior to structural injury, cultured neurons 
expressed specific cytoskeletal associated proteins indicative of cellular maturity such 
as tau and MAP-2 (Chuckowree and Vickers, 2003; Haas et al., 2004). In the current 
investigation Tau was localised throughout cell bodies and axonal bundles (Figure 
4.4A).  MAP-2, a somato-dendritic marker was confined in its expression and 
specifically labelled the cell body cluster and dendrites extending only a short distance 
from the cluster (Figure 4.4B), but was not present within interconnecting process 
bundles (Figure 4.4C). This polarisation of neuronal processes has been previously 
established to occur, in vitro, during early development (Dotti et al., 1988; Banker and 
Goslin, 1988), with the elaboration and specification of an axon occurring at 48hrs (de 
Anda et al., 2005). At 24hrs post-injury, confocal microscopy revealed that the 
processes emanating from the cell cluster were already immunopositive for tau only 
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(Figure 4.4D and G) with MAP-2 expression again restricted to cell bodies and minor 
processes confined to the cell cluster (Figure 4.4E and H). MAP-2 and tau expression 
was compartmentalised with no-colocalisation of expression (Figure 4.4F and I). 
Additionally, tau labelling indicated that the morphology of the sprouts emanating from 
the cell clusters was consistent with that reported for axons during development (Dotti 
et al., 1988). 
 
4.3.4 Regenerating growth cones are smaller than developmental growth cones 
but are cytoskeletally comparable 
By 24 hrs post-injury, approximately half of the regenerative axonal sprouts (57.3 +/- 
3.19%) were tipped by growth cone like structures. Comparative analysis of the mean 
area of the growth cones at the end of developing and post-injury axons revealed that 
the structures on the tips of regenerative neurites were significantly (p<0.05) smaller 
than their developmental counterparts at 3 DIV (Figure 4.5A). Replating the injured 
neurons onto the astrocyte monolayer resulted in increased GFAP expression and 
altered astrocyte morphology, indicative of increased reactivity (Raivich et al., 1999) 
(Figure 4.5B,C).  However, comparison between the mean areas of growth cones of 
neurons plated onto a substrate of poly-L-lysine or an astrocyte monolayer revealed no 
significant (p<0.05) differences in growth cones area in both developing neurons and 
injured neurons (Figure 4.5A). Application of either uninjured embryonic neurons or 
conditioned media from injured neurons did not elicit astrocyte reactivity (data not 
shown). 
 
Immunocytochemical labelling with a range of cytoskeletal and growth associated 
proteins in the growth cones of developing axons and on the tips of the axonal sprouts 
further demonstrated this distinct difference in size however, specific protein 
localisation patterns were comparable (Figure 4.6A-L). Growth cones on the tips of 
developing axons possessed complex tau (Figure 4.6A) and F-actin (Figure 4.6D) 
labelled structures. Tau and F-actin expression was concentrated in the central domain 
of the developmental growth cone and also crossed into the transitional domain into the 
periphery of the growth cone (Figure 4.6C and F). The growth cones on the tips of 
regenerative sprouts had a less extensive pattern of tau (Figure 4.6G) and F-actin 
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(Figure 4.6J) localisation that was evident only in the central domain of the growth cone 
(Figure 4.6I and L). These smaller regenerative growth cones appeared to be lacking the 
peripheral domain evident in the developmental growth cones.  Alpha-acetylated 
tubulin was localised predominately to the neurite shaft in both developmental (Figure 
4.6B,C) and regenerative (Figure 4.6H,I) growth cones and GAP-43 expression was 
present predominately within the central domain of both developing (Figure 4.6E,F) and 
regenerating growth cones (Figure 4.6K,L).   
 
4.3.5 Growth cone dynamics of regenerative sprouts differ from development 
Live imaging over a two-hour period was used to investigate the dynamics of the 
growth cones of sheared regenerative axonal sprouts compared to that occurring during 
development (Figure 4.7A,B). Analysis of growth cone position over this time 
demonstrated that developing axons exhibit a wide range of movement involving rapid 
phases of extension and retraction with many changes in direction, as previously 
reported in Chapter 3 (Figure 4.7A,B).  Analysis of regenerative growth cones, post-
injury, revealed that the growth cones underwent distinct and quantifiable phases of 
extension, retraction and pausing.  The growth cones present on the tips of regenerative 
sprouts, at 24hrs post-injury, spent 55.78 +/- 1.61 % extending, 33.93 +/- 1.27 % 
retracting and 10.28 +/- 0.61 % pausing (n=5) (Figure 4.7B). This data indicates that 
growth cones post-injury spent a significantly (p<0.05) greater percentage of time 
extending and a significantly (p<0.05) lower percentage of time pausing, as compared 
to developmental growth cones at 3, 5 and 7 DIV; replicating the data for regenerating 
growth cone behaviour following axonal transection, investigated in Chapter 3. 
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4.4 DISCUSSION 
 
TBI can be categorised into two broad phases; the direct injury occurring from the 
tearing of shearing of axons at time of impact and the sequence of events occurring after 
injury, known as secondary injury. The current experiments utilises a simple, 
reproducible and novel in vitro model replicating the primary axonal tearing and 
subsequent regenerative sprouting in cultured primary cortical neurons. This model 
utilises mechanical tearing or shearing of axons as an injury model, which may be more 
representative, than the discreet transection model, of the widespread neuronal and non-
neuronal injury occurring in vivo. To validate this model and further define the post-
injury response the dynamic and cytoskeletal axonal changes occurring after the injury 
was investigated and found a stereotype reminiscent of those observed during 
experimental and in vivo TBI and distinct from initial developmental outgrowth. 
 
While an increase in neurogenesis has been reported after brain injury in vivo (for 
example: Braun et al., 2002; Emsley et al 2005), whether such an injury evokes a 
neurogenic response that can contribute to repair remains contentious (Holmin et al., 
1997; Salman et al. 2004). Neurogenesis as a result of injury was not observed in the 
current in vitro model, as indicated by an absence in BrdU uptake and nestin labelling.  
Thus the neuronal response observed in this model can be attributed to the resident 
population of relatively mature cortical neurons.  
 
In this chapter neuronal cultures were immunolabelled for the protein calretinin, a cell 
type specific marker that labels a subset of GABAergic interneurons (Pappas and 
Parnavelas, 1998).  Calretinin immunopositive neurons survived the injury and 
extended processes from the cell clusters after replating. Similarly, another subset of 
axonal sprouts were labelled by the antibody SMI312, which specifically recognises 
phosphorylated neurofilament triplet proteins.  SMI312 has been previously reported to 
be expressed in pyramidal neurons, albeit not exclusively (Masliah et al., 1993; Dickson 
et al., 2000; 2005). These results indicate that there was not one specific cell type that 
survived the injury, instead suggesting comparable potential to survive and attempt 
regeneration across multiple neuronal populations.  However, only the SMI312 
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immunolabelled pyramidal neurons attempted to regenerate in the form of extending 
sprouts out from the cell cluster, with no calretinin immunolabelling present away from 
the cell cluster, suggesting that the regenerative sprout response observed in the Chapter 
3 and the current Chapter, may be neuronal cell type specific. 
 
As previously discussed in Chapter 3, the ability of neurons to polarise and elaborate a 
single molecularly and morphologically defined axon, tipped by a growth cone, and 
multiple, equally specific dendrites is critical to neuronal function and the establishment 
of the precise and extensive networks that characterise the brain.  Cortical neurons, in 
vitro, display markers indicative of neurite polarisation by 3 DIV (Dotti et al., 1988).  
Previous investigations in Chapter 3 established that the tightly associated neurite 
bundles emanating from the neuronal cell clusters, derived from E18 rats and grown for 
21 DIV, are primarily composed of axons, as evidenced by labelling for the axon 
specific MAP tau and no immunoreactivity for the dendritic marker MAP-2.  In the 
present set of experiments, these processes were removed, whilst leaving the cell 
cluster, and associated synaptic connections within the cluster, intact.  As such, the 
model is one of partial deafferentation, comparable to in vivo injury (reviewed in 
Chuckowree et al., 2004).  At 24 hrs post-injury, morphologically axon-like structures, 
had emanated from the cell body cluster.  Labelling for the dendrite specific protein 
MAP-2 indicated that dendritic processes remained confined to the networked cell 
clusters, consistent with that reported prior to injury. Furthermore 
immunocytochemically, after injury the differentiation of single axons and multiple 
dendrites, demonstrated by distinct compartmentalised tau and MAP-2 labelling 
(Bernhardt and Matus, 1984; Binder et al., 1985). However, regenerative axonal sprouts 
that formed post-injury did not fasciculate and extend together, as seen in the initial 
development of the culture.  Instead single axonal sprouts were distributed non-
uniformly around the cell cluster.  
 
The axon-like structures, post-injury, were tipped by a characteristic growth cone. 
Previous investigations, including those in Chapter 3, have suggested that growth cones 
on the tips of regenerating cortical neurons in vitro posses a different morphology to the 
growth cones present in development (Chuckowree and Vickers, 2003; Haas et al., 
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2004). Analysis of the mean growth cone area for developing and regenerating growth 
cones indicated that indeed, regenerating growth cones in the current model are 
significantly smaller than their developmental counterparts. Interestingly, there was no 
significant change in mean growth cone area for growth cones in contact with reactive 
astrocytes. Classically, astrogliosis has been considered one of the fundamental 
extrinsic limitations to regeneration (Silver and Miller, 2004; Fawcett 2006).  However, 
reactive astrocytes are thought to have both beneficial and undesirable effects.  
Moreover, in vitro, many studies have indicated that reactive astrocytes can be growth 
permissive (Chung et al., 2004). The astrocyte monolayer became reactive when 
exposed to the injured neurons, classified by an increase in GFAP expression and 
altered morphology (Raivich et al., 1999). The absence of reaction from both 
conditioned media and uninjured immature neurons indicated that this reactivity may be 
mediated by direct cell contact of the injured neurons. There was no significant change 
in mean growth cone area for growth cones in contact with reactive astrocytes compared 
to poly-L lysine substrate. The smaller size of the growth cones in regeneration 
compared to development, coupled with lack of response to reactive astrocytes, is 
further evidence that these structures have a diminished capacity to respond to the 
extracellular environment. 
 
Despite, these distinct morphological size differences the regenerative growth cones 
exhibited a similar complement and expression pattern of cytoskeletal proteins 
compared to that of their developmental counterparts (for review see Suter and 
Forscher, 2000; Gordon-Weeks, 2004; Pak et al., 2008). This included the presence of 
tau (Black et al., 1986), GAP43 (Goslin et al., 1988; 1990) and an F-actin network 
(Bradke and Dotti, 1999). The growth cone is vital for the translation of extracellular 
cues into pathway selection. This guidance is enabled through the interaction between 
various components of the cytoskeleton that are expressed throughout the specific 
domains of the growth cone; the central domain the transition zone and the peripheral 
domain. In the central domain no actin superstructures are present, however this area is 
rich in microtubules. The peripheral domain contains two distinct superstructures based 
on actin filaments, the linear actin bundles comprise filopodia which protrude outward 
and mesh-like actin gels comprise lamellipodia, located between the filopodia  (For 
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recent review see Pak et al., 2008). Hence the diminished surface area of regenerating 
growth cones, and the lack of an extensive peripheral domain may offer an explanation 
for the diminished capacity to ‘pause’ that was evident in regenerative axonal sprouts – 
thus morphologically resembling the dystrophic growth cones characteristic of spinal 
cord injury in vivo (Kwon et al., 2002) and in in vitro models that have also proven to 
be highly dynamic but aberrant in their ability to forward progress (Tom et al., 2004). 
 
In agreement to Chapter 3, developmental growth cones spent a proportional percentage 
of time extending, pausing and retracting, which was highly comparable to 
characteristic behaviour analysis in vivo, by neurons at decision points in the developing 
brain (Skaliora et al., 2000).   As stated, growth cone pausing is implicitly linked to 
pathway selection, and occurs in vivo in development when a growth cones reaches a 
decision region. Regenerative growth cone behaviour was in striking contrast to that 
observed during development.  The striking lack of the ability to pause, demonstrated 
by the regenerating growth cones in comparison to development, in coherence with 
Chapter 3, further suggests a lack of ability to path-find of regenerating growth cones. 
Additionally the growth cone dynamics were highly comparable to Chapter 3, 
indicating that regenerating characteristics are transferable over a range of injury 
models. 
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5 FOCAL DAMAGE TO THE ADULT RAT NEOCORTEX INDUCES 
WOUND HEALING ACCOMPANIED BY AXONAL SPROUTING AND 
DENDRITIC STRUCTURAL PLASTICITY 
 
5.1 INTRODUCTION 
 
Ultimately, an appropriate adaptive brain response to trauma will require the induction 
of neurogenesis and either directed regeneration or compensatory plasticity of neural 
pathways.  Structural injury to the brain does evoke a distinct sequence of events 
indicative of an attempt to repair and heal, including the activation of microglial, 
oligodendroglial precursor, meningeal, astrocyte and stem cell populations (Reviewed 
in Fawcett and Asher, 1999). Alterations in neural progenitor populations and cell 
proliferation have been demonstrated in diverse models of experimental brain lesion 
and stroke conditions and are proposed to contribute to post-lesion brain recovery 
(Clarke et al., 1994; Duggul et al., 1997; Holmin et al., 1997; Kernie et al., 2001; 
Arvidsson et al., 2002; Chen et al., 2003b; Douen et al., 2004; Salman et al., 2004). 
However, whether brain injury evokes a neurogenic response that contributes to 
functional recovery currently remains contentious, with the presence of neurogenic 
events differing for different injury paradigms (Holmin et al., 1997; Kernie et al., 2001; 
Kuroda et al., 2002; Rice et al., 2003; Salman et al., 2004; Yu et al., 2008). It is now 
established in Chapter 3 and 4, in agreement with previous studies, that neurons can 
also actively react to injury through the formation of reactive axonal sprouts.   However, 
another mode in which neurons respond actively to injury is through the altered 
connectivity of pre-existing pathways, compensatory plasticity (reviewed in 
Chuckowree et al., 2004; Carmichael, 2006; Fitzgerald and Fawcett 2007; Macias, 
2008).  
 
Examples of neuronal plasticity, manifesting as alterations in synaptic strength and 
wiring, remodelling of axonal and dendritic arbors and changes in dendritic spine and 
axonal bouton turnover, have been observed in the mature brain and in response to 
alterations in sensory experience and injury/lesion (for a selection of recent examples 
see Grutzendler et al., 2002; Knott et al., 2002; Trachtenberg et al., 2002; Majewska and 
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Sur, 2003; Portera-Cailliau et al., 2003; Holtmaat et al., 2005; Tailby et al., 2005; Lee et 
al., 2006; Majewska et al., 2006; Brown et al., 2007; Brown et al., 2008; Lee et al., 
2008; Yamahachi et al., 2009; Brown et al., 2010).  However, the specificity and degree 
of remodeling that can occur in response to injury has not been fully elucidated. 
Cortical neurons demonstrate axonal and synaptic remodelling in response to various 
models of injury (for example King et al., 2001; Knott et al., 2002; Trachtenberg et al., 
2002; Majewska et al., 2006). Reorganization such as this may correlate with functional 
recovery not only in stroke (Carmichael, 2003; Carmichael, 2006; Brown, 2008; De 
Filippo et al., 2008), but comparable plasticity may also account for the recovery 
observed after forms of spinal cord injury (reviewed in Edgerton, 2004; Dunlop, 2008).  
Recent research indicates that populations of interneurons within the barrel cortex 
demonstrate adaptive plasticity, specifically with regards to the remodelling of dendritic 
arbors (Lee et al., 2006; Lee, 2008).  Modifications of the dendritic tree and synaptic 
contacts may also occur following injury, with studies showing that the plastic potential 
of cortical dendrites are enhanced following injury (Kolb and Gibb, 1991; Jones and 
Schallert, 1992), lasting over two weeks post-injury (Jones and Schallert, 1992). 
Interestingly, studies have indicated that not all subpopulations of neurons are equal in 
their capacity for such adaptive structural plasticity.  For example, interneurons in the 
intact neocortex have been demonstrated to be capable of dendritic arbor remodelling 
while pyramidal neuronal subpopulations remain stable (Lee et al., 2006). 
 
The current investigations utilised a model of focal brain injury to generate a discrete 
unilateral lesion in the adult rodent somatosensory cortex. The cellular response to 
injury was investigated over a time course of up to 14 DPI (days post-injury) utilising 
immunohistochemistry and transmission electron microscopy (TEM). To determine the 
regenerative and plastic potential of different subpopulations of neurons following focal 
in vivo injury, the sprouting response and morphological plasticity of resident 
interneuron and pyramidal neuron populations around the injury site was investigated 
utilising immunohistochemistry, confocal and multi-photon microscopy. 
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5.2 MATERIALS AND METHODS 
5.2.1 In vivo brain injury  
Acute focal neocortical injuries were performed on adult male Hooded-Wistar rats (250-
270g, corresponding to approximately 8 weeks old) and adult male thy1 GFP-M mice 
(between 8-10 weeks old), the injury protocol described in Chapter 2.3. The thy1 GFP-
M mice were kept as a homozygous mouse colony, hence no routine genotyping was 
required. Thy1 GFP-M mice have a limited expression in a variety of neurons, 
including neurons within the cortex, cerebellum, motor neurons within the spinal cord, 
retinal ganglion cells and dorsal root ganglia (Feng et al., 2000).  Importantly, GFP-M 
mice were utilised by the current studies due to the fact that the expression pattern 
within the neocortex was restricted to a subpopulation of pyramidal neurons (Feng et 
al., 2000).  Following recovery, animals were terminally anaesthetised (pentabarbitone 
sodium, 140mg/kg) and transcardially perfused with 4% PFA/0.01M PBS, following a 
0.01M PBS clearing procedure, at a range of post-injury time intervals up to 14 days 
following injury (n ≥ 5 animals per time-point at 1, 7 and 14 DPI) and brains were 
processed for either immunohistochemistry or transmission election microscopy (TEM) 
as described in the relevant sections below. Non-injured, age-matched controls 
corresponding to the 1, 7 and 14 DPI time-points (n=5 animals per time-point) were 
also perfused 
 
To determine the phenotype of cells proliferating within the first 7 days following 
injury, animals were administered with 12.5mg/ml solution of the BrdU, (Sigma, USA) 
in 7mM NaOH/0.9% NaCl by intraperitoneal injection.  Animals were injected with 
BrdU (25mg/kg/day), between 1 and 6 DPI and were transcardially perfused (4% 
PFA/0.01M PBS at 7 days following injury. Prior to immunohistochemistry, antigen 
retrieval was performed by incubating sections in 2M HCl for one hour at 37°C, 
followed by three neutralisation washes in 0.1M borate buffer (pH 8.5).   
 
5.2.2 Immunohistochemistry  
Brain sections (50µm vibratome) were collected coronally and also horizontal to the 
pial surface, through the injury site, from control and experimental animals and were 
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immunohistochemically labelled in single as well as double-labelling combinations, 
with a range of cell specific antibodies (Table 2.1), as described in Chapter 2.4.    
 
5.2.3 Ultrastructural/TEM studies 
Animals were injured, as above, and then perfused at 7 or 14 DPI with 4% 
PFA/2%glutaraldehyde/0.01M PBS.  Brains were post-fixed in the same fixative 
solution overnight at 4°C and then stored in PBS until sectioned.  Small regions of the 
injury site (or equivalent regions of control non-injured brains) were removed and 
trimmed to 1-2mm cubes. Tissue blocks were then osmicated, stained with uranyl 
acetate, dehydrated and embedded in Epon resin. Thick (1µm) plastic survey sections 
were cut and stained with 1% toluidine blue in 1% borax until a suitable region was 
found. Thin sections (70-90nm) were then cut on a Reichert Ultracut ultramicrotome 
and placed onto copper-palladium mesh grids. Following staining with uranyl acetate 
and lead citrate, grids were examined using a Philips CM100 transmission electron 
microscope. 
 
5.2.4 Analysis of dendrite orientation 
For these investigations five male rats and five male thy1 GFP mice at 14 DPI were 
matched to five-control animals, for both species, with focal injuries in the 
somatosensory cortex, as detailed above, sham injury performed post-mortem. 
Vibratome brain sections (80µm) were serially sectioned through the injury site for each 
control and experimental animal, and for rat sections, immunolabelled with calretinin, 
the calcium binding protein localised to a subset of GABAergic neurons (Pappas and 
Parnavelas, 1998). A series of digital images were captured at optimal z-axis intervals 
(maximum 2.5µm), using a Zeiss LSM 510 multi-photon/confocal dual purpose 
microscope with Zen software.  Multi-photon microscopy was utilised to enable 
visualisation through the whole brain sections. Four 20x fields of view were captured 
around each injury site for two separate sections from each animal and all cells within 
the field of view identified for analysis.  Flattened 3D projection stacks were overlaid 
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with a target that had an 80µm circumference (for example see Figure 5.6 A and B), and 
analysed blinded to experimental conditions, using ImageJ© freeware.  
 
To quantify the orientation of the dendrites, the angle of all dendrites intersecting the 
80µm circumference for each neuron was measured, relative to the direction of the 
injury site.  This was calculated by drawing a line from the injury site to the centre of 
each soma and then measuring the acute angle between the intersection points for each 
dendrite at the 80µm circumference. Thus for each dendrite this angle of intersection 
ranged between 0 and 90°. Therefore an angle of 0° indicates that the dendrite is 
orientated directly in line with the injury site (either towards or away from) and angle of 
90° indicates that the dendrite is orientated laterally relative to the injury site, with a 
random distribution having an expected angle of 45° (Figure 5.6A). From this data the 
mean dendrite angle per neuron (θ) was calculated. Thus the null hypothesis was that 
there was no significant change in the mean dendrite angle, relative to the injury site, at 
14 DPI in comparison to sham-injured control. Mean dendrite angle in correlation with 
distance from the injury site were investigated for significance using two-way ANOVA, 
t-tests, and linear regression, respectively with the InStat statistical package 
(GraphPad). Circular variance of angle distribution was analysed with the Oriana 3.0 
statistical package. 
 
A limitation to analysing changes in mean dendrite angle, is that the statistical analysis 
can demonstrate significant changes in orientation relative to the control, but cannot 
give an indication of the direction of the alteration.  To determine the direction of any 
significant changes in dendrite orientation, the polarity of all dendrites was determined 
for calretinin positive neurons.  The number of dendrites in four quadrants - proximal, 
lateral 1 and 2 and distal (Figure 5.7A), to the injury site, intersecting at 80µm from the 
cell body, was calculated to determine dendrite polarity, and analysed using a two-way 
ANOVA (InStat, GraphPad). 
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5.2.5 Confocal and multi-photon microscopy 
All confocal and multi-photon images collected in this study were obtained on a Zeiss 
LSM 510 microscope, as described in Chapter 2.3.  Both lasers were passed through 
either a 20x/0.8 NA plan-apochromat (Zeiss) objective to visualise the entire injury site 
and a 64x/0.8 NA plan-apochromat (Zeiss) oil immersion objective for high power 
images. For quantification of potential dendritic changes, calretinin immunolabelled 
cells were visualised with the HeLa 594 laser passing through a 20x/0.8 NA plan-
apochromat (Zeiss), the laser and pinhole settings remaining constant.  GFP cells were 
visualised with a Mai Tai multiphoton laser, at the wavelength 850 nm, with constant 
power, passing through a 20x/1.0 DIC VIS IR W Plan-apochromat (Zeiss) water 
immersion objective. 
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5.3 RESULTS 
 
5.3.1 Focal injury induces an active healing response culminating in the 
formation of a glial scar and neovascularisation 
The cellular alterations following localised injury to the neocortex were examined at 1, 
7 and 14 DPI.  Analysis of cortical post-injury material sectioned in the horizontal plane 
revealed distinct cellular changes as the response to injury progressed, within this tissue 
core and surrounding the injury site, that were less evident using traditional coronal 
sectioning. Focal neocortical injury resulted in substantial tissue destruction at the site 
of the lesion and subsequent alterations indicative of attempted brain repair. 
Microscopic analysis demonstrated no detectable histopathological changes in control 
brains or in brain regions contralateral to the lesion site, evidenced with both resin 
sections (Figure 5.1A and F) and also with immunolabelling for GFAP (Figure 5.1K). 
The neuropil in control non-injured resin sections was essentially homogenous, tightly 
associated and dense (Figure 5.1A and F).  At 1 DPI, tissue destruction was noted 
within the injury site, with a clear needle tract being visible (Figure 5.1B). This lesion 
site at 1 DPI was characterised by massive red blood cell infiltration (Figure 5.1G). By 
7 DPI the injury site had increased in size and now ranged from 200 – 300µm in 
diameter. The blood cells that were present at 1 DPI had cleared and neovascularisation 
of the lesion site had commenced with the area infiltrated by occasional new blood 
vessels and sparsely populated with cells and processes (Figure 5.1C).  The neuropil 
within the injury site, however, remained significantly less dense than surrounding 
tissue (Figure 5.1H).  Immunolabelling for GFAP demonstrated that the injury and peri-
lesion site had now become filled with reactive astrocytes with their processes directed 
towards the central lesion site (Figure 5.1M). At 14 DPI, blood vessels permeated the 
injury tract (Figure 5.1D and I, arrows) and a significant proportion of the tract had 
closed together leaving a central dense GFAP labelled core (Figure 5.1N) (King et al., 
2001), with a glial scar extending approximately 500µm from the edges of the lesion 
(Figure 5.1N and O). GFAP immunolabelling was greatest directly adjacent to the 
injury site, as indicated by increased immunoreactivity, with this labelling progressively 
decreasing with increasing distance from the injury (Figure 5.1N and O).  
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Ultrastructural studies of the central lesion site at 7 and 14 DPI demonstrated, in support 
of immunohistochemical analysis, the presence of activated microglia with inclusions 
(Figure 5.1E) and also proliferating cells (Figure 5.1J). 
 
5.3.2 Cortical injury induces neural progenitor proliferation but not 
neurogenesis 
As noted above, proliferating cells were a prominent feature of the tissue surrounding 
the injured neocortex (Figure 5.1J). These cells were further characterised utilising the 
progenitor marker nestin and the mitotic markers, BrdU and PCNA. Nestin 
immunoreactive cells were not evident in the grey matter of the neocortex of control 
non-injured brains (Figure 5.2A), although some labelling was observed in the 
periventricular region (data not shown). By 7 DPI, nestin immunoreactive profiles were 
localised throughout the neocortical laminae and were especially abundant adjacent to 
the injury site (Figure 5.2B and C). Alterations in the localisation of nestin 
immunoreactivity within the neocortex were restricted to the ipsilateral cortex and were 
not observed in cortical tissue contralateral to the lesion. BrdU and PCNA 
immunopositive nuclei were rarely observed within non-injured tissue sections, where 
cell proliferation was limited and generally restricted to the SVZ and pial covering, with 
occasional labelled nuclei distributed elsewhere in the brain parenchyma (data not 
shown). By 7 DPI, both BrdU and PCNA labelling was distributed in a broad zone 
surrounding the injury site and extending into the corpus callosum (Figure 5.2D and E) 
and SVZ (Figure 5.2F and G), co-localising with nestin. 
 
To determine the phenotype of proliferating cells, tissue sections were double 
immunolabelled for either BrdU, in animals administered with BrdU at 1 DPI, or nestin, 
in addition to markers for astrocytes (GFAP), microglia/macrophages (ferritin) and 
neurons (NF-M, α-internexin, calretinin and parvalbumin) (Figure 5.3).  Neuronal 
markers were selected to represent pyramidal neuron (NF-M and α-internexin) and 
cortical interneuron (calretinin and parvalbumin) populations. Examination of injured 
tissue at 7 DPI showed that both BrdU and nestin immunolabelling co-localised with 
expression of GFAP (Figure 5.3A and B). Additionally, a number of ferritin positive 
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microglia/macrophages were double labelled with BrdU (Figure 5.3C) indicating they 
were mitotically active following injury.  Contrary to the widespread colocalisation 
between nestin and GFAP, nestin immunoreactivity was not localised within ferritin-
immunopositive activated microglia/macrophages (Figure 5.3D).  Furthermore, BrdU 
and nestin immunoreactivity was absent from all neuronal populations examined within 
peri lesion tissue, including those immunopositive for NF-M (Figure 5.3E and F), 
alpha-internexin (Figure 5.3G and H), calretinin (Figure 5.3I and J) and parvalbumin 
(Figure 5.3K and L). 
 
5.3.3 Pyramidal neurons respond to injury with axonal sprouting by 7 DPI 
Cortical sections, cut in a parallel/horizontal plane to the pial surface through the injury 
site at 7 DPI, were immunolabelled with a range of neuronal markers to examine the 
neuronal response to injury.  The antibody cocktail to phosphorylated neurofilaments, 
SMI312 (Figure 5.4A and B), and the intermediate neurofilament marker, α-internexin 
(Figure 5.4C and D) demonstrated that, although no neurogenesis had occurred, 
neuronal sprouting of resident neuronal populations characterised the response to injury 
at 7 DPI (Dickson et al., 2005). SMI312 and α-internexin has been previously reported 
to be expressed in pyramidal neurons, albeit not completely exclusively (Masliah et al., 
1993; Dickson et al., 2005).  Immunoreactivity for both SMI312 and α-internexin had 
increased around the injury site (Figure 5.4A and C respectively), and high power 
confocal images revealed fine sprout like structures within the injury lesion (Figure 
5.4B and D, arrows, respectively).  However, immunolabelling with calretinin, a 
calcium binding protein that labels a subset of interneurons exclusively, was confined to 
the intact tissue, with a discreet injury border (Figure 5.4F), these calretinin 
immunopositive neurons did not exhibit a sprouting response (Figure 5.4F). 
 
5.3.4 Calretinin neurons show dendritic remodelling at 14 DPI 
At 14 DPI, calretinin labelling in the injured rat brains (Figure 5.5A), and the injured 
thy1 GFP mouse brains (Figure 5.5B), confirmed that a tissue core had formed around 
the injury site (Figure 5.5A and B, dotted lines). Immunolabelling for calretinin 
demonstrated a distinguishable neuronal difference between injured and control sham-
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injured brains.  At 14 DPI the horizontally projecting dendrites of calretinin labelled 
neurons (Figure 5.5A, arrows) differed from their sham-injured controls (Figure 5.5C). 
The dendrites of calretinin labelled cells, at 14 DPI, were radially orientated around the 
lesion site. Expression of GFP in a subset of pyramidal cells at 14 DPI (Figure 5.5B), in 
comparison to contralateral control sham-injured sections (Figure 5.5D), demonstrated 
no differences in dendrite alignment between the injured and control sham-injured 
sections, albeit there was an increase in non-specific immunoreactivity around the 
injury site.  
 
5.3.5 Calretinin neurons had a significant change in dendritic orientation around 
the injury site at 14 DPI 
To quantitate injury-induced changes in the dendritic arbor orientation of calretinin 
labelled interneurons, horizontally projecting dendrites were visualised and their 
orientation relative to the injury site and control sham-injury site determined.  All 
calretinin immunolabelled cells within the four 20x fields of view around the injury 
were included in analysis for both injured and control sham-injured sections.  All 
dendrites intersecting a circumferential point 80µm from the centre of the neural cell 
body were analysed. Neurites at this distance corresponded predominately to secondary 
dendrites that were morphologically elaborate with multiple branch points.  Figure 5.6A 
and B, illustrates a representation of horizontal dendrites of neurons most characteristic 
for the populations at 14 DPI and control sham injuries, respectively.   
 
To investigate dendritic remodelling in this subpopulation of neurons, the orientation of 
the individual dendrites for each neuron was determined (see methods). The distribution 
of the mean angle of all dendrites for each neuron, from control sham-injured and 
injured animals, relative to the distance the neuron was from the injury site, is 
represented in Figures 5.6C and D, respectively.  This data demonstrates the distinct 
shift in dendrite angle relative to injury in neurons from injured brains (Figure 5.6D), 
with a trend for this shift to increase at increasing distances from the injury site, 
however linear regression demonstrated that this trend was not significant (p=0.05). 
One-way ANOVA of the mean dendrite angle for each injured cell demonstrated a 
significant (p<0.001) decrease in mean dendrite angle at 14 DPI (n=51) in comparison 
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to control sham-injured (n=82) (Figure 5.6E). Furthermore, analysis utilising biaxial θ 
parameters of circular statistics further identified a difference in plot distributions.  
Mean dendrite angle for neurons from control animals was 45.509° with a circular 
standard deviation of 10.542° and for neurons from injured animals 19.065° with a 
circular standard deviation of 17.065°.  
 
To confirm that the alteration in dendrite orientation was not a result of either dendrite 
damage or growth, the mean dendrite length and mean dendrite number was quantified.  
One-way ANOVA demonstrated no significant (p>0.05) difference in the mean number 
of dendrites between the injured and control sham-injured brains, (mean=2.97, SD=+/-
1.90 for control sham-injured and mean=2.87, SD=+/-2.16 for 14 DPI). Mean neurite 
length for all primary, secondary and tertiary dendrites and other dendrites (with more 
than three branch points) for each interneuron around the injury site in comparison to 
control, was also analysed.  The number of neurites that branched at more than three 
points was minimal (data not shown).  There was no significant (p>0.05) difference in 
mean dendrite lengths for primary, secondary and tertiary dendrites, analysed with a 
one-way ANOVA (Figure 5.6F).   
 
To determine the directionality of the decrease in mean dendrite angle, the polarity of 
each neuron investigated was determined. This was analysed by dividing the 
quantitation zone of each cell into four quadrants (Figure 5.7A). For each dendrite, the 
quadrant in which the dendrite intersects at 80µm was recorded. The quadrants were 
divided into proximal, lateral 1 and 2 and distal, relative to the injury site. Two-way 
ANOVA revealed a significant (p<0.05) increase in the mean number of dendrites in the 
distal quadrant (Figure 5.7B) at 14 DPI in comparison to the control sham-injured. 
Additionally there was a significant (p<0.05) decrease in the mean number of dendrites 
per neuron in the lateral 1 quadrant (Figure 5.7 C). 
 
5.3.6 The dendrites of pyramidal neurons expressing GFP did not undergo 
remodelling around the injury site at 14 DPI 
To investigate whether the remodelling response was specific to the calretinin positive 
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interneurons examined or was a stereotypical neuronal response, a subset of pyramidal 
neurons was also investigated in a transgenic mouse line with GFP expression restricted 
to this cell type. All GFP positive cells within four 20x fields of view around the injury 
site were included in analysis for both injured and control sham-injured sections.  
Again, dendrites intersecting a circumferential point 80µm from the centre of the cell 
bodies were analysed. Figure 5.8 A and B, illustrates a representation of horizontal 
dendrites of neurons most characteristic for the populations at 14 DPI and control sham-
injuries, respectively. Measurements of mean dendrite angle, for pyramidal neurons in 
relation to the distance of the cell from the injury site, demonstrated no significant 
(p>0.05) shift in the injured neurons at 14 DPI (n=86) in comparison to control sham-
injured (n=46) (Figure 5.8C,D,E). Additionally there was no significant (p>0.05) 
difference in mean dendrite lengths for primary, secondary and tertiary dendrites, 
analysed with a one-way ANOVA (Figure 5.8F).  
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5.4 DISCUSSION 
 
The experimental model used in this Chapter produced a discrete lesion, causing 
structural damage to the neocortical laminae, but not surrounding or underlying 
structures (King et al., 1997; 2001). This form of injury generates a stereotypical 
sequence of changes that ultimately culminate in wound healing, including phases of 
acute haemorrhage, necrosis and oedema, followed by glial activation, scar formation 
and wound contraction (Maxwell et al., 1990; King et al., 2001). The present 
investigations highlight distinct mechanisms of injury-induced neuronal plasticity, 
which are specific to discrete subpopulations of cortical neurons and progenitor cells. 
Although there was no evidence of neurogenesis within the damaged cortex, resident 
pyramidal and inter-neurons undergo contrasting alterations in response to structural 
injury; pyramidal neurons respond by elaborating fine axonal sprouts into the injury 
site, whereas interneurons undergo dendritic remodelling, whereby the dendritic arbor 
becomes reoriented away from the injury site. These responses occurred concurrent 
with a stereotypical gliogenic response. 
 
Several studies have demonstrated evidence of neuronal proliferation in response to 
experimental brain injury (for examples see Kernie et al., 2001; Rice et al., 2003), 
providing support for neurogenesis as a mechanism of brain repair following traumatic 
brain injury.  However, this and other investigations (Holmin et al., 1997; Kuroda et al., 
2002; Salman et al., 2004) have indicated that neurogenesis does not lead to nerve cell 
replacement in the neocortex following an acute focal lesion. Specifically, we observed 
nestin-labelled cells within the SVZ and corpus callosum by 7 DPI, with nestin 
immunoreactivity extending up to the injury site.  The nestin immunoreactive profiles 
present within both the SVZ and corpus callosum co-localised with the markers PCNA 
and BrdU, respectively, indicating they were mitotically active. Double labelling studies 
indicated that nestin positive cells did not express neuronal marker proteins, however 
nestin was found to co-localise with the astrocytic marker, GFAP, indicative of a 
gliogenic, but not neurogenic, response.  These results were consistent with the in vitro 
findings in Chapter 4, which additionally did not observe neurogenesis in response to 
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acute injury. Whether this upregulation of nestin is a result of new cell division or the 
re-expression of nestin within existing glia (Kronenberg et al., 2005) is unclear.  
 
The lack of post-injury neurogenesis in the neocortex, in the present investigation, may 
be due to the location and severity of the injury. Many models of cortical lesion 
generate widespread neural damage (Posmantur et al., 1996), which often directly 
affects regions associated with high plasticity, such as the SVZ or hippocampus, or at 
least damages the cortex more extensively. The model utilised in the current 
investigation, however, specifically targeted the upper layers of the cortical grey matter 
and thus may not evoke the same signalling mechanisms initiated in more disruptive 
forms of trauma.  The absence of constitutive cortical neurogenesis has been postulated 
to result from a lack of appropriate micro-environmental cues, rather than a limit of the 
endogenous precursors themselves (Emsely et al., 2005), and this deficiency may also 
account for the absence of neurogenesis in the cortex following injury in the present 
study. 
 
Focal injury to the neocortex evoked a characteristic neurite sprouting response adjacent 
to the lesion.  This sprouting response was likely to be axonal in origin and confined to 
pyramidal neurons, and was not demonstrated to occur from a subpopulation of 
interneurons immunopositive for calretinin. This induction of axonal growth after injury 
may be maladaptive, potentially exacerbating a clinically poor outcome.    Both in vitro 
studies) including the findings in Chapters 1 and 2 (McKinney et al., 1997, Chuckowree 
and Vickers, 2003), and in vivo (Salin et al., 1995) experimental models indicate that 
post-injury sprouting may not always be functionally appropriate, with potential 
aberrant axonal connectivity possibly contributing to the development of epilepsy 
following brain lesions such as stroke (Carmichael, 2003).  Furthermore, studies have 
indicated that regenerative axonal sprouts differ from their developmental counterparts, 
being tipped by bulbous end structures in vivo (King et al., 2001; Dickson et al., 2005), 
and lacking the ability to path find in vitro evidenced by an altered growth cone 
behaviour in mature regenerating growth cones in comparison to developing growth 
cones in Chapters 1 and 2.  Recent research indicates that the anatomical and functional 
plasticity of surrounding intact cortex, rather than frank regeneration of damaged 
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neurons, may play a more fundamental role following injury. Hence, understanding the 
mechanisms underpinning the lack of injury-induced axonal sprouting in interneuron 
subpopulations may reveal fundamental differences in the intrinsic plastic capabilities 
of different cortical neuron populations and what implications this may have for brain 
healing. 
 
Although post-injury axonal sprouting was shown to be specific to pyramidal neurons, 
interneurons were not without injury-induced remodelling capabilities. This chapter 
demonstrated a particularly novel property of a subpopulation of interneurons, namely 
those that were calretinin immunoreactive, to remodel dendritic arbors in response to 
acute brain lesion.  Cortical interneurons within the barrel cortex have previously been 
shown to have a capacity for morphological plasticity (Lee et al., 2006), however, this 
was under physiologically normal conditions. Furthermore, previous investigations have 
suggested that the potential sites for structural plasticity are the horizontal connections 
within the superficial layers of the cortex (Darian-Smith and Gilbert, 1994; Kaas et al., 
1990; Lee et al., 2008). Following acute brain injury in the current study, the dendritic 
arbor of calretinin positive interneurons was orientated away from the injury site, 
relative to sham-injured controls. Although it was postulated that this change in 
dendritic orientation was due to new dendrite growth in response to injury, further 
analyses of both mean dendrite number and mean neurite length revealed that neither 
parameter was altered as a result of the injury.  Hence the alteration in dendrite 
alignment was most likely a result of remodelling of existing arbors, such that those 
close to the injury retracted, while those distal to the injury grew.  These findings are 
consistent with studies demonstrating that GABA positive interneurons exhibit dynamic 
arbor re-arrangements while pyramidal populations remain stable, under physiologically 
normal conditions (Frahm et al., 2004).  
 
A subset of pyramidal neurons, specifically those expressing GFP in the transgenic 
mouse, was also investigated to determine if this remodelling was cell-type specific.  
While the injury site in these mice had formed a comparable tissue core by 14 DPI, 
which indicates an active brain response, statistical analysis revealed no significant 
remodelling in the dendrites of these pyramidal neurons.  Thus the dendritic 
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remodelling observed at around the injury site, in our model of brain injury, may be 
confined to interneurons, specifically the calretinin positive population, demonstrating a 
cell-type specific response to injury.  These findings are in coherence with studies 
demonstrating that the GABA positive interneurons exhibit dynamic arbor re-
arrangements while pyramidal populations  
 
This Chapter supports the proposal that the adult brain has a frequently unappreciated 
capacity for cytoarchitectural remodeling and repair following injury.  In particular, this 
Chapter demonstrated a novel cell-type specific response of neuronal populations to 
acute injury; a subpopulation of pyramidal neurons elaborated axonal sprouts into the 
injury site whereas a subpopulation of interneurons (calretinin neurons) underwent a 
reorganization of their dendrites for a distal bias away for the injury site.  These distinct 
responses, within different cortical neuron populations, provide novel insight into the 
potential of the mature brain for structural plasticity following injury. 
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6 COMPLETE LOSS OF THE NEUROFILAMENT LIGHT CHAIN 
PROTEIN INTRINSICALLY REDUCUES THE REGENERATIVE 
PLASTICTY OF MATURE CNS NEURONS 
 
6.1 INTRODUCTION 
 
The axonal cytoskeleton plays a vital role in axon outgrowth and pathfinding in both 
development and regeneration (Gordon and Weeks, 2004; Graham et al., 2000).  A key 
component of the cytoskeleton is the neurofilament triplet proteins, which enable 
elongation of the axons (Walker et al., 2001) and provide mechanical strength to axons 
by counteracting compressive forces of the local environment (Hoffman et al, 1984; 
Cleveland et al., 1991; Lee and Cleavland, 1996; reviewed in Lariviere and Julien, 
2004).  The neurofilament triplet component is predominately comprised of three main 
neurofilament proteins, NF-L, NF-M and NF-H. The expression of the neurofilaments 
during neuronal development follows a highly co-ordinated sequence of expression, 
which is directly related to the maturity of the neuron. During development, NF-L is the 
first neurofilament triplet protein to be expressed, which is then sequentially followed 
by NF-M and then NF-H as the neuron matures (Benson et al., 1996). However, the 
early expression of NF-L can overlap with the other neurofilament proteins, which are 
expressed early in development, α-internexin and peripherin (Willard and Simon, 1983; 
Carden et al., 1987; Escurat et al., 1990).    
 
Classically, NF-L was believed to play a pivotal role in the formation of the triplet 
protein, and importantly, without NF-L, the triplet protein would not form (Carter et al., 
1997).  Furthermore, lack of NF-L or NF-L dysfunction has been linked to the aetiology 
of amyotrophic lateral sclerosis and Charcot-Marie-Tooth disease, highlighting the 
importance of this cytoskeletal component (Beaulieu et al., 2000; Mersiyanova et al., 
2000; reviewed in Lin and Schlaepfer, 2006). NF-L forms a core of protein which NF-
M and NF-H bind to, forming the triplet protein (Nixon 1993). NF-L enables the 
formation of this triplet through binding to the protein NDel1 (Nyugen et al., 2004).  
NDel1 is the mammalian homologue of the Aspergillus nidulans NudE, which was 
initially shown to be involved in microtubule migration.  NDel1 binds directly to NF-L, 
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and indirectly to NF-H and this binding facilitates the triplet formation (Nyugen et al, 
2004).  
 
Neurofilaments have traditionally been thought to be obligate heterodimers with a 
subunit stoichiometry of 4:2:1 (NF-L:NF-M:NF-H) (Scott et al., 1985).  However, 
recent studies have challenged this traditional stoichiometry, specifically, α-internexin 
has now been shown to closely associate to the neurofilament triplet protein in vivo 
(Yuan et al., 2006).  Indeed, the purification of neurofilament quadruplets from optic 
nerve and spinal cord suggests a new stoichiometry of 4:2:2:1 (NF-L: α-internexin: NF-
M: NF-H) (Yuan et al., 2006).  The current Chapter endeavoured to investigate the 
effect a total knock out of NF-L would have on the formation of the triplet protein.  
Furthermore, while the effect such a loss of NF-L has on regeneration has been 
investigated within the peripheral nervous system (McLean et al., 2005; Toth et al., 
2008), few studies have looked at the CNS.   To investigate the role of the 
neurofilament triplet protein in regeneration a transgenic model of mice with a targeted 
disruption of the NF-L gene was utilised (Zhu et al., 1997; Zhang et al., 2002).  This 
Chapter investigated the cytoskeletal alterations, specifically the reactive and 
regenerative changes that characterise the axonal response to physical injury in neurons 
lacking NF-L.  An in vitro model of axonal transection in mouse cortical neurons was 
established, and used in conjunction with the focal neocortical injury model described 
in Chapter 5. The neuronal characteristics and response of regenerating axons was 
analysed using multi-labelling immunohistochemistry, immunocytochemistry and 
molecular techniques. 
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6.2 MATERIALS AND METHODS 
 
6.2.1 Neuronal culture and in vitro model of axonal transection 
Primary dissociated cortical cultures were prepared as previously described (Chapter 
2.1), with alterations in the protocol. A transgenic homozygous mouse colony with a 
complete knock out of NF-L on a black C57 background was utilised for these studies 
(kind donation from Dr Mala Rao, Dr Stephen Ginsberg and Professor Jean-Pierre 
Julien) compared to wild type mice derived from a black C57 mouse colony. 
Cortical neurons were derived from E14 NF-L-/- (Zhu et al., 1997) and C57/bl6 
(wildtype) mouse embryos, cultured separately.  Axonal transection was carried out on 
relatively mature cultures (15 DIV), when a reduction of developmental proteins 
coincided with the expression of proteins correlating to maturity of the neuron and its 
processes (Figure 6.1). Four injuries were made per coverslip, ensuring that complete 
axonal transection had occurred as described in Chapter 2.2, leaving a cell free lesion 
(approx 50 to 150µm wide). Cultures were fixed and examined at 24 hrs PI. 
 
6.2.2 Immunocytochemistry and Immunohistochemistry 
Cultures (3, 7 and 15 DIV and 24 hrs post-injury in 21 DIV cultures) were fixed in 4% 
PFA/0.01M PBS for 30 mins at room temperature on an orbital shaker and processed 
for immunocytochemistry as described in Chapter 2.4 (for antibody details see Table 
2.1).  For immunohistochemistry NF-L-/- mice animals were terminally anaesthetised 
(pentabarbitone sodium, 140mg/kg) and transcardially perfused with 4% PFA/0.01M 
PBS, following a 0.01M PBS clearing procedure.  Non-injured, age-matched wildtype 
controls corresponding to the 1, 7 and 14 DPI time-points (n=5 animals per time-point) 
were also perfused. Brain sections (50µm vibratome) were collected coronally and also 
horizontal to the pial surface, through the injury site, from control and experimental 
animals and were immunohistochemically labelled in single as well as double-labelling 
combinations, with a range of cell specific antibodies (Table 2.1), as described in 
Chapter 2.4.  Alexa Fluor® 594 and 488 (1:1000, Invitrogen) secondary antibodies 
(diluted in 0.01M PBS) were applied for 90 min, at room temperature. Immunolabelling 
was visualised using a Leica (Germany) DMLB2 upright fluorescent microscope. 
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6.2.3 Immunoblotting and Coimmunoprecipitation 
Coimmunoprecipitation and immunoblotting was performed on relative mature neurons 
(15 DIV).  Neurons were grown at a density of 4x108 in 25 mm flasks (Iwaki, Japan) 
and harvested at 4°C in mammalian tissue lysis buffer (Sigma, USA), supplemented 
with a cocktail of protease inhibitors and phosphatase inhibitors.  
Coimmunoprecipitation was performed using the Pierce  (USA) coimmunoprecipitation 
kit, as per manufacturers instructions.  Antibody concentrations and elution time were 
optimised.  For immunoblotting, initially, proteins were separated by SDS-PAGE using 
a Mini-PROTEAN® II (Bio-Rad, USA) system.  8.5% 0.375M Tris-HCl separating 
gels were used.  The separating gel was overlayed with a 4% 0.125M Tris-HCl, pH 6.8 
stacking gel.  Samples were prepared by dilution in 2x Laemelli sample buffer (1:2), 
which were then heat treated at 90°C for five minutes and incubated on ice for five 
minutes.  A broad range, pre-stained rainbow molecular weight marker (Bio-Rad, USA) 
was included in each separation to facilitate protein molecular weight determination.  
The gel was run at 100V for the duration of the separation. 
 
After separation, gels were stained for total protein with Coomassie stain, or used for 
immunoblotting, utilising a Mini Trans-Blot® Electrophoretic Transfer Cell (Bio-Rad, 
USA).  Prior to transfer, gels were equilibrated in transfer buffer for 15 minutes at room 
temperature, on an orbital shaker.  The gel ‘sandwich’, containing a nitrocellulose 
membrane (Bio-Rad,USA) and the gel, was inserted into the transfer cell.  Protein 
transfer was performed overnight at 4°C, 30V.  The nitrocellulose membrane was 
washed three times with tris buffered saline with tween (TTBS) for five minutes, before 
blocking with TTBS / 5% skim milk powder overnight.  Blocking solution was removed 
by washing with TTBS.  Primary antibodies were diluted in TTBS and incubated with 
the membrane overnight at 4°C on an orbital shaker.  Membranes were washed three 
times with TTBS for ten minutes, then incubated with species appropriate horseradish 
peroxidase conjugated secondary antibodies (1:1000 to 1:2000, DAKO, Denmark), 
diluted in TTBS, for 1.5 hours at room temperature, on a shaker.  After this, membranes 
were washed three times with Tris buffered saline (TBS), for ten minutes. 
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Protein bands were labelled using an ECL™ chemiluminescence system (Sigma, USA), 
according to the manufacturers instructions.  Bands were visualised on the 
ChemCapture 5000 and ChemCapture program. 
 
6.3 RESULTS 
 
6.3.1 Mouse cortical neurons develop in vitro and become relatively mature by 15 
DIV. 
The experiments included in this chapter utilised cultured cortical neurons derived from 
embryonic mice instead of rats and thus it was first necessary to determine if cultured 
mouse neurons follow a similar time-course of maturity to that established for cultured rat 
neurons.  Cortical neurons were derived from E14 mouse pups, this earlier time-point in 
comparison to rats yielding a greater proportion of viable neurons.   Cortical neurons 
were plated as a monolayer on a poly-L-lysine substrate and the expression of maturity 
related markers investigated (Figure 6.1).  Immunocytochemistry indicated that mouse 
cortical neurons became relatively mature by 15 DIV.  By 7 DIV, neurons were clearly 
polarised with MAP-2 positive dendrites and a Tau positive axon (Figure 6.1A).  
However, an increase in expression of MAP-2 was clearly evident by 15 DIV (Figure 
6.1B).  GAP-43 was enriched in cell bodies, axons, dendrites and growth cones (inset) at 
7 DIV (Figure 6.1C).  By 15 DIV the immunoreactivity of GAP43 was decreased, with 
minimal immunoreactivity in the axons and dendrites (Figure 6.1D).  Colocalisation of 
βIII tubulin and the synaptic vesicle marker synaptophysin at 7 DIV indicated that 
synaptophysin was diffusely localised in the neurites.  By 15 DIV synaptophysin was 
localised alongside the dendrite shafts (inset), demonstrating that synaptophysin had 
moved out of the dendrite shafts into the synapses, indicating mature synapses were 
present (King et al., 2006). 
 
6.3.2 NF-L-/- cortical neurons develop polarised neurites in vitro by 3 DIV 
Light microscopy and immunocytochemistry was performed on cortical neurons derived 
from wildtype control and NF-L-/-, to determine whether NF-L-/- cortical neurons 
undergo characteristic neuronal development in vitro. NF-L-/- cortical cultures adhered to 
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the substrate and had extended neurites by 3 DIV (Figure 6.2B).   These neurites were 
tipped with characteristic growth cones (Figure 6.2A and B inset).  Immunolabelling for 
the microtubule associated proteins tau and MAP-2 at 3 DIV, demonstrated that both 
control and NF-L-/- neurons had developed polarised neurites, with clearly defined 
dendrites (red) and one longer axon (green) (Figure 6.2C and D respectively). By 15 DIV 
(Figure 6.3), wildtype and NF-L-/- neurons demonstrated a comparable increase in the 
expression of MAP-2, when colocalised with Tau (Figure 6.3A and B respectively) when 
compared to 3 DIV (Figure 6.2C and D).  Labelling with an antibody directed NF-L 
confirmed that wildtype neurons expressed NF-L at 15 DIV (Figure 6.3C) while the 
neuronal cultures derived from NF-L-/- mutants had no immunoreactivity for this protein 
(Figure 6.3D). 
 
6.3.3 The expression profile of neuronal intermediate filaments in developing and 
relatively mature NF-L-/- cortical neurons differs from wildtype cortical 
neurons both in vitro and in vivo 
To investigate the expression of neuronal intermediate filaments in the NF-L-/- cortical 
neurons in comparison to wildtype cortical neurons, immunocytochemistry was 
performed on cultured neurons at 7 DIV and 15 DIV NF-L-/-.  At 7 DIV NF-M and α-
internexin were present throughout axons in both wildtype and NF-L-/- cortical cultures 
(Figure 6.4A-D).  NF-M immunoreactivity was decreased within NF-L-/- neurons (Figure 
6.4B) in comparison to wildtype control (Figure 6.4A).  However, there was an increased 
immunoreactivity for α-internexin in NF-L-/- neurons at 7 DIV, in comparison to 
wildtype control (Figure 6.4A and B). Dual labelling immunocytochemistry utilising NF-
M and α-internexin antibodies at 7 DIV demonstrated that both wildtype (Figure 6.4E) 
and NF-L-/- (Figure 6.4F) neurons extended axons that expressed NF-M and α-internexin 
independently. Additionally, at 7 DIV, there were axons present that expressed both 
proteins  (Figure 6.4E and F, arrows). Immunolabelling of NF-M and α-internexin at 15 
DIV demonstrated that wildtype axons were predominately immunoreactive for either 
NF-M or α-internexin exclusively (Figure 6.5A, arrows).  NF-L-/- axons were 
immunopositive for both NF-M and α-internexin (Figure 6.5B, arrowheads). The 
decrease in NF-M expression and increase in α-internexin expression in cultures derived 
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from NF-L-/- mice relative to wildtype mice was confirmed through a western 
immunoblot, from cells harvested at 15 DIV (Figure 6.5C).  
 
To confirm the difference in expression of neuronal intermediate filament proteins in 
vivo, dual labelling immunohistochemistry utilising NF-M and α-internexin antibodies 
was performed in neocortical neurons from coronal sections of wildtype and NF-L-/-
mice. In wildtype mice, axons of neocortical neurons similarly demonstrated 
immunoreactivity for either α-internexin or NF-M exclusively (Figure 6.5D, arrows).  In 
the NF-L-/- axons however, were primarily immunopositive for both NF-M and α-
internexin (Figure 6.5E, arrowheads) confirming the widespread colocalisation of NF-M 
and α-internexin observed in vitro in cultures derived from these animals (Figure 6.5A 
and B). 
 
The immunoreactivity profile of a range of antibodies was investigated in the neocortex 
of wildtype and NF-L-/- coronal sections.  MAP-2 labelling of the neocortex of wildtype 
and NF-L-/- sections demonstrated no detectable differences between the conditions 
(Figure 6.6A and B). Nuclear yellow staining (wildtype and NF-L-/-, Figure 6.6 B and C 
respectively) indicated that there was a similar distribution of nuclei throughout the 
neocortex. Immunohistochemistry for the interneuronal marker parvalbumin (wildtype 
and NF-L-/-, Figure 6.6E and F respectively) also did not reveal any distinguishable 
differences in the immunoreactivity pattern within the neocortex.  Parvalbumin 
immunoreactivity was widespread throughout the neocortex, with a high density of 
parvalbumin immunoreactive neurons in layer V (Figure 6.6E and F).  
Immunohistochemical labelling for the neurofilament markers SMI312, NF-M and α-
internexin in wildtype sections was predominately within the pyramidal cortical layers, 
specifically layer III and V (Figure 6.7A,C and E respectively).  SMI312 
immunoreactivity was decreased within the NF-L-/- neocortex and the distinct 
immunoreactive layer patterning demonstrated in the wildtype neocortex was not present 
(Figure 6.7B).  NF-M immunoreactivity was also decreased within the NF-L-/- cortex 
(Figure 6.7D) in comparison to wildtype control (Figure 6.7C), with no pattern of 
immunoreactivity corresponding to cortical layers.  Cortical layers within NF-L-/- 
neocortex (Figure 6.7F) were also not distinguishable with α-internexin immunoreactivity 
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in comparison to wildtype control (Figure 6.7E), despite an increase in immunoreactivity 
within the NF-L-/- neocortex (Figure 6.7E and F).   
 
 
6.3.4 The neurofilament associated protein NDel1 is present and associates with 
α-internexin in the absence of NF-L  
The deletion of NF-L-/- utilised by these studies resulted in an increase in α-internexin 
within the neurons.  Thus it was hypothesised that α-internexin may be compensating for 
the NF-L loss and allowing the formation of the neurofilament triplet protein.  
Furthermore, it was hypothesised that NDel1, in the absence of NF-L, may bind to α-
internexin to facilitate the formation of the triplet protein.  The expression of NDel1 in 
NF-L-/- and wildtype mice and it’s interaction with α-internexin was investigated using 
immunohistochemical techniques in vivo and in vitro and coimmunoprecipitation of 
protein derived from cultured neurons (Figure 6.8E). In vitro, NDel1 immunoreactivity 
was present at 15 DIV in both wildtype and NF-L-/- neurons (Figure 6.8A and B).  A 
similar immunoreactivity profile between wildtype and NF-L-/- neurons was also 
observed in vivo with NDel1 immunoreactivity being confined to axonal shafts (Figure 
6.8C and D. Alpha-internexin was immunoprecipitated from 15 DIV wildtype and NF-L-
/- neurons.  NDel1 was immunoprecipitated with α-internexin in the NF-L-/- neurons, but 
did not co-precipitate with α-internexin in the wildtype neurons (Figure 6.8D). 
 
6.3.5 NF-L-/- mice respond actively in response to a focal neocortical injury, 
which culminates in axonal sprouting and the formation of the glial scar. 
The response of the NF-L-/- to acute focal neocortical injury was investigated utilising 
the model previously described in Chapter 5. To investigate the glial response to acute 
injury in the mouse neocortex sections were immunolabelled with GFAP.  There was 
minimal GFAP immunolabelling in the uninjured neocortex of wildtype mice (Figure 
6.9A). NF-L-/- neocortex in contrast, had a population of resident astrocytes that 
expressed GFAP under physiologically normal conditions (Figure 6.9B, arrows).  This 
increase in GFAP had been previously described within the spinal cord of these mice 
(McLean et al., 2005). Immunolabelling for GFAP at 4 DPI in both NF-L-/- and wildtype 
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mice demonstrated that the injury and peri-lesion site had now become filled with 
reactive astrocytes (Figure 6.9C and D).  By 7 DPI (Figure 6.9E and F) GFAP labelling 
indicated that an astrocyte filled glial scar had formed at the injury site.  By 14 DPI 
(Figure 6.9G and H) a significant proportion of the tract had closed together leaving a 
central dense GFAP labelled core.  There were no differences between the injury 
response of the wildtype and NF-L-/- neocortex, when visualised with GFAP 
immunoreactivity.  To determine the sprouting response in both conditions, sections were 
immunolabelled with the phosphorylated neurofilament marker SMI312. At 4 DPI, 
SMI312 labelling demonstrated that NF-L-/- neurons responded actively to the focal 
injury, with fine sprouts present within the injury site similar to those present in wildtype 
mice (Figure 6.10A and B, arrows).   
 
6.3.6 There was a significant decrease in the number of NF-L-/- sprouts within 
the injury site in vitro 
To further investigate differences in the wildtype and NF-L-/- regenerative response, the 
neuronal response to injury was investigated in relatively mature neurons in vitro. The 
neuronal network of dendrites and axons in cultures at 15 DIV were completely 
transected, leaving a clear injury site (Chuckowree and Vickers 2003; Haas et al., 2004). 
Injured neurons were fixed at 24 hrs PI and the axonal regenerative response investigated 
using tau immunocytochemistry (Figure 6.11).  Fine sprouts were transversing the injury 
at 24 hrs for both wildtype and NF-L-/- neurons; these fine sprouts were tipped with 
characteristic growth cones (Figure 6.11A and B respectively, arrows). There was no 
significant difference in mean sprout length for wildtype (68.76+/-3.44µm) and NF-L-/-
(56.19+/-15.47µm) regenerative sprouts at 24 hrs PI (Figure 6.11C).  However, there was 
a significant (p<0.05) difference between mean numbers of sprouts per injury (Figure 
6.11D), was significantly less NF-L-/- (4.79+/-0.58) sprouts within the injury site in 
comparison to wildtype control (10.47+/-1.11).   
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6.4 DISCUSSION 
 
Primary neuronal cultures have traditionally been derived from rat embryos; therefore 
these protocols are well established in the literature (Dotti et al., 1988; Goslin et al., 
1990; Bradke and Dotti, 1999; Haas et al., 2004; King et al., 2006).  Increasingly 
researchers are using transgenic mice to model aspects of certain diseases and to 
understand the biological function of specific proteins, thus more recent studies report 
using cultured neurons derived from these transgenic mice (Lee and Zheng, 2008; Ashe 
and Zahs 2010; Luebke et al., 2010) These protocols are, however, less well established 
and require optimisation depending on the background of the strain.  Cortical cultures 
derived from wildtype (black C57) neurons utilised in this Chapter became relatively 
mature by 15 DIV.  While the cause for this decrease in days in vitro required by mouse 
neurons to mature in comparison to neuronal cultures derived from rats has not been 
directly determined, it is most likely reflective of variations in the gestation time 
between species. 
 
Development of NF-L-/- neurons in culture followed a similar time-course to the 
wildtype neurons, with appropriately polarised neurites extended by 3 DIV, indicating 
that NF-L is not required for neurite initiation.  This confirms the hypothesis that initial 
neurite growth and growth cone formation is governed by the microtubules and 
microfilaments (Dent and Kalil 2003; Gordon and Weeks 2004).  However, 
neurofilaments are required for appropriate neuronal polarisation (Lee and Cleveland, 
1996).   This thesis demonstrates that appropriate polarisation is not reliant upon NF-L, 
indicating a possible functional redundancy between the neuronal intermediate 
filaments in the initiation of polarisation.  Both during development and in relatively 
mature neurons, there were distinct differences in immunoreactivity for the 
neurofilaments markers NF-M and α-internexin.  
 
Previous studies have indicated that α-internexin may, under certain circumstances, 
form part of the neurofilament triplet protein.  Alpha internexin has been shown to be 
associated closely to NF-M in the optic nerve (Yuan et al., 2006), and in the absence of 
NF-L and NF-H, is required for NF-M transport (Yuan et al., 2003).  Furthermore, both 
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NF-M and α-internexin immunoreactivity is in a linear arrangement continuously down 
the axon, indicative of neurofilament triplet formation (Nguyen et al., 2004).  In the 
current study NF-M immunoreactivity was decreased in NF-L-/- mice with a relative 
increase in α-internexin both during development and after reaching maturity, 
confirmed with immunoblotting (Zhu et al., 1997; Zhang et al., 2002). Importantly, NF-
L-/- neurons both in vitro and in vivo demonstrated a complete colocalisation for NF-M 
and α-internexin, indicating that NF-M and α-internexin associated together within the 
NF-L-/- neurons.  Under normal conditions NF-L expression outnumbers α-internexin 
2:1 (Yuan et al, 2006).  Furthermore, it has been suggested that there may be a 
functional redundancy within the neurofilament triplet proteins, with deletion of one 
protein compensated for by another neurofilament (Rao et al., 2003; Yuan et al., 2003; 
Yuan et al., 2006).  The relative increase in α-internexin immunoreactivity and 
expression, coupled with the exclusive colocalisation with NF-M, indicates that α-
internexin in fact may be compensating for the loss of NF-L, providing further evidence 
that α-internexin is potentially able to form the triplet protein. 
 
Additional evidence for the role of α-internexin in the assembly of the triplet protein 
was demonstrated through coimmunoprecipitation of NDel1 with α-internexin.  NDel1 
has been shown to facilitate the formation of the triplet protein, through direct binding 
to NF-L, and indirect binding to NF-H (Nyguen et al; 2004).  In the current 
investigation, only in the absence of NF-L, did NDel1 bind to α-internexin.  This 
activity titration of NDel1 has previously been observed in the peripheral nervous 
system (Toth et al., 2008).  In dorsal root ganglia of NF-L-/- mice, NDel1 was shown to 
bind to vimentin, another intermediate filament family member (Toth et al., 2008).  The 
interaction of α-internexin and NDel1, in conjunction with the increase in expression of 
α-internexin, observed in the current study suggests that there may be a functional 
redundancy of α-internexin and NF-L, within the triplet protein.  However, the specific 
binding affinity for α-internexin with NDel1remains to be fully elucidated, and would 
provide significant insight into the role of α-internexin in the triplet protein. 
 
Behavioural analysis of NF-L null mice has shown that by 6 months NF-L-/- mice have 
mild sensorimotor dysfunction and spatial deficits (Dubios et al., 2005). The current 
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study observed discreet differences within the organisation of neocortical 
immunoreactivity of NF-L-/- mice in comparison to wildtype control. The neocortex is 
a highly specialised structure, which is organised into 6 layers, or laminae (Silberberg et 
al., 2005). In the wildtype control, labelling for the neurofilament markers was 
intensified within the pyramidal layers of the neocortex.  This layer specificity was not 
present within the NF-L-/- neocortex, which may be due to the alterations of the 
expression of neurofilament proteins in the different cell types of the cortical laminae.  
The loss of layer immunoreactivity profiles was restricted to the neurofilament proteins 
investigated, and was not present within the interneuronal populations.  The loss of 
layer specificity may affect the neural processing within NF-L-/- mutants as interactions 
between cortical pyramidal cells and interneurons facilitate highly integrated cortical 
processing (Douglas and Martin 2004).  
 
NF-L-/- null mice underwent a characteristic active response to injury, which 
culminated in axonal regeneration and the formation of the glial scar. As previously 
addressed in the current thesis, following injury neurons can attempt to regenerate in 
two ways.  This is either through the frank regeneration of the directly injured neurite, 
or collateral sprouting of surrounding, uninjured neurites. A classical hallmark of many 
neurodegenerative diseases is the disruption and accumulation of neurofilaments within 
the cell body and axons (reviewed in Liem and Messing 2009).  Models of TBI have 
demonstrated that neurofilament loss and/or compaction are a common consequence of 
injury and neurofilament disruption following injury has severe effects on neuronal 
structure and function (Posmantur et al., 2000). Importantly, however, neurofilament 
proteins may play an important role in axonal regeneration as in animal models where 
robust axonal regeneration occurs, the regenerating axonal sprouts are neurofilament 
rich (Jacobs et al., 1997).  The current Chapter demonstrated that the neurofilaments, 
specifically NF-L are also involved in axonal regeneration in the CNS.   NF-L-/- 
neurites were able to mount a regenerative response, which culminated in sprout like 
structures transversing the injury site, both in vitro and in vivo.  There was no 
significant difference in the mean length of these regenerating neurites, in comparison 
to control.  However, there was a significant reduction in the number of sprouts within 
the injury. Previous investigations have shown that mice lacking NF-L have a reduced 
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ability to regenerate in the PNS (Zhu et al., 1997).   However, this reduced ability to 
regenerate may be a delayed response, as by 2 months post-injury there were similar 
numbers of myelinated axons in the NF-L-/- mice and wildtype controls (Zhu et al., 
1997).  In the current study, 24 hrs PI represents a relatively prolonged time-point in 
vitro, suggesting that the delayed response to injury which has been demonstrated in the 
PNS, may not account for the reduction in regeneration within relatively mature CNS 
neurons.  The demonstrated reduction of sprouts within the injury site could either be a 
result of less injured neurites frankly regenerating, or a decrease in the plasticity of the 
surrounding uninjured neurites (reviewed in Chuckowree et al., 2004).  Utilising both in 
vitro and in vivo models, the current Chapter demonstrated that NF-L deletion resulted 
in a decreased regenerative ability, indicating that regeneration within the mature CNS 
is intrinsically driven (Li et al., 1995; Blackmore and Letourneau 2006). 
 
 A novel interaction between α-internexin and the NF-L binding protein, NDel1 was 
demonstrated within NF-L-/- neurons.  This interaction, in conjunction with 
immunohistochemical evidence, suggests that α-internexin may be forming the 
functional neurofilament triplet protein in the absence of NF-L.  However, while α-
internexin may be compensating for NF-L, the compensatory intermediate filament 
structure present demonstrated an attenuated response to injury both in vitro and in vivo, 
indicating that presence NF-L, and most likely the proper formation of the 
neurofilament triplet protein, is an intrinsic requirement for axonal regeneration and 
plasticity. 
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7 DISCUSSION 
 
Traumatic brain injury remains a leading cause of death and disability in persons under 
the age of 45 years, in developed nations (Adams, 1995; Egeler-Peerdeman, 1993; 
Povlishock, 2005; Maas et al., 2008).  TBI has such an impact primarily due to the 
limitations on repair of the mature CNS following injury. Current research efforts are 
focused upon finding a cure or therapeutic intervention that can overcome the brains’ 
limited capacity to regenerate in order to prevent or correct functional deficits.  
However, strategies for intervention are difficult as the pathobiology of the brain 
following injury involves a complex sequence of events that remains to be fully 
elucidated, which is confounded by individual patient differences (reviewed in 
Lingsman et al., 2010).  Understanding the cellular mechanisms underlying the capacity 
of the damaged brain to attempt repair from injury is, thus, vital for devising effective 
future therapies to treat brain injury. The inability for the brain to repair has been 
commonly attributed to the non-permissive nature of the mature CNS to functional 
neuronal regeneration.  However, removal of this environment does not induce 
spontaneous robust neuronal regeneration (eg Li et al., 1995; Blackmore and 
Letourneau 2006) indicating that the lack of regeneration in the mature CNS is also an 
intrinsic limitation.  This failure to regenerate is restricted to the mature CNS, with both 
the immature CNS and mature PNS demonstrating a robust regenerative capacity 
following injury. 
 
The loss of brain function and the resulting ongoing disability that occurs following TBI 
is ultimately a result of disconnections in the intricate neuronal network of the brain, this 
disconnection being either a result of overt neuron loss or neuron damage, the latter 
particularly affecting the axon.  Ultimately, recovery will therefore require the 
replacement and recovery of the dead and dying cells within the injury, the frank 
regeneration of injured axons and/or compensatory plasticity of intact pathways to 
reinstate the interrupted connections. This thesis addressed these three main pathways for 
adaptation to injury in endeavouring to characterise the response of the mature brain to 
injury, specifically focussing on cell proliferation that occurs as a response to injury, 
axonal injury and the regenerative response and the compensatory plasticity that can 
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occur in the brain following acute injury.  This thesis utilised a range of both in vitro and 
in vivo methodological approaches, focusing on specific neuronal subpopulations within 
the neocortex following injury, to provide novel insight into how the mature mammalian 
brain responds to injury. 
 
Whether brain injury evokes a neurogenic response in the neocortex that contributes to 
functional recovery remains contentious (Kornack and Rakic, 2001; Gould and Gross 
2002; Rakic, 2002; Koketsu et al., 2003).  In the current thesis, data obtained from both 
in vitro and in vivo experiments clearly show that neurogenesis does not occur in 
response to a variety of forms of injury. The lack of neurogenesis could be due to the 
absence of extrinsic signalling pathways (Emsely et al., 2005), for example, due to the 
lack of these factors in in vitro preparations, or the absence of injury extending to 
germinal regions in the in vivo model.  Indeed, other studies involving relatively 
discreet CNS injury also found no evidence of neurogenesis (Holmin et al., 1997; 
Kuroda et al., 2002; Salman et al., 2004).  Hence, the absence of neurogenesis in both in 
vitro and in vivo models investigated may be due to the absence of appropriate micro-
environmental cues, rather than a limit of the endogenous precursors themselves 
(Emsely et al., 2005).  This indicates that while neurogenesis has the potential to play a 
vital role when there is extensive damage and cell death, it may not be an ideal target 
for intervention in forms of TBI that do not induce widespread ipsilateral and 
contralateral injury.  Hence, focal brain injuries may be more dependent upon axonal 
sprouting and extant neuronal remodelling to achieve some degree of functional 
improvement. 
 
Axons are highly vulnerable to TBI due to their unique size, morphology and high 
metabolic activity.  The current study investigated the active response of axons to a 
variety of models of primary injury, both in vivo and in vitro. Acute neocortical injury 
in vivo and both models of axonal injury in vitro clearly demonstrate that the mature 
neurons can survive a traumatic insult and some neurons possess a capacity to attempt 
regeneration following injury. These fine neurites correspond to sprouting axons that 
transverse experimental injury sites, and have been previously documented in both in 
vitro (Chuckowree et al., 2003; Chung et al., 2004) and in vivo (King et al., 2000) 
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models.  Studies presented in this thesis further characterised these sprouts to be axonal 
of origin and no evidence of comparable dendrite spouting was found indicating that 
sprouting in response to injury was axonal specific.  
 
Axonal injury has been shown to involve a specific sequence of alterations, suggestive 
of a stereotypical reaction to injury (King et al., 1997; 2000; 2001; Chen et al., 2003a).  
Studies performed in vitro in the current thesis, included in Chapters 3 and 4, 
demonstrated that this axonal regenerative attempt occurred regardless of the mode of 
primary injury. Thus the axonal regenerative response can be considered a stereotypical 
intrinsic response to injury, which is neuron type-specific and not necessarily dependent 
upon the mode of injury, or severity, supporting previous investigations that have 
demonstrated that while an increase in injury severity increases the response time of 
regenerative sprouts, the ultimate outcome was the same (Levent et al., 2007). 
Additionally, the similarities in the neuronal response after the two different types of 
primary injury in vitro, axonal transection or complete axonal shearing, indicates the 
reproducibility of the response over a range of different models of traumatic injury.    
NF-L-/- studies provided further evidence of the intrinsic nature of the regenerating 
sprouts. Deletion of NF-L resulted in a significant reduction in the sprouting response in 
vitro, indicating that there was a reduction in the intrinsic capacity of axons for 
structural remodelling related to the absence of a normal neurofilamentous network. 
This loss of structural plasticity as a result of NF-L deletion following injury has been 
previously demonstrated following PNS injury (McLean et al., 2005; Toth et al., 2008).  
Thus, this thesis has demonstrated that this intrinsic reduction in regenerative ability 
related to the absence of NF-L also pertains to the CNS.  
 
The limited axonal outgrowth of regenerating neurites in comparison to development 
observed in this thesis may be responsible for the lack of robust CNS axonal extension 
that has been observed in permissive environments (Li et al., 1995; Blackmore and 
Letourneau 2006).  However, while robust axonal regeneration occurs in the PNS, 
misdirection of regenerating axons has been investigated in the PNS and may account 
for the poor functional recovery (eg de Ruiter et al., 2008). This thesis suggests that 
misdirection of regenerative sprouting may not be limited to the PNS.  In this regard, 
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the regenerative axonal sprouts in both in vitro and in vivo models of CNS injury were 
tipped with growth cone-like structures, but these lacked key morphological and 
dynamic characteristics of developing neurites, which indicates an impeded path finding 
ability and/or an inability to appropriately branch, both of which would contribute to a 
poor outcome post-injury.  Furthermore, this thesis demonstrated that regenerative 
sprouts were unresponsive to growth factors, despite the presence of relevant receptors. 
This also supports the proposal that CNS neuronal regeneration lacks intrinsic capacity 
to respond to guidance cues in the same fashion as in initial brain development. In this 
regard, intervening after injury to create a more growth permissive environment would 
still not likely be advantageous if the regenerating axons are not able to respond to 
growth factors and other cues for guiding appropriate synaptogenesis. Thus, a 
potentially more suitable way to induce a robust axonal extension may be to alter the 
intrinsic growth state of a mature injured axon.  
 
Another way neurons can respond to injury and recover following injury is through the 
induction of compensatory morphological or structural plasticity in either the injured 
neurons or surrounding non-injured neurons. Collateral sprouting from uninjured axons 
has been indicated as a potential adaptive response to injury (Deller and Frotscher, 
1997), and may be stimulated due to availability of vacant synaptic territory within the 
injury site (McKinney et al., 1997). Previous investigations have demonstrated that the 
outgrowth of dendrites following injury can be correlated to axonal rearrangement and, 
interestingly, that alterations in dendritic morphology are associated with synaptic 
modifications (reviewed in Macias, 2008).  This thesis demonstrated that not only is the 
axonal sprouting response cell type specific within the cortex, but also that specific 
subpopulations of interneurons have a remarkable capacity for structural dendrite 
remodelling, directed towards the intact cortex. This novel finding may provide further 
powerful insight into how the structural plasticity of the CNS and how this may 
contribute to adaptation to brain injury. Manipulation of the plastic potential of these 
inhibitory neurons around the injury site may provide a novel therapeutic window for 
rewiring the intact connections to establish new pathways for the functional deficits lost 
as a result of TBI. 
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7.1 CONCLUSIONS 
 
The adult brain has a frequently unappreciated capacity for cytoarchitectural remodeling 
and repair following injury.  This thesis provided significant insight into why particular 
forms of regenerative neuronal changes are limited or aberrant, as well as how the 
response may be neuronal subtype-specific in the neocortex.  In summary, the findings 
of the thesis indicate that induction of axonal sprouts into the injury site following 
trauma may not result in a functionally appropriate or desirable outcomes.  Instead the 
compensatory plasticity around the injury site, directed to the uninjured or less damaged 
cortex, may provide a more functionally appropriate therapeutic target for future 
directions. 
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9 APPENDIX 
 
9.1 SOLUTIONS 
 
9.1.1 General solutions 
0.01M PBS, pH 7.4 
100mL  9% NaCl (90g of NaCl (Sigma, USA) per 1L Milli-Q® water) 
40mL  Na2HPO4 (BDH) (28.4g per 1L Milli-Q® water) 
10mL  NaH2PO4.2H2O (Sigma) (31.2g per 1L Milli-Q® water) 
850mL  Milli-Q® water 
 
9.1.2 Cell culture solutions 
0.001% poly-l-lysine 
450mL  sterile 0.01M PBS 
50mL   0.01% poly-l-lysine (Sigma, USA) 
 
10mM HEPES buffer 
1.19g   HEPES (BDH, USA) 
500mL  0.01M PBS 
Combine and heat sterilise 
 
Imaging buffer 
15.5mL 4M NaCl (23.4g per 100mL Milli-Q® water) 
2.5mL  2M KCl (Sigma; 7.46g per 50mL Milli-Q® water) 
50mL  2M CaCl2 (BDH; 14.7g per 50mL Milli-Q® water 
250mL  2M MgCl2 (Sigma; 20.33g per 50mL Milli-Q® water) 
7.5mL  2M Dextrose (D-glucose) (Sigma; 18.02g per 50mL Milli-Q® water) 
6.25mL 2M HEPES (26.03g per 50mL Milli-Q® water) 
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Adjust to pH 7.3 with 2M NaOH, make up to 500mL with Milli-Q® water, filter 
sterilise and store at 4°C. 
 
9.1.3 Immunocytochemistry and immunohistochemistry solutions 
4% Paraformaldehyde (PFA) 
40g  PFA (Sigma, USA) 
40g  Sucrose (Sigma, USA) 
100mL  9% NaCl 
400mL  Na2HPO4 
500mL  NaH2PO4.2H2O 
Heat while stirring in a fume hood. 
 
0.3% Triton/PBS 
600µL  Triton X (Fluka, Switzerland) 
200mL  0.01M PBS 
 
9.1.4 Immunoblotting solutions 
Bis/Acrylamide 
29.2g   acrylamide (Sigma, USA) 
0.8g   N’N’-bis-methylene-acrylamide (Sigma, USA) 
Make up to 100mL with Milli-Q® water, filter through Whatman filter paper and store 
at 4°C, in the dark 
 
1.5M Tris-HCl, pH 8.8 
27.23g  Tris base (Bio-Rad, USA) 
~80mL  Milli-Q® water 
Adjust to pH 8.8 with 10M HCl and make up to 150mL with Milli-Q® water.  Store at 
4°C. 
 
0.5M Tris-HCl, pH 6.8 
6g  Tris base 
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~60mL Milli-Q® water 
Adjust to pH 6.8 with 10M HCl and make up to 100mL with Milli-Q® water.  Store at 
4°C. 
 
10% Sodium Dodecyl Sulfate (SDS) 
10g  SDS (BDH, USA) 
Dissolve in 90mL of Milli-Q® water with gentle stirring and adjust to 100mL with 
Milli-Q®.  Store at room temperature. 
 
5X Running Buffer, pH 8.3 
9g  Tris base 
43.2g  Glycine (Bio-Rad, USA) 
3g  SDS 
Combine and add 600mL of Milli-Q® water.  Store at 4°C.  Prior to use combine 
100mL Running Buffer with 400mL Milli-Q® water. 
 
Transfer Buffer 
3.03g   Tris base 
14.4g   Glycine 
200mL  Methanol (Sigma, USA) 
Combine reagents in a fume cabinet and make up to 1L with 800mL of Milli-Q® water.  
Store at room temperature. 
 
Tris buffered saline (TBS) 
4.84g   Tris base 
58.4g   NaCl 
1.5L   Milli-Q® 
Adjust to pH 7.5 with 10M HCl and make up to 2L with Milli-Q® water. 
 
Tris buffered saline with Tween (TTBS) 
1.1L   TBS 
550uL   Tween-20 (Bio-Rad, USA) 
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TTBS/5%FCS/5% skim milk powder 
100mL  TTBS 
5mL   FCS (Gibco, USA) 
5g   skim milk powder 
Store at 4°C for a limited time. 
 
12% Separating gel 
3.35mL Milli-Q® water 
2.5mL  1.5M Tris-HCl, pH 8.8 
100µL  10% SDS 
4mL  Bis/Acrylamide 
Add quickly immediately prior to pouring 
50µL  10% APS (Bio-Rad, USA) 
5µL  TEMED (Bio-Rad, USA) 
Combine ingredients in the listed order and pour gel immediately.  Allow to polymerise 
for 45 minutes. 
 
7.5% Separating gel 
4.85mL  Milli-Q® water 
2.5mL  1.5M Tris-HCl, pH 8.8 
100µL  10% SDS 
2.5mL  Bis/Acrylamide 
Add quickly immediately prior to pouring 
50µL  10% APS 
5µL  TEMED 
Combine ingredients in the listed order and pour gel immediately.  Allow to polymerise 
for 45 minutes. 
 
4% Stacking gel 
6.1mL  Milli-Q® water 
2.5mL  0.5M Tris-HCl, pH 6.8 
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100µL  10% SDS 
1.33mL Bis/Acrylamide 
50µL  10% APS 
10µL  TEMED 
 
Coomassie stain 
1g  Coomassie blue R-250 (Bio-Rad, USA) 
40mL  methanol, 10% 
10mL  acetic acid (Spectrum, USA) 
 
Coomassie destain 
40mL  methanol, 10% 
10mL  acetic acid 
50mL  Milli-Q® water 
 
2X Sample buffer 
2.5mL  0.5M Tris HCl pH6.8 
2mL  glycerol (Sigma) 
200µL  2-β mercaptoethanol (Serva) 
2mL  10% SDS (in water) 
Make up to 10mL with Milli-Q® water, add a small amount of bromophenol blue, 
aliquot and freeze 
 








Figure 3.1 Cytoskeletal profile of cortical neurons during development and 
regeneration. (A and B) A neuronal aggregate at (A) 5 DIV and (B) a 
transected axon bundle (21 DIV) at 6 hrs PI immunolabelled for both tau 
(green) and MAP-2 (red). Tau was distributed throughout the axon bundles 
(arrow) and growth cones (arrowhead) whereas MAP-2 localisation was more 
restricted (arrow and arrowhead). (C and D) A typical neuronal aggregate (C) at 
5 DIV and (D) a transected axonal bundle at 6hrs PI immunolabelled for both 
ßIII-tubulin (green) and NF-M (red).  ßIII-tubulin was distributed throughout 
axonal bundles (arrows) and extending into growth cones (arrowheads), 
however NF-M was restricted to axonal shafts (arrows). (E and F) Tau 
labelling, co-localised with MAP-2 which was completely absent, of a growth 
cone (E) at 5 DIV and a (F) regenerative sprout at 6 hrs PI demonstrated that 
the growth cones under investigation were axonal of origin.   Scale bar A-D = 
10µm; E, F = 2µm 
 

Figure 3.2 The morphology and cytoskeletal profile of growth cones of 
developing and regenerating axons at 5 DIV and 6 hrs PI.  (A and B) Growth 
cones at (A) 5 DIV and (B) 6 hrs PI immunolabelled for both ßIII-tubulin (green) and 
ERM (red) demonstrated that ßIII-tubulin was confined predominately to the central 
domain of the growth cone, while total ERM was confined to the peripheral region. 
(C and D) Immunolabelling and staining for both tau (green) and F-actin (red) in 
growth cones at (C) 5 DIV and (D) 6 hrs PI indicated a widespread distribution of 
both cytoskeletal components throughout the growth cones. Both cytoskeletal dual-
labelling combinations indicated that the 6 hrs PI growth cones were smaller, simpler 
structures than their developmental counterparts.  Scale bar = 2µm 
 

Figure 3.3 Axonal motility, extension and retraction in development and 
regeneration. (A) X, Y graphs demonstrating growth cone motility in development 
(3, 5, 7 DIV) and regeneration (6, 24 hrs PI). Data points illustrate the position of the 
centre of the growth cone (µm), at two min intervals, over a two hrs imaging period. 
(B) Mean axonal extension in development and regeneration (n=25). (C) Mean 
axonal retraction in development and regeneration (n=25). *p<0.05. Error bars 
represent SEM. 
 

Figure 3.4 Growth cone dynamics in development and regeneration. (A) Live 
imaging of a dynamic growth cone (3 DIV) (arrowheads) over a two hrs time period 
indicating a range of morphological changes. (B) Live imaging of a growth cone (6 
hrs PI) (arrowheads) over a two hrs time period indicating the range of morphological 
changes observed in development were not apparent in the regenerating growth 
cones.  (C) Time-lapse images of an injured immature axon bundle (5 DIV) over a 
one hrs time period indicating no net axonal outgrowth in the immature bundles.  
Scale bar = 10µm, for inset 6.5µm 
 

Figure 3.5 Growth cone dynamics and response to growth factors. (A) The 
distribution of time spent extending, retracting and pausing for each imaging time 
point in development and regeneration (n=25). (B) The effect of BDNF and GDNF 
on developmental neurite outgrowth compared to post-injury regenerative sprouting. 
*p<0.05. Error bars represent SEM.  
 

Figure 3.6 BDNF receptor localisation. (A and B) Immunolabelling with antibodies 
to both neuron specific βIII-tubulin (green) and the BDNF receptor TrkB (red) at (A) 
5 DIV and (B) 21 DIV, indicated a widespread punctate localisation of the 
neurotrophin receptor throughout nerve cell bodies and processes at both ages in 
culture.  Scale bar = 15µm, for inset 5µm 
 

Figure 4.1 DIC and fluorescent immunolabelled images of neurons at 21 DIV.  
(A and B) At 21 DIV neurons formed closely associated cell clusters interconnected 
by axon bundles (arrows). (C) At 6 hrs post-injury neurons were still present as 
clusters, however, all interconnecting neurites had been stripped. (D) By 24 hrs post-
injury many neurons within the cluster had extended processes, tipped with growth 
cone like structures (arrow). (E) Immunolabelling for the axon specific microtubule 
associated protein, tau, at 24 hrs post-injury, revealed numerous axonal sprouts 
emanating from the cell clusters (arrows).  (F) By 7 DPI, single axonal (tau 
immunoreactive) sprouts connected with surrounding cell clusters.   Scale bar: A = 
100µm, B-E = 25 µm 
 

Figure 4.2 Confocal microscopy at 24 hrs post-injury. A subset of the sprouts 
within the cell cluster were immunopositive for calretinin (red, arrowhead), with a 
further larger group of sprouts extending out form the cell cluster that were 
immunoreactive for SM312 (green, arrows). No colocalisation between these markers 
was evident. Scale bar =15µm 
 

Figure 4.3 Confocal microscopy of immunocytochemical labelling for cell-type-
specific proteins and markers of neurogenesis in relatively mature neurons after 
structural injury. (A-C) (A) Labelling for the thymidine analogue, BrdU, (B) in 
combination with a neuronal marker tau, (C) indicated that the structurally injured 
neurons under investigation did not incorporate BrdU (arrow). (D-F) (D) Labelling 
with the neural precursor marker nestin, (E) in conjunction with tau, indicated the 
presence of precursors cells (nestin immunopositive) present after injury, (F) however 
the labelling did not co-localise with tau. (G-I) Colocalisation between (G) nestin and 
(H) GFAP immunolabelling, (arrows, (I)) indicated that the precursor cells present 
within the cell clusters after injury, were of glial origin.  Scale bar: A-C= 15µm, D-I 
= 20µm 
 

Figure 4.4 Tau and MAP-2 expression in cortical neurons at 21 DIV and post-
injury. (A-C) At 21 DIV (A) tau was distributed throughout cell clusters and 
neuronal processes, (B) whereas MAP-2 was confined to cell clusters and processes 
extending for only a short distance (arrows). (D-F) Similarly, at 24hrs post-injury tau 
was distributed throughout cell clusters and (D) newly extending neurites (arrows), 
(E) whereas MAP-2 remained in the cell clusters. (F) Confocal microscopy revealed 
no colocalisation between the two markers in the sprouting neurites. (G-I) High 
power confocal microscopy revealed (G) distinct distal tau immunolabelled axons 
and (H and I) single neurons within the clusters with multiple dendrites expressing 
only MAP-2.  Scale bar: A-C = 50 µm, D-I = 25 µm 
 

Figure 4.5 Growth cone area for developing axons at 3 DIV in comparison to 
regenerative axons at 24 hrs post-injury. (A) The mean growth cone area was 
significantly (*p<0.05) greater in developing neurites at 3 DIV compared to 
regenerative neurites at 24 hrs post-injury. (A) There were no significant differences 
for mean growth cone area on astrocytes in comparison to poly-L-lysine for 
developing and regenerating growth cones. (B and C) Regenerating neurons (24 hrs 
post-injury), (C) when plated on to a monolayer of astrocytes, induced an increase in 
the fluorescence intensity of GFAP labelling and an alteration in astrocyte 
morphology, (B) in comparison to an astrocyte monolayer without injured neurons or 
developing neurons. Scale bar = 20µm 
 

Figure 4.6 Immunocytochemical profile of growth cones of developing and 
regenerating axons at 3 DIV and 24 hrs post-injury. (A-F) Growth cones at 3 DIV 
were large and showed extensive labelling (A and C, green) for tau and  (D and F, 
green) staining for F-actin, using phalloidin that was concentrated in the central 
domain (arrow) of the growth cone but crossed into the peripheral domain 
(arrowhead). At 24 hrs post-injury the growth cones were smaller and (G,I, green) the 
tau and (J,L, green) F-actin expression was concentrated in the central domain 
(arrow), with no peripheral domain labelling evident. (B,C and H,I, red) Alpha-
acetylated tubulin was confined predominately to the central domain of the growth 
cone and neurite shaft in both (B,C) developmental and (H,I) regenerative growth 
cones. (E,F and K,L, red) Similarly, GAP-43 expression was concentrated in the 
growth cones central domains in both (E,F) development at 3 DIV and (K,L) 24 hrs 
post-injury (arrows).  Scale bar = 5 µm 
 

Figure 4.7 Growth cone dynamics in development and attempted regeneration. 
(A) An example of live imaging of a dynamic growth cone (arrow) (24 hrs PI) at 20 
min intervals for two hrs. (B) The distribution of time growth cones spent extending, 
retracting and pausing (assessed every min for 120 mins) in development and at 24 
hrs post-injury (n=30). Growth cones on the tips of regenerating axons spent 
significantly (p<0.05) more time extending and less time pausing then developing 
growth cones at 3, 5 and 7 DIV.  Scale bar = 10µm, for inset 6.5 µm  
 

Figure 5.1 Immunofluorescent, light and transmission electron microscopy 
following focal brain injury. (A and F) Resin sections cut in the horizontal plain 
from the control non-injured cortex showed that the neuropil of the somatosensory 
cortex of the right hemisphere was dense unbroken structure comprising of cell 
bodies and their processes and blood vessels. (B and G) At 1 DPI a discreet, circular 
injury site was clearly visible in the horizontal sections. (G) The injury site was filled 
with red blood cells indicating there had been bleeding within the injury site. (C) By 
7 DPI the injury site (arrow) had dramatically increased in size.  (H) The red blood 
cells had cleared and the injury site was populated with cells (arrowheads) and 
processes, the area innervated with new blood vessels (arrows).  (D) The injury site at 
14 DPI remained large in comparison to that at 1 DPI and had become more densely 
infiltrated with cells and their processes, in comparison to 7 DPI.  (I) At 14 DPI blood 
vessels permeated the injury tract (arrows). (E) TEM analysis at 7 and 14 DPI 
demonstrated that the injury site was infiltrated with activated microglia with 
prominent inclusion bodies (arrow). (J) Proliferating cells (arrow denotes a dividing 
nuclei) were also present within the lesion site at 7 DPI.  (K) Immunofluorescent 
labelling of horizontal sections with an antibody to GFAP demonstrated minimal 
expression in the uninjured brain.  (L) There was little GFAP immunoreactivity 
around the injury site at 1 DPI.  (M) At 7 DPI there was a localised increased 
expression of GFAP around the injury site. (N) By 14 DPI there was substantial 
GFAP reactivity around the injury site that extended to 500µm away from the injury.  
(O) Coronal sections labeled with GFAP demonstrated that by 14 DPI a dense glial 
scar had formed within the injury tract. Scale bar: A-D = 250µm, F-I = 100µm, E and 
J = 2µm, K- N = 150µm, O = 500µm, asterisk in L-N denotes injury site 
 

Figure 5.2 Immunofluorescence labelling for nestin within the cortex at 7 DPI. 
Nestin immunoreactive cells were not evident in the grey matter of the neocortex of 
control non-injured brains (A), but by 7 DPI, were abundant within the lesioned 
tissue (B). Nestin immunoreactive profiles were present in tissue extending from the 
SVZ and corpus callosum up to the injury site (C). Double immunofluorescence 
labelling for BrdU, administered at 1 DPI, (D) and nestin (E) demonstrated 
localisation of these markers to the same cells within peri lesion tissue. Double 
labelling for PCNA (F) relative to nestin (G) confirmed the proliferation of nestin-
labelled cells within the SVZ.   Scale bar: A and B = 100µm, C = 800µm, D-G = 
50µm 
 

Figure 5.3 Double immunofluorescence labelling for BrdU and nestin (green) 
relative to astrocyte, microglial/macrophage and neuronal markers (red) in 
cortical peri lesion tissue at 7 DPI. Numerous GFAP labelled cells also contained 
BrdU immunoreactive nuclei (A), indicating that a proportion of the reactive 
astrocyte population proliferates in response to injury. Nestin labelling exclusively 
co-localised with GFAP (B) within the peri lesion tissue. Ferritin immunopositive 
microglia/macrophages were also mitotically active following injury, with a number 
of cells double labelling with BrdU (C).  Nestin labelling was not present within the 
ferritin positive microglia/macrophages (D).  Colocalisation with BrdU or nestin was 
not observed for any of the neuronal markers including NF-M, (E and F, double 
labeled for BrdU and nestin, respectively), α-internexin (G and H, double labeled for 
BrdU and nestin, respectively), calretinin (I and J, double labeled for BrdU and 
nestin, respectively) and parvalbumin (K and L, double labeled for BrdU and nestin 
respectively). Scale bar = 50µm 
 

Figure 5.4 Immunofluorescent microscopy and confocal microscopy on 
horizontal sections at 7 DPI. (A, C) Immunolabelling with the pyramidal neuron 
markers (A) SMI312 and (C) α-internexin showed an increased immunoreactivity 
around the injury site. (B, D) High power confocal images demonstrated that fine 
sprouts (arrows), (immunopositive for (B) SMI312 and (D) α-internexin, were 
transversing the injury site. However, neurons immunopositive for the interneuronal 
marker calretinin did not demonstrate the same response. (E and F) Immunolabelling 
for calretinin was confined to the intact tissue.  (F) Furthermore high power confocal 
images confirmed no sprouting response present beyond the lesion edge. Scale bar: 
A, C, E = 200µm, B, D, F = 50µm, dotted line denotes edge injury site 
 
 

Figure 5.5 Confocal images for calretinin immunolabelling and GFP localisation 
at 14 DPI.  (A and B) Confocal images for (A) calretinin and (B) GFP horizontal 
sections at 14 DPI demonstrated that the injury site had filled, forming a dense tissue 
core. (C) Horizontally projecting dendrites (arrows) of calretinin labelled 
interneurons can be clearly visualised around the injury site in sham inured control 
sections. (A) At 14 DPI the horizontally projecting dendrites of calretinin labeled 
interneurons had realigned around the injury site (arrows), as demonstrated with 
confocal microscopy. (B, D) Comparison between GFP localisation at (B) 14 DPI and 
(D) control sham injured section revealed no detectable differences.  Scale bar = 
150µm, dotted line denotes edge of injury site 
 

Figure 5.6 Quantitation of horizontally projecting neurites of calretinin-
immunolabelled cells at 14 DPI.  Horizontally projecting dendrites were visualised 
using flattened z-stacks. (A and B), illustrate representative flattened z-stacks for 
calretinin immunolabelled neurons in (A) control sham-injured and (B) injured 
horizontal sections. (C and D) Plot distribution for (C) the control sham-injured and 
(D) injured populations in relation to the distance of the cell from the injury site 
further demonstrated (D) the distinct shift in dendrite angle bias of the injured 
neurons, with a trend for this bias to be increased away from the injury site, however 
linear regression demonstrated that this trend was not significant (p=0.05). (E) The 
mean of dendrite angle bias for each cell was significantly (p<0.01) decreased at 14 
DPI in comparison to control. (F) The quantitation of the mean neurite length of 
primary secondary and tertiary branches at 14 DPI and in sham injured control 
revealed no significant differences between 14 DPI and control. Error bars denote 
SEM. 
 

Figure 5.7 Polarity quantitation of horizontally projecting neurites of calretinin-
immunolabelled cells, at 14 DPI. (A and B inset) A template comprised of four 
quadrants was layered over each neuron under investigation and the quadrant in 
which each dendrite intersected the 80µm line (B, arrow) recorded.  (C) The 
quantitation of dendrite orientation at 14 days post injury demonstrated a significant 
(p<0.01) difference in number of dendrites in the distal quadrant away from the injury 
site, in comparison to dendrites on neurons in control sham-injured tissue. Error bars 
denote SEM.  Scale bar = 200µm, 100µm for inset 
 

Figure 5.8 Horizontally projecting neurites of GFP expressing pyramidal cells 
underwent no significant change in dendrite orientation or mean length, at 14 
DPI. Horizontally projecting dendrites were visualized using flattened z-stacks. A 
and B, illustrate representative flattened z-stacks for GFP expressing neurons in (A) 
control sham-injured and (B) injured horizontal sections. (C and D) Plot distribution 
for the (C) control populations and (D) injured populations in relation to the distance 
from the injury site further demonstrated no distinct shift in dendrite angle bias of the 
injured neurons. (E) There was no significant difference in the mean dendrite angle 
bias between 14 DPI and sham injured control for this subpopulation of neurons. (F) 
The quantitation of the mean neurite length of primary secondary and tertiary 
branches at 14 DPI and sham injured control revealed no significant differences 
between 14 DPI and control. Error bars denote SEM. 
 

Figure 6.1 Immunocytochemistry of mouse cortical neurons in vitro. 
Immmunocytochemistry was performed to investigate the maturation of neurons 
derived from wild type mice.  (A) Immunocytochemistry at 7 DIV demonstrated 
neurons were polarised with MAP-2 positive dendrites (red) and a single tau 
immunopositive axon (green). (B) At 15 DIV tau (green) was abundant in axonal 
processes and MAP-2 (red) immunoreactivity was increased within dendrites. (C) 
GAP-43 (red) was enriched in cell bodies, axons, dendrites and growth cones (inset) 
at 7 DIV.  (D) By 15 DIV there was minimal immunoreactivity for GAP-43 within 
the cortical neurons.  (E) At 7 DIV colocalisation of βIII tubulin (red) and the 
synaptic vesicle marker synaptophysin (green) indicated that βIII tubulin was present 
throughout cell bodies and processes while synaptophysin (green) was confined to 
dendritic shafts (inset). (F) By 15 DIV synaptophysin was located in punctate 
positions lateral to the dendrite shaft (inset), indicating that mature synapses were 
present. Scale bar = 50µm, for inset 20µm 
 

Figure 6.2 Immunocytochemistry of wildtype and NF-L-/- cortical neurons at 3 
DIV. To visualise individual neuronal characteristics, both wildtype and NF-L-/- 
dissociated neurons were grown as a monolayer on a poly-L-lysin substrate.  (A and 
B) DIC images demonstrated that (A) wildtype and (B) NF-L-/- cortical cultures 
adhered to the substrate and had extended neurites by 3 DIV, with no distinguishable 
differences between the two conditions.  (A and B inset) These neurites were tipped 
with characteristic growth cones. (C and D) Immunolabelling for the microtubules 
associated proteins tau (green) and MAP-2 (red), demonstrated that both (C) wildtype 
and (D) NF-L-/- neurons had developed polarised neurites, with clearly defined 
dendrites (red) and a single axon (green) at 3 DIV. Scale bar = 50µm, for inset 20µm 
 

Figure 6.3 Wildtype and NF-L-/- neurons’ expression of MAP-2 and Tau at 15 
DIV. The immunoreactivity profile of 15 DIV NF-L-/- neurons was compared to 
wildtype controls.  (A) Immunohistochemistry of the antibody direct at NF-L 
demonstrated that there was NF-L present in wildtype neurons throughout the cell 
bodies and processes.  (B) There was no immunoreactivity for NF-L and the NF-L-/- 
neurons. (C and D) Immunolabelling for the microtubules associated proteins Tau 
(green) and MAP-2 (red), demonstrated that by 15 DIV in both (C) wildtype and (D) 
NF-L-/- neurons tau abundant in axonal processes and MAP-2 (red) 
immunoreactivity was present throughout all dendrites. Scale bar = 40µm 
 

Figure 6.4 Immunolabelling of α-internexin and NF-M and 7 DIV in wildtype 
and NF-L-/- neurons.  The immunoreactivity profile of developing NF-L-/- neurons 
was compared to wildtype controls.  (A and B) Alpha internexin labelling at 7 DIV in 
(A) wildtype and (B) NF-L-/- neurons was predominately confined to neurite 
processes, with an increase in immunoreactivity for (B) NF-L-/- in comparison to (A) 
wildtype.  (C and D) NF-M labelling at 7 DIV in (C) wildtype and (D) NF-L-/- 
neurons was also confined to neurite processes, however immunoreactivity was 
decreased for NF-L-/-.  (E and F) Colocalisation investigations of α-internexin (red) 
and NF-M (green) in both (E) wildtype and (F) NF-L-/- neurons demonstrated that 
there were axons which were immunopositive for exclusively α-internexin (red) or 
NF-M (green) (arrows) as well as axons in which α-internexin and NF-M were co-
localised (arrowheads). Scale bar = A-D, 50µm, E&F, 20µm 
 

Figure 6.5 NF-M and α-internexin immunohistochemistry at 15 DIV in wildtype 
and NF-L-/- neurons. (A) Colocalisation investigations of α-internexin (red) and 
NF-M (green) in wildtype neurons at 15 DIV demonstrated that wildtype axons 
demonstrated a distinct expression of NF-M (green) or α-internexin (red) (arrows), 
with no colocalisation. (B) 15 DIV NF-L-/- axons demonstrate complete 
colocalisation of NF-M (green) and α-internexin (red)(arrowheads). (C) Immunoblot 
analysis of 15 DIV cortical neurons demonstrated that in comparison to wildtype, 
NF-L-/- neurons had a relatively decreased expression of NF-M (120 Kd) and 
increased expression of α-internexin (66kd). (D) Colocalisation 
immunohistochemistry within coronal brain sections, in the wildtype cortex also 
demonstrated that axons were immunopositive for exclusively α-internexin (red) or 
NF-M (green) within the neocortex (arrows).  (E) NF-L-/- axons within the neocortex 
demonstrated a colocalisation of α-internexin (red) and NF-M (green) (arrowheads).  
Scale bar = 20µm 
 

Figure 6.6 Immunohistochemistry of interneuronal markers within the wildtype 
and NF-L-/- neocortex. (A) Labelling for MAP-2 in the wildtype neocortex 
demonstrated widespread immunoreactivity throughout the cortical layers, with a 
marginal decrease in immunoreactivity corresponding to layer IV.  (B) There was 
also widespread immunoreactivity to MAP-2 within the NF-L-/- neocortex. (C and D) 
Immunolabelling for calretinin was throughout the cortical layers within both the (C) 
wildtype and (D) NF-L-/- neocortex, with an increase in density of calretinin positive 
cells corresponding to layer IV of the neocortex.  Furthermore, there was very little 
immunoreactivity within layer I in both (C) wildtype and (D) NF-L-/- neocortex.  (E 
and F) Parvalbumin expression was throughout the neocortex of (E) wildtype and (F) 
NF-L-/- mice, with a defined increase in immunoreactivity corresponding to layer V. 
Scale bar =100µm 
 

Figure 6.7 Immunohistochemistry of neurofilament markers within the wildtype 
and NF-L-/- neocortex.  (A) Immunohistochemistry on coronal sections 
demonstrated that SMI312 immunoreactivity was predominately confined to layer V 
and to a lesser extent layer III of the neocortex. (B) There was a reduced 
immunoreactivity for SMI312 within the NF-L-/- neocortex with no discernible 
cortical layers. (C and D) Additionally NF-M labelling was predominately confined 
to layers III and V within the (C) wildtype neocortex,  (D) with no laminar expression 
present within the NF-L-/- neocortex. (E) Alpha internexin immunoreactivity was 
predominately confined to layers III and V of the wildtype neocortex. (F) 
Immunoreactivity for α-internexin was increased within the NF-L-/- neocortex 
compared to wildtype however the cortical layers were not distinguishable.  
Scale bar =100µm 
 

Figure 6.8 NDel1 immunoreactivity in mature NF-L-/- neurons and 
coimmunoprecipitation with α-internexin.  (A-D) Immunolabelling with an 
antibody direct at NDel1 demonstrated immunoreactivity both in vitro and in vivo, in 
mature NF-L-/- neurons.  (A and B) NDel1 immunolabelling was present throughout 
cell bodies and axons at 15 DIV in both (A) wildtype and (B) NF-L-/- neurons.  (C 
and D) In vivo brain sections demonstrated immunoreactivity within axon segments 
in both (C) wildtype and (D) NF-L-/- brains. (E) An immunoblot of 
immunoprecipitation with the polyclonal α-internexin antibody demonstrated that 
NDel1 coimmunoprecipitated with α-internexin exclusively in NF-L-/- neurons at 15 
DIV.  Both wildtype and NF-L-/- neurons precipitated α-internexin when probed with 
a polyclonal α-internexin antibody (column 1 and 2 or the first row respectively).  
However, only the NF-L-/- sample precipitated with α-internexin 
coimmunoprecipitated NDel1 on an immunoblot (column 2 row 2).  Both control 
samples (no antibody control and a control resin, column 3 and 4 respectively) did no 
produce any detectable bands for either α-internexin or NDel1. Scale bar =50µm 
 

Figure 6.9 Time course of GFAP immunoreactivity following focal neocortical 
injury. (A and B) GFAP immunoreactivity within non-injured wildtype (A) and NF-
L-/- (B) neocortex demonstrated an increase in GFAP immunopositive astrocytes 
within the neocortex of NF-L-/- mice (arrows).   (C and D) At 4 DPI there was an 
increase in immunoreactivity for GFAP within the injury site in both (C) wildtype 
and (D) NF-L-/- neocortices. (E and F) By 7 DPI there was a localised increased 
expression of GFAP around the injury site within both (E) wildtype and (F) NF-L-/- 
neocortices.  (G and H, wildtype and NF-L-/- respectively) Immunoreactivity was 
confined to a discreet central core by 14 DPI, demonstrating that an astrocyte 
infiltrated glial scar had formed. Scale bar =100µm 
 

Figure 6.10 Immunofluorescent labeling a 4 DPI.  (A and B) 
Coimmunohistochemistry for GFAP (green) and a combination of SMI312 and 
SMI32 (red) demonstrated that fine sprout like structures were transversing the injury 
site at 4 DPI (arrows) in both the (A) wildtype and (B) NF-L-/- injury site. Scale bar 
=30µm 
 

Figure 6.11 Quantitation of the number and mean length of NF-L-/- sprouts 
within the injury site in vitro.  The sprouting response was investigated at 24 hrs 
post injury in relatively mature (15 DIV) neurons in vitro. (A) Tau labelling of 
wildtype neurons at 24 hrs PI demonstrated that fine sprouts were transversing the 
injury site, tipped with characteristic growth cones (arrows).  (B) Tau positive 
regenerative sprouts, tipped with growth cones (arrows), were also present within the 
injury site of NF-L-/- cortical neurons.  (C) There was no significant difference 
between the mean sprout lengths for NF-L-/- regenerating sprouts in comparison to 
wildtype control.  (D) However there was a significant reduction in the mean number 
of spouts, within each injury site, in NF-L-/ neurons in comparison to wildtype 
control. Scale bar =20µm 
 
